category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology
GO:0005488,5.486112684609773e-86,1,984,14904,binding,MF
GO:0003674,2.0813260376389436e-85,1,1068,17267,molecular_function,MF
GO:0005622,8.986948450782954e-80,1,958,14622,intracellular,CC
GO:0044424,6.545969692529529e-79,1,956,14612,intracellular part,CC
GO:0008150,1.8440600362853693e-76,1,1062,17874,biological_process,BP
GO:0005737,1.8816744710632757e-74,1,819,11401,cytoplasm,CC
GO:0044464,1.3071710704109342e-69,1,1023,16770,cell part,CC
GO:0005575,1.3373019736341933e-69,1,1083,18853,cellular_component,CC
GO:0005515,2.0422717022183472e-69,1,818,11611,protein binding,MF
GO:0009987,4.529260448245669e-69,1,995,16356,cellular process,BP
GO:0005623,5.489043493828609e-69,1,1024,16837,cell,CC
GO:0043226,1.142938368951874e-65,1,891,13675,organelle,CC
GO:0044444,3.0925379383104697e-62,1,705,9556,cytoplasmic part,CC
GO:0044446,5.1459957465022975e-61,1,688,9455,intracellular organelle part,CC
GO:0043229,6.717059932006926e-61,1,846,12865,intracellular organelle,CC
GO:0044422,1.5781517689545707e-60,1,702,9755,organelle part,CC
GO:0043227,6.507919421975106e-60,1,834,12663,membrane-bounded organelle,CC
GO:0043231,5.403712517651988e-54,1,753,11174,intracellular membrane-bounded organelle,CC
GO:0065007,2.8451393238737576e-48,1,797,12454,biological regulation,BP
GO:0071840,5.938114775383639e-46,1,511,6533,cellular component organization or biogenesis,BP
GO:0005829,2.0737671053683417e-45,1,423,4979,cytosol,CC
GO:0050789,1.7803286195477773e-44,1,756,11774,regulation of biological process,BP
GO:0016043,1.6448867936785198e-43,1,495,6349,cellular component organization,BP
GO:0031974,1.7415016909323715e-42,1,439,5585,membrane-enclosed lumen,CC
GO:0043233,1.7415016909323715e-42,1,439,5585,organelle lumen,CC
GO:0070013,1.7415016909323715e-42,1,439,5585,intracellular organelle lumen,CC
GO:0044237,1.2959534953668104e-41,1,711,11021,cellular metabolic process,BP
GO:0008152,1.2336091776654477e-40,1,747,12108,metabolic process,BP
GO:0071704,1.9717259906693856e-40,1,726,11652,organic substance metabolic process,BP
GO:0044238,6.683277213350928e-40,1,701,10906,primary metabolic process,BP
GO:0097159,1.9519740133043728e-39,1,471,6183,organic cyclic compound binding,MF
GO:1901363,2.3845317110017772e-39,1,466,6096,heterocyclic compound binding,MF
GO:0005634,1.1450405820602354e-37,1,539,7675,nucleus,CC
GO:0031981,1.3946946858702116e-37,1,362,4441,nuclear lumen,CC
GO:0006807,4.604959565021489e-37,1,670,10430,nitrogen compound metabolic process,BP
GO:0050794,1.1328796000486012e-36,1,695,10751,regulation of cellular process,BP
GO:0043232,1.4051321207395307e-36,1,364,4523,intracellular non-membrane-bounded organelle,CC
GO:0043228,2.244308930744566e-36,1,364,4532,non-membrane-bounded organelle,CC
GO:0044428,2.4421189788589125e-36,1,381,4832,nuclear part,CC
GO:0050896,2.1536739881338483e-35,1,604,8945,response to stimulus,BP
GO:0043170,3.0227120097623676e-33,1,631,10092,macromolecule metabolic process,BP
GO:0044260,5.798596345977335e-31,1,556,8259,cellular macromolecule metabolic process,BP
GO:0051716,6.480080782590664e-31,1,514,7413,cellular response to stimulus,BP
GO:0005654,1.4844252802925486e-30,1,299,3497,nucleoplasm,CC
GO:0003723,6.788572358953465e-30,1,184,1871,RNA binding,MF
GO:0006950,1.3914181849282456e-29,1,320,3946,response to stress,BP
GO:0006996,2.1397000946462635e-29,1,315,3841,organelle organization,BP
GO:0032991,1.202147293313772e-28,1,400,5711,protein-containing complex,CC
GO:0048518,1.3425440251461195e-28,1,436,6062,positive regulation of biological process,BP
GO:1901564,6.914337267770727e-28,1,472,6867,organonitrogen compound metabolic process,BP
GO:0010033,2.4837168435098646e-27,1,275,3250,response to organic substance,BP
GO:0043167,4.853314244885511e-27,1,442,6155,ion binding,MF
GO:0048522,6.644804065321132e-27,1,393,5357,positive regulation of cellular process,BP
GO:0031982,1.4133074314519384e-26,1,304,3803,vesicle,CC
GO:0051179,2.2915808308676613e-26,1,453,6561,localization,BP
GO:0016020,3.286201291948508e-26,1,587,9115,membrane,CC
GO:0051128,5.623264572041213e-26,1,225,2480,regulation of cellular component organization,BP
GO:0034641,7.44921126959458e-26,1,459,6904,cellular nitrogen compound metabolic process,BP
GO:0003676,3.558017716455164e-25,1,319,4222,nucleic acid binding,MF
GO:0019222,4.850703905623593e-25,1,466,7104,regulation of metabolic process,BP
GO:0048519,2.3912703323069647e-24,1,391,5747,negative regulation of biological process,BP
GO:1901360,4.908327097343488e-24,1,439,6595,organic cyclic compound metabolic process,BP
GO:0006139,7.875288633376655e-24,1,416,6167,nucleobase-containing compound metabolic process,BP
GO:0006810,1.81275509818123e-23,1,364,5041,transport,BP
GO:0006725,2.3279170386767176e-23,1,425,6371,cellular aromatic compound metabolic process,BP
GO:0023052,3.153252104756712e-23,1,439,6429,signaling,BP
GO:0019538,4.21194136340415e-23,1,402,5834,protein metabolic process,BP
GO:0007154,7.184945593276872e-23,1,439,6456,cell communication,BP
GO:0032502,7.50636235704482e-23,1,428,6258,developmental process,BP
GO:0043230,1.04940101205441e-22,1,192,2135,extracellular organelle,CC
GO:0051234,1.0623895518691607e-22,1,368,5165,establishment of localization,BP
GO:0010646,1.1744829713323802e-22,1,278,3514,regulation of cell communication,BP
GO:0046483,1.2398257713985048e-22,1,420,6326,heterocycle metabolic process,BP
GO:0048583,1.721322269802548e-22,1,314,4181,regulation of response to stimulus,BP
GO:0023051,4.22123286653782e-22,1,279,3563,regulation of signaling,BP
GO:1903561,4.460308699831867e-22,1,190,2130,extracellular vesicle,CC
GO:0070062,7.412539578877069e-22,1,188,2107,extracellular exosome,CC
GO:0080090,1.0586391756070141e-21,1,415,6097,regulation of primary metabolic process,BP
GO:0044267,1.0987252321635619e-21,1,365,5230,cellular protein metabolic process,BP
GO:0031323,1.3433307379970008e-21,1,421,6228,regulation of cellular metabolic process,BP
GO:0048856,1.3981353186413866e-21,1,402,5844,anatomical structure development,BP
GO:0048523,1.451989433303124e-21,1,344,4831,negative regulation of cellular process,BP
GO:0048731,2.0435749542599448e-21,1,345,4784,system development,BP
GO:0044085,2.3253730850247822e-21,1,258,3274,cellular component biogenesis,BP
GO:0060255,2.7532238478078344e-21,1,426,6593,regulation of macromolecule metabolic process,BP
GO:0090304,6.207327851118743e-21,1,372,5512,nucleic acid metabolic process,BP
GO:0036094,6.247666037901441e-21,1,214,2481,small molecule binding,MF
GO:0000166,7.205052664024588e-21,1,191,2107,nucleotide binding,MF
GO:1901265,7.550665509393734e-21,1,191,2108,nucleoside phosphate binding,MF
GO:0044421,8.943348032773121e-21,1,264,3555,extracellular region part,CC
GO:0071310,1.3703551954357305e-20,1,221,2671,cellular response to organic substance,BP
GO:0003824,1.3922033886396877e-20,1,388,5656,catalytic activity,MF
GO:1901575,1.900434345451536e-20,1,190,2168,organic substance catabolic process,BP
GO:0043168,2.098034879723879e-20,1,229,2749,anion binding,MF
GO:0007165,2.4086798563786196e-20,1,403,5964,signal transduction,BP
GO:0002376,2.6131262721066618e-20,1,233,2893,immune system process,BP
GO:0007275,3.008175470275526e-20,1,371,5350,multicellular organism development,BP
GO:0009058,3.669243103032521e-20,1,416,6259,biosynthetic process,BP
GO:0051171,3.763117697074123e-20,1,400,5926,regulation of nitrogen compound metabolic process,BP
GO:0005615,4.1081572928759754e-20,1,250,3355,extracellular space,CC
GO:0044271,5.602675241233485e-20,1,347,4953,cellular nitrogen compound biosynthetic process,BP
GO:1901576,6.872229955837655e-20,1,411,6182,organic substance biosynthetic process,BP
GO:0012505,7.482637963323883e-20,1,318,4399,endomembrane system,CC
GO:0044249,7.550397743550971e-20,1,406,6090,cellular biosynthetic process,BP
GO:0065008,1.7989868473582568e-19,1,296,4023,regulation of biological quality,BP
GO:0033554,1.8757846192593417e-19,1,180,2055,cellular response to stress,BP
GO:0051239,4.244347936851301e-19,1,247,3213,regulation of multicellular organismal process,BP
GO:0042221,4.48813298723974e-19,1,331,4716,response to chemical,BP
GO:0048869,7.225688475960914e-19,1,311,4305,cellular developmental process,BP
GO:0070887,7.891759246090718e-19,1,248,3240,cellular response to chemical stimulus,BP
GO:0051704,8.582035212688954e-19,1,208,2552,multi-organism process,BP
GO:0097367,8.93892770965936e-19,1,191,2200,carbohydrate derivative binding,MF
GO:0009056,1.0557366195677568e-18,1,211,2607,catabolic process,BP
GO:0009893,1.5851338052768266e-18,1,269,3589,positive regulation of metabolic process,BP
GO:0033036,3.900874260864118e-18,1,237,3096,macromolecule localization,BP
GO:0032501,4.04801566251683e-18,1,475,7562,multicellular organismal process,BP
GO:0030154,4.318546994028935e-18,1,298,4113,cell differentiation,BP
GO:0009057,5.5773889220668835e-18,1,134,1390,macromolecule catabolic process,BP
GO:0022607,9.7925315714119e-18,1,233,3036,cellular component assembly,BP
GO:0009966,9.862698275425582e-18,1,240,3144,regulation of signal transduction,BP
GO:0010604,1.3388311337653818e-17,1,251,3319,positive regulation of macromolecule metabolic process,BP
GO:0010467,2.333609108561344e-17,1,380,6236,gene expression,BP
GO:0016070,2.3629740117224868e-17,1,331,4989,RNA metabolic process,BP
GO:0035556,2.48319848542512e-17,1,227,2928,intracellular signal transduction,BP
GO:0006952,2.973895669719573e-17,1,148,1656,defense response,BP
GO:0005576,3.109346500481232e-17,1,295,4356,extracellular region,CC
GO:0044403,3.3648640455572375e-17,1,97,880,symbiont process,BP
GO:0034097,6.022893951070014e-17,1,118,1182,response to cytokine,BP
GO:0050793,6.488863020066248e-17,1,208,2660,regulation of developmental process,BP
GO:0006955,9.870270825050018e-17,1,168,1990,immune response,BP
GO:0031325,1.2783141481401514e-16,1,246,3287,positive regulation of cellular metabolic process,BP
GO:0016032,1.551933397950723e-16,1,92,829,viral process,BP
GO:0035639,2.20164652556881e-16,1,159,1796,purine ribonucleoside triphosphate binding,MF
GO:0044419,2.5577477015121294e-16,1,98,928,interspecies interaction between organisms,BP
GO:0051246,2.825232465220206e-16,1,216,2849,regulation of protein metabolic process,BP
GO:0065009,2.918522101810775e-16,1,225,2963,regulation of molecular function,BP
GO:0065003,3.921537878905423e-16,1,160,1900,protein-containing complex assembly,BP
GO:0051173,3.932965025185086e-16,1,237,3157,positive regulation of nitrogen compound metabolic process,BP
GO:0034645,4.861157320377258e-16,1,329,4891,cellular macromolecule biosynthetic process,BP
GO:0051649,6.1567389494025285e-16,1,180,2226,establishment of localization in cell,BP
GO:0042802,6.184079251317825e-16,1,150,1715,identical protein binding,MF
GO:0016192,8.421999647806918e-16,1,167,1996,vesicle-mediated transport,BP
GO:0034341,9.112288907327798e-16,1,38,181,response to interferon-gamma,BP
GO:0032553,1.1480926614262195e-15,1,162,1877,ribonucleotide binding,MF
GO:0044265,1.4140122818004382e-15,1,112,1156,cellular macromolecule catabolic process,BP
GO:0007166,1.6577855466501352e-15,1,220,2906,cell surface receptor signaling pathway,BP
GO:0043933,1.879825751342129e-15,1,177,2218,protein-containing complex subunit organization,BP
GO:0010468,2.0227498677234098e-15,1,316,4942,regulation of gene expression,BP
GO:0017076,2.1579256358754064e-15,1,161,1874,purine nucleotide binding,MF
GO:0032555,2.5026517470959346e-15,1,160,1861,purine ribonucleotide binding,MF
GO:0044248,2.5874004541979806e-15,1,183,2316,cellular catabolic process,BP
GO:0051641,2.801455712424024e-15,1,217,2905,cellular localization,BP
GO:0032879,2.9096543970937775e-15,1,211,2812,regulation of localization,BP
GO:0009653,3.1198365471748292e-15,1,207,2708,anatomical structure morphogenesis,BP
GO:0009059,4.09832637447849e-15,1,333,5044,macromolecule biosynthetic process,BP
GO:0009605,4.1045148986408866e-15,1,188,2405,response to external stimulus,BP
GO:0048513,5.517423968102269e-15,1,250,3463,animal organ development,BP
GO:0044093,6.062711873831793e-15,1,151,1763,positive regulation of molecular function,BP
GO:0019899,7.520706191401896e-15,1,177,2206,enzyme binding,MF
GO:1901362,1.0008715139422373e-14,1,302,4436,organic cyclic compound biosynthetic process,BP
GO:0034654,1.2757072863476197e-14,1,290,4214,nucleobase-containing compound biosynthetic process,BP
GO:1901700,1.6488414294918438e-14,1,140,1622,response to oxygen-containing compound,BP
GO:0045087,1.6538873440575852e-14,1,93,910,innate immune response,BP
GO:0009892,1.916699076763462e-14,1,229,3451,negative regulation of metabolic process,BP
GO:0019438,1.9998817446737123e-14,1,293,4287,aromatic compound biosynthetic process,BP
GO:0018130,2.6279220732541125e-14,1,292,4277,heterocycle biosynthetic process,BP
GO:2000026,3.2823464115670896e-14,1,168,2126,regulation of multicellular organismal development,BP
GO:0005856,3.3916530543063606e-14,1,169,2092,cytoskeleton,CC
GO:0008219,3.441634120744749e-14,1,175,2232,cell death,BP
GO:0034655,4.400687822362492e-14,1,73,647,nucleobase-containing compound catabolic process,BP
GO:0009889,4.4550746722619474e-14,1,292,4339,regulation of biosynthetic process,BP
GO:0051707,4.958248316334469e-14,1,94,941,response to other organism,BP
GO:0046907,5.1270869424278046e-14,1,150,1833,intracellular transport,BP
GO:0043207,5.591546534155979e-14,1,94,943,response to external biotic stimulus,BP
GO:0010605,5.749286145721246e-14,1,214,3216,negative regulation of macromolecule metabolic process,BP
GO:0005730,6.616837929462995e-14,1,105,1293,nucleolus,CC
GO:0071345,8.95547270970144e-14,1,104,1093,cellular response to cytokine stimulus,BP
GO:0051130,9.021705174092062e-14,1,115,1251,positive regulation of cellular component organization,BP
GO:0032268,1.0891964479907785e-13,1,196,2653,regulation of cellular protein metabolic process,BP
GO:0051049,1.172393815666902e-13,1,152,1860,regulation of transport,BP
GO:0010628,1.3960203480206084e-13,1,160,1974,positive regulation of gene expression,BP
GO:0019904,1.6394236621473768e-13,1,78,704,protein domain specific binding,MF
GO:0009607,1.7858891072685013e-13,1,95,975,response to biotic stimulus,BP
GO:0033043,1.8380513283735234e-13,1,113,1240,regulation of organelle organization,BP
GO:0045595,2.0923478758673087e-13,1,151,1856,regulation of cell differentiation,BP
GO:0061024,2.149121088025885e-13,1,85,818,membrane organization,BP
GO:0046700,2.3106832254050884e-13,1,75,694,heterocycle catabolic process,BP
GO:0009894,2.684613605058601e-13,1,95,975,regulation of catabolic process,BP
GO:0008283,2.7372039697920446e-13,1,156,1984,cell proliferation,BP
GO:0045296,3.1744936947483323e-13,1,48,330,cadherin binding,MF
GO:0009719,3.230344940406078e-13,1,138,1644,response to endogenous stimulus,BP
GO:0008104,3.334204344032859e-13,1,200,2746,protein localization,BP
GO:0019219,3.7272364355987264e-13,1,277,4082,regulation of nucleobase-containing compound metabolic process,BP
GO:1901361,4.228714714753549e-13,1,78,744,organic cyclic compound catabolic process,BP
GO:0007049,4.424389240981964e-13,1,148,1843,cell cycle,BP
GO:0007010,5.536506959604979e-13,1,118,1321,cytoskeleton organization,BP
GO:0031326,5.95529274139267e-13,1,283,4262,regulation of cellular biosynthetic process,BP
GO:0071702,6.777732327263138e-13,1,200,2773,organic substance transport,BP
GO:0044270,6.832043447566854e-13,1,74,695,cellular nitrogen compound catabolic process,BP
GO:0019439,7.520504956800683e-13,1,75,711,aromatic compound catabolic process,BP
GO:0060333,7.711946213844693e-13,1,22,73,interferon-gamma-mediated signaling pathway,BP
GO:0031410,7.99508333138111e-13,1,174,2285,cytoplasmic vesicle,CC
GO:0016071,8.029727564484982e-13,1,84,843,mRNA metabolic process,BP
GO:0097708,8.835934343011218e-13,1,174,2288,intracellular vesicle,CC
GO:0031324,9.688567268942417e-13,1,190,2606,negative regulation of cellular metabolic process,BP
GO:0071346,1.0705940281105463e-12,1,32,162,cellular response to interferon-gamma,BP
GO:2000112,1.2976633235891034e-12,1,265,3939,regulation of cellular macromolecule biosynthetic process,BP
GO:0006401,1.3519927587440699e-12,1,51,397,RNA catabolic process,BP
GO:0044445,1.4423156168790848e-12,1,38,242,cytosolic part,CC
GO:0045935,1.4607471394464236e-12,1,151,1867,positive regulation of nucleobase-containing compound metabolic process,BP
GO:0014070,1.5236592514358344e-12,1,90,907,response to organic cyclic compound,BP
GO:0051252,1.5558893588453648e-12,1,258,3768,regulation of RNA metabolic process,BP
GO:0051172,1.6060407393484976e-12,1,180,2444,negative regulation of nitrogen compound metabolic process,BP
GO:0034340,1.676613851914889e-12,1,24,92,response to type I interferon,BP
GO:1990904,2.507724281806792e-12,1,98,1368,ribonucleoprotein complex,CC
GO:0006915,2.531020419467474e-12,1,153,1963,apoptotic process,BP
GO:0048584,2.7583960126358294e-12,1,176,2358,positive regulation of response to stimulus,BP
GO:0012501,2.805210070457559e-12,1,161,2103,programmed cell death,BP
GO:0043603,2.8402412543458518e-12,1,99,1138,cellular amide metabolic process,BP
GO:0051240,3.4364003654761146e-12,1,142,1788,positive regulation of multicellular organismal process,BP
GO:0043412,3.685066573971473e-12,1,283,4341,macromolecule modification,BP
GO:0005925,3.728235873262028e-12,1,52,405,focal adhesion,CC
GO:0010556,3.92993943375073e-12,1,270,4078,regulation of macromolecule biosynthetic process,BP
GO:0016787,4.016364132755355e-12,1,185,2507,hydrolase activity,MF
GO:0033993,4.189347716335734e-12,1,89,919,response to lipid,BP
GO:0005912,4.3158723540817046e-12,1,63,546,adherens junction,CC
GO:0009891,4.571593932461407e-12,1,156,1988,positive regulation of biosynthetic process,BP
GO:0005924,4.968383946111616e-12,1,52,408,cell-substrate adherens junction,CC
GO:0031328,5.192886256240794e-12,1,154,1957,positive regulation of cellular biosynthetic process,BP
GO:0045862,5.291220458004765e-12,1,48,361,positive regulation of proteolysis,BP
GO:0006793,5.698224320519179e-12,1,227,3310,phosphorus metabolic process,BP
GO:1902531,5.884180688976488e-12,1,151,1947,regulation of intracellular signal transduction,BP
GO:0070161,6.18595550439856e-12,1,64,562,anchoring junction,CC
GO:0006464,6.501779691074784e-12,1,271,4131,cellular protein modification process,BP
GO:0036211,6.501779691074784e-12,1,271,4131,protein modification process,BP
GO:0006796,7.68678823496221e-12,1,225,3283,phosphate-containing compound metabolic process,BP
GO:0045184,7.690530195346263e-12,1,158,2097,establishment of protein localization,BP
GO:0030055,7.704831202418925e-12,1,52,412,cell-substrate junction,CC
GO:0006402,7.763154743352715e-12,1,47,364,mRNA catabolic process,BP
GO:0034622,8.378104378265655e-12,1,98,1109,cellular protein-containing complex assembly,BP
GO:0046872,1.0874712679549603e-11,1,275,4145,metal ion binding,MF
GO:0071944,1.1722234057630747e-11,1,344,5428,cell periphery,CC
GO:0050790,1.2108866525073777e-11,1,171,2316,regulation of catalytic activity,BP
GO:0030162,1.2287470885517136e-11,1,76,763,regulation of proteolysis,BP
GO:0010647,1.2815632266517404e-11,1,144,1835,positive regulation of cell communication,BP
GO:0034613,1.3654133631466775e-11,1,144,1862,cellular protein localization,BP
GO:0010629,1.680026652898915e-11,1,156,2354,negative regulation of gene expression,BP
GO:0044433,1.7339373356642315e-11,1,122,1477,cytoplasmic vesicle part,CC
GO:0005886,1.9214161530928705e-11,1,337,5309,plasma membrane,CC
GO:0008144,1.9310344245099823e-11,1,138,1710,drug binding,MF
GO:0070727,2.0731826198182274e-11,1,144,1873,cellular macromolecule localization,BP
GO:0044877,2.108650197765059e-11,1,99,1107,protein-containing complex binding,MF
GO:0043169,2.4183938212091645e-11,1,278,4234,cation binding,MF
GO:0010942,2.5145631547096827e-11,1,72,720,positive regulation of cell death,BP
GO:0043067,2.850448987666254e-11,1,127,1590,regulation of programmed cell death,BP
GO:0022008,3.0456034081735896e-11,1,132,1614,neurogenesis,BP
GO:0051276,3.200035578005167e-11,1,104,1212,chromosome organization,BP
GO:0023056,3.211050498084552e-11,1,143,1842,positive regulation of signaling,BP
GO:0060337,3.319837137933599e-11,1,22,88,type I interferon signaling pathway,BP
GO:0071357,3.319837137933599e-11,1,22,88,cellular response to type I interferon,BP
GO:0008092,3.355471264831658e-11,1,91,973,cytoskeletal protein binding,MF
GO:0043065,3.8856106556717073e-11,1,68,664,positive regulation of apoptotic process,BP
GO:0010557,3.8866548475613234e-11,1,145,1848,positive regulation of macromolecule biosynthetic process,BP
GO:0010941,5.325769402109178e-11,1,133,1709,regulation of cell death,BP
GO:0031090,5.5936589018725254e-11,1,198,2853,organelle membrane,CC
GO:0045202,5.693135385518996e-11,1,104,1169,synapse,CC
GO:0043068,5.7943345967321824e-11,1,68,672,positive regulation of programmed cell death,BP
GO:0050839,6.594363580559253e-11,1,57,498,cell adhesion molecule binding,MF
GO:0098805,6.759642805401091e-11,1,130,1637,whole membrane,CC
GO:0051254,7.149745744001743e-11,1,134,1676,positive regulation of RNA metabolic process,BP
GO:0051094,7.56672315993816e-11,1,115,1404,positive regulation of developmental process,BP
GO:0022603,7.574751907550569e-11,1,97,1138,regulation of anatomical structure morphogenesis,BP
GO:0009628,8.364691997305716e-11,1,105,1225,response to abiotic stimulus,BP
GO:0005524,8.833201190596208e-11,1,121,1460,ATP binding,MF
GO:0080134,9.702627509326416e-11,1,124,1569,regulation of response to stress,BP
GO:0022613,9.845201692371398e-11,1,53,467,ribonucleoprotein complex biogenesis,BP
GO:0031175,9.982634345356353e-11,1,90,972,neuron projection development,BP
GO:0019221,1.0999227305138408e-10,1,75,775,cytokine-mediated signaling pathway,BP
GO:0006986,1.2585874771605908e-10,0.9999999999782203,30,175,response to unfolded protein,BP
GO:0048699,1.2662439948810148e-10,1,124,1515,generation of neurons,BP
GO:0046983,1.322718178561427e-10,1,109,1316,protein dimerization activity,MF
GO:1901565,1.4502137837122035e-10,1,108,1290,organonitrogen compound catabolic process,BP
GO:0060627,1.5787423127328728e-10,1,58,529,regulation of vesicle-mediated transport,BP
GO:0006518,1.6671969975896278e-10,1,77,875,peptide metabolic process,BP
GO:0097435,1.6688600197955983e-10,1,68,664,supramolecular fiber organization,BP
GO:0007399,1.6697784877436138e-10,1,173,2360,nervous system development,BP
GO:0072594,1.6986228417532729e-10,1,58,544,establishment of protein localization to organelle,BP
GO:0007267,1.7098023505414727e-10,1,131,1643,cell-cell signaling,BP
GO:0030182,1.778307065664623e-10,1,114,1356,neuron differentiation,BP
GO:0044430,1.883249238364252e-10,1,126,1584,cytoskeletal part,CC
GO:0042981,1.9410620683158063e-10,1,123,1566,regulation of apoptotic process,BP
GO:0006351,2.1736510586182695e-10,1,240,3615,"transcription, DNA-templated",BP
GO:0001816,2.1868334473648197e-10,1,74,778,cytokine production,BP
GO:0022402,2.616412939398111e-10,1,111,1384,cell cycle process,BP
GO:0098588,2.7248232449301613e-10,1,152,2051,bounding membrane of organelle,CC
GO:0097659,2.80815174994719e-10,1,242,3663,nucleic acid-templated transcription,BP
GO:0048468,2.8225177410006997e-10,1,160,2163,cell development,BP
GO:0042592,3.449381866648682e-10,1,142,1901,homeostatic process,BP
GO:0030554,4.1123738331499003e-10,1,123,1529,adenyl nucleotide binding,MF
GO:0045934,4.1969563101745064e-10,1,118,1466,negative regulation of nucleobase-containing compound metabolic process,BP
GO:0032774,4.2397172308580663e-10,1,242,3680,RNA biosynthetic process,BP
GO:0005694,4.4878230973141335e-10,1,91,1055,chromosome,CC
GO:0043604,4.6425535072416377e-10,1,75,858,amide biosynthetic process,BP
GO:0031327,5.023682754973757e-10,1,123,1610,negative regulation of cellular biosynthetic process,BP
GO:0032559,5.140859931372269e-10,1,122,1518,adenyl ribonucleotide binding,MF
GO:0044456,5.690766726903001e-10,1,86,936,synapse part,CC
GO:0072657,5.941497175662472e-10,1,62,618,protein localization to membrane,BP
GO:0006413,6.049083973292158e-10,0.9999999998695157,30,193,translational initiation,BP
GO:0006974,6.080767381887944e-10,1,78,848,cellular response to DNA damage stimulus,BP
GO:2000113,6.325179047437847e-10,1,114,1455,negative regulation of cellular macromolecule biosynthetic process,BP
GO:0009890,6.38297095029176e-10,1,124,1634,negative regulation of biosynthetic process,BP
GO:0031329,6.398628568858514e-10,1,79,867,regulation of cellular catabolic process,BP
GO:0043085,6.409343952467839e-10,1,114,1421,positive regulation of catalytic activity,BP
GO:0035966,6.641471623346428e-10,0.9999999998523258,31,198,response to topologically incorrect protein,BP
GO:0015031,6.789141006161033e-10,1,144,1983,protein transport,BP
GO:0051336,7.048227523795061e-10,1,105,1290,regulation of hydrolase activity,BP
GO:0032270,7.192384425450352e-10,1,124,1599,positive regulation of cellular protein metabolic process,BP
GO:0071705,7.350461831526988e-10,1,165,2357,nitrogen compound transport,BP
GO:0048666,7.537079187124396e-10,1,96,1104,neuron development,BP
GO:0097190,8.737213099398696e-10,1,61,598,apoptotic signaling pathway,BP
GO:0048585,8.936269408695753e-10,1,126,1668,negative regulation of response to stimulus,BP
GO:0002682,1.058386956579709e-9,1,118,1519,regulation of immune system process,BP
GO:0042886,1.0605111153289348e-9,1,147,2050,amide transport,BP
GO:0051253,1.087805899920619e-9,1,109,1336,negative regulation of RNA metabolic process,BP
GO:0002252,1.1291272410851312e-9,1,96,1150,immune effector process,BP
GO:0022626,1.1458618458964903e-9,0.9999999998227234,21,109,cytosolic ribosome,CC
GO:0010558,1.2032205419552414e-9,1,118,1543,negative regulation of macromolecule biosynthetic process,BP
GO:0015833,1.210794361447003e-9,1,145,2019,peptide transport,BP
GO:0006508,1.474240062609928e-9,1,133,1799,proteolysis,BP
GO:0030054,1.4947096202044466e-9,1,107,1297,cell junction,CC
GO:0001817,1.5373649187235624e-9,1,67,707,regulation of cytokine production,BP
GO:0051726,1.539844528184383e-9,1,98,1205,regulation of cell cycle,BP
GO:0023057,1.609459079360629e-9,1,110,1401,negative regulation of signaling,BP
GO:0060548,1.8481307134164157e-9,1,86,1005,negative regulation of cell death,BP
GO:0009968,1.8517859808582429e-9,1,103,1292,negative regulation of signal transduction,BP
GO:0008284,1.9157864399117708e-9,1,82,936,positive regulation of cell proliferation,BP
GO:0071495,1.921848928852667e-9,1,110,1383,cellular response to endogenous stimulus,BP
GO:0033365,2.0135761597148157e-9,1,80,916,protein localization to organelle,BP
GO:1903506,2.032707220105959e-9,1,230,3514,regulation of nucleic acid-templated transcription,BP
GO:0009615,2.0651663802617975e-9,1,41,326,response to virus,BP
GO:0006887,2.0944934096023527e-9,1,80,899,exocytosis,BP
GO:0120036,2.1102091542357326e-9,1,117,1488,plasma membrane bounded cell projection organization,BP
GO:0051247,2.120872627061486e-9,1,128,1701,positive regulation of protein metabolic process,BP
GO:0030030,2.340840693676075e-9,1,119,1525,cell projection organization,BP
GO:0009725,2.4079295300934414e-9,1,85,979,response to hormone,BP
GO:2001141,2.516208552339158e-9,1,230,3523,regulation of RNA biosynthetic process,BP
GO:0051092,2.5574299287418672e-9,0.9999999994848053,26,149,positive regulation of NF-kappaB transcription factor activity,BP
GO:0042493,2.6730325606083968e-9,1,87,1011,response to drug,BP
GO:0010648,2.6927151308491218e-9,1,109,1397,negative regulation of cell communication,BP
GO:0045597,2.8811457697211273e-9,1,85,982,positive regulation of cell differentiation,BP
GO:0006355,2.9894365774087236e-9,1,226,3454,"regulation of transcription, DNA-templated",BP
GO:0010243,3.121841801652951e-9,1,85,991,response to organonitrogen compound,BP
GO:0005525,3.1947870874565288e-9,1,44,369,GTP binding,MF
GO:1903508,3.4054717673491405e-09,1,123,1591,positive regulation of nucleic acid-templated transcription,BP
GO:0030163,3.4725175516111137e-9,1,81,926,protein catabolic process,BP
GO:1902680,3.5097197678825394e-9,1,123,1592,positive regulation of RNA biosynthetic process,BP
GO:1901701,3.6767444590497948e-9,1,93,1129,cellular response to oxygen-containing compound,BP
GO:0097458,3.696224765240189e-9,1,131,1721,neuron part,CC
GO:1901566,3.9458287998070405e-9,1,136,1932,organonitrogen compound biosynthetic process,BP
GO:0048471,4.016787271880081e-9,1,67,708,perinuclear region of cytoplasm,CC
GO:0002520,4.108315325064092e-9,1,84,974,immune system development,BP
GO:0032550,4.270409833300497e-9,1,44,373,purine ribonucleoside binding,MF
GO:0032940,4.290648631145401e-9,1,116,1514,secretion by cell,BP
GO:0042176,4.361449087779116e-9,1,44,378,regulation of protein catabolic process,BP
GO:0044427,5.09521589519858e-9,1,80,931,chromosomal part,CC
GO:0001883,5.446632137019513e-9,1,44,376,purine nucleoside binding,MF
GO:0031344,5.4730303943201025e-9,1,65,679,regulation of cell projection organization,BP
GO:0045664,5.782876131040873e-9,1,64,652,regulation of neuron differentiation,BP
GO:0043069,5.839497631073163e-9,1,79,916,negative regulation of programmed cell death,BP
GO:0032989,5.912616808416233e-9,1,95,1136,cellular component morphogenesis,BP
GO:0032549,5.916333433597681e-9,1,44,377,ribonucleoside binding,MF
GO:0000278,6.137544660562506e-9,1,84,1009,mitotic cell cycle,BP
GO:0098657,6.6592933741047415e-9,1,75,840,import into cell,BP
GO:0045893,6.953553710858634e-9,1,117,1506,"positive regulation of transcription, DNA-templated",BP
GO:0046903,7.188212803615013e-9,1,123,1649,secretion,BP
GO:0120035,7.50932289424589e-9,1,64,669,regulation of plasma membrane bounded cell projection organization,BP
GO:0040007,7.838376341927178e-9,1,83,972,growth,BP
GO:0000902,8.577449775078801e-9,1,88,1030,cell morphogenesis,BP
GO:0005794,9.137468425828476e-9,1,117,1536,Golgi apparatus,CC
GO:0006259,9.194696622181061e-9,1,84,1004,DNA metabolic process,BP
GO:1901698,9.322447702207276e-9,1,89,1080,response to nitrogen compound,BP
GO:0009967,9.652629416414688e-9,1,124,1677,positive regulation of signal transduction,BP
GO:0042127,9.726942146824795e-9,1,121,1663,regulation of cell proliferation,BP
GO:0060341,9.83311715495763e-9,1,78,899,regulation of cellular localization,BP
GO:0035239,9.974116561955758e-9,1,76,901,tube morphogenesis,BP
GO:0034620,1.0128242389474066e-8,0.9999999979129252,24,140,cellular response to unfolded protein,BP
GO:0001882,1.0318079741432179e-8,1,44,384,nucleoside binding,MF
GO:0031984,1.0661094261863293e-8,1,125,1685,organelle subcompartment,CC
GO:0030029,1.0685953991451384e-8,1,69,752,actin filament-based process,BP
GO:0035295,1.3938451969660427e-8,1,87,1087,tube development,BP
GO:0099080,1.3999426212267411e-8,1,77,865,supramolecular complex,CC
GO:0006928,1.4230123401302914e-8,1,147,2124,movement of cell or subcellular component,BP
GO:0010975,1.4287985437364291e-08,1,52,497,regulation of neuron projection development,BP
GO:0019001,1.4985647226449437e-8,1,44,389,guanyl nucleotide binding,MF
GO:0032561,1.4985647226449437e-8,1,44,389,guanyl ribonucleotide binding,MF
GO:0002253,1.5018190431709258e-8,1,58,601,activation of immune response,BP
GO:0001959,1.6041708869400214e-8,0.9999999961876362,27,175,regulation of cytokine-mediated signaling pathway,BP
GO:0007409,1.9682658660777763e-8,1,50,465,axonogenesis,BP
GO:0061564,1.98669404249949e-8,1,53,510,axon development,BP
GO:0006954,2.1487429413598985e-8,1,68,778,inflammatory response,BP
GO:0098794,2.1647564091011963e-8,1,60,612,postsynapse,CC
GO:0090150,2.1863395587893496e-8,0.9999999946615095,38,329,establishment of protein localization to membrane,BP
GO:0002684,2.2497666398210527e-8,1,86,1052,positive regulation of immune system process,BP
GO:0006897,2.312215460099184e-8,1,65,715,endocytosis,BP
GO:0051091,2.458557746310295e-8,0.9999999931823541,34,258,positive regulation of DNA-binding transcription factor activity,BP
GO:0000228,2.4672848833112437e-8,1,57,592,nuclear chromosome,CC
GO:0051050,2.719982462078223e-8,1,81,971,positive regulation of transport,BP
GO:0001775,2.801784985532376e-8,1,104,1359,cell activation,BP
GO:0099081,2.8134161540363832e-8,1,76,864,supramolecular polymer,CC
GO:0048534,2.8273675143534783e-8,1,78,921,hematopoietic or lymphoid organ development,BP
GO:0031347,2.9767477020132905e-8,1,71,828,regulation of defense response,BP
GO:0006886,3.2179246113709295e-8,1,88,1112,intracellular protein transport,BP
GO:0000904,3.262023712497205e-8,1,68,740,cell morphogenesis involved in differentiation,BP
GO:0043043,3.263899112230055e-8,1,61,721,peptide biosynthetic process,BP
GO:0010035,3.6044502023825485e-8,1,54,556,response to inorganic substance,BP
GO:0050778,3.6114507334174967e-8,1,68,771,positive regulation of immune response,BP
GO:0045892,3.728395427502746e-8,1,95,1194,"negative regulation of transcription, DNA-templated",BP
GO:0010952,3.956220046617863e-8,0.9999999897959357,28,196,positive regulation of peptidase activity,BP
GO:0044454,4.1841581999032454e-8,1,54,557,nuclear chromosome part,CC
GO:1903507,4.2197533674462384e-8,1,98,1247,negative regulation of nucleic acid-templated transcription,BP
GO:0016567,4.335320923802211e-8,1,71,816,protein ubiquitination,BP
GO:1902679,4.554850270975818e-8,1,98,1249,negative regulation of RNA biosynthetic process,BP
GO:0050767,4.6748595105997694e-8,1,72,817,regulation of neurogenesis,BP
GO:0030036,4.6956835136648204e-8,1,61,659,actin cytoskeleton organization,BP
GO:0050804,4.810978511843696e-8,1,47,435,modulation of chemical synaptic transmission,BP
GO:0051345,4.8530646382720706e-8,1,68,769,positive regulation of hydrolase activity,BP
GO:0098984,4.957776854913529e-8,0.9999999871414266,41,349,neuron to neuron synapse,CC
GO:0099177,5.0912474043120315e-8,1,47,436,regulation of trans-synaptic signaling,BP
GO:0001961,5.466492467745458e-8,0.9999999935765674,14,50,positive regulation of cytokine-mediated signaling pathway,BP
GO:0016072,5.649697824277994e-8,0.9999999843864052,32,252,rRNA metabolic process,BP
GO:0048646,5.682077786134913e-8,1,89,1153,anatomical structure formation involved in morphogenesis,BP
GO:0040011,5.774152168216583e-8,1,131,1890,locomotion,BP
GO:0060759,6.300359206303196e-8,0.9999999838578543,27,186,regulation of response to cytokine stimulus,BP
GO:0010950,6.955654201342101e-8,0.9999999826418096,26,177,positive regulation of endopeptidase activity,BP
GO:0099003,7.550988164353912e-8,0.9999999795536796,29,205,vesicle-mediated transport in synapse,BP
GO:0050776,7.597659634528721e-8,1,80,984,regulation of immune response,BP
GO:0043122,7.62291817499246e-8,0.9999999782560852,31,235,regulation of I-kappaB kinase/NF-kappaB signaling,BP
GO:0032990,7.687576203402301e-8,1,63,681,cell part morphogenesis,BP
GO:0030097,7.842324670799144e-8,1,74,880,hemopoiesis,BP
GO:0032606,8.341491062899613e-8,0.9999999820461835,22,128,type I interferon production,BP
GO:0006412,9.798050432089839e-8,1,58,696,translation,BP
GO:0016049,1.0261527230740376e-7,1,48,476,cell growth,BP
GO:1903047,1.0609354495458879e-7,1,71,866,mitotic cell cycle process,BP
GO:0043066,1.0639310023279076e-7,1,74,897,negative regulation of apoptotic process,BP
GO:0000785,1.0765500466259446e-7,1,52,546,chromatin,CC
GO:0046677,1.2183009055511324e-7,0.9999999620260804,37,323,response to antibiotic,BP
GO:0048812,1.2714423942688172e-7,1,60,644,neuron projection morphogenesis,BP
GO:0015630,1.3108407632859452e-7,1,92,1189,microtubule cytoskeleton,CC
GO:0005783,1.417416728785258e-7,1,131,1884,endoplasmic reticulum,CC
GO:0035967,1.579344696606635e-7,0.9999999614661742,24,161,cellular response to topologically incorrect protein,BP
GO:0043903,1.663497639009669e-7,0.9999999530003516,29,222,"regulation of symbiosis, encompassing mutualism through parasitism",BP
GO:0048608,1.701435237257157e-7,0.9999999523094911,45,425,reproductive structure development,BP
GO:0099512,1.7265141209235488e-7,1,73,857,supramolecular fiber,CC
GO:0005198,1.8251849639929117e-7,1,64,748,structural molecule activity,MF
GO:0003677,1.8579259974357108e-7,1,164,2464,DNA binding,MF
GO:0051090,1.8923950750197619e-7,0.9999999472412305,44,422,regulation of DNA-binding transcription factor activity,BP
GO:0007417,1.8931503718590256e-7,1,81,992,central nervous system development,BP
GO:0005768,1.8947918540195616e-7,1,73,881,endosome,CC
GO:0061458,2.0083620450730943e-7,0.9999999434336366,45,428,reproductive system development,BP
GO:0045055,2.0226867171786245e-7,1,67,790,regulated exocytosis,BP
GO:0022618,2.0959502109434583e-7,0.9999999378470382,30,243,ribonucleoprotein complex assembly,BP
GO:0046982,2.272088609958355e-7,0.9999999340833511,48,497,protein heterodimerization activity,MF
GO:0048667,2.331395422210902e-7,1,55,579,cell morphogenesis involved in neuron differentiation,BP
GO:0048545,2.4787140644075415e-7,0.9999999162919668,41,382,response to steroid hormone,BP
GO:0016772,2.518454438136666e-7,1,75,909,"transferase activity, transferring phosphorus-containing groups",MF
GO:0120039,2.601792085453827e-7,1,60,658,plasma membrane bounded cell projection morphogenesis,BP
GO:0016740,2.6694823400187935e-7,1,151,2259,transferase activity,MF
GO:0012506,2.7522605912631967e-7,1,66,772,vesicle membrane,CC
GO:0048870,2.8488688703802653e-7,1,115,1664,cell motility,BP
GO:0051674,2.8488688703802653e-7,1,115,1664,localization of cell,BP
GO:0140096,2.874766220538871e-7,1,145,2156,"catalytic activity, acting on a protein",MF
GO:0032479,2.8757081382826615e-7,0.9999999358101582,21,126,regulation of type I interferon production,BP
GO:0016477,2.9863736556292026e-7,1,106,1505,cell migration,BP
GO:0030968,3.215014030994869e-7,0.9999999308256375,20,121,endoplasmic reticulum unfolded protein response,BP
GO:0051960,3.2211919893555173e-7,1,76,922,regulation of nervous system development,BP
GO:0060760,3.2333090275468234e-7,0.9999999547165827,14,57,positive regulation of response to cytokine stimulus,BP
GO:0032446,3.304332330794967e-7,1,73,900,protein modification by small protein conjugation,BP
GO:0017111,3.596365223999743e-7,1,71,854,nucleoside-triphosphatase activity,MF
GO:0016462,3.6128034151800997e-7,1,74,903,pyrophosphatase activity,MF
GO:0050769,3.6822562138685885e-7,0.99999989268038,47,469,positive regulation of neurogenesis,BP
GO:0072359,3.721482691075823e-7,1,85,1147,circulatory system development,BP
GO:0006396,3.755432426578412e-7,1,84,1297,RNA processing,BP
GO:0016310,3.8165091866260606e-7,1,155,2385,phosphorylation,BP
GO:0000956,3.825695459868207e-7,0.999999894577555,26,207,nuclear-transcribed mRNA catabolic process,BP
GO:0022625,3.924231390172427e-7,0.9999999479813363,13,61,cytosolic large ribosomal subunit,CC
GO:0070997,4.0169210253859627e-7,0.9999998595032896,38,345,neuron death,BP
GO:0007249,4.0734618130476713e-7,0.9999998696589075,32,267,I-kappaB kinase/NF-kappaB signaling,BP
GO:0042803,4.1919986568236676e-7,1,70,853,protein homodimerization activity,MF
GO:0034248,4.2554179686705113e-7,0.9999998496719128,43,469,regulation of cellular amide metabolic process,BP
GO:0005102,4.521001071458259e-7,1,109,1534,signaling receptor binding,MF
GO:0014069,4.649291796981899e-7,0.9999998390267826,37,323,postsynaptic density,CC
GO:0048858,4.6959083219105645e-7,0.9999998506880751,60,662,cell projection morphogenesis,BP
GO:0003779,4.801677865526455e-7,0.9999998284969928,44,430,actin binding,MF
GO:0002757,4.981658559270571e-7,0.9999998512749457,49,518,immune response-activating signal transduction,BP
GO:0044432,5.059986627832295e-7,1,98,1336,endoplasmic reticulum part,CC
GO:0071407,5.191887067942996e-7,0.9999998427423968,51,539,cellular response to organic cyclic compound,BP
GO:0050792,5.289050902334397e-7,0.9999998478222171,27,208,regulation of viral process,BP
GO:0060249,5.290026228446925e-7,0.9999998121960214,43,431,anatomical structure homeostasis,BP
GO:0044440,5.771680005505594e-7,0.9999998282525564,48,503,endosomal part,CC
GO:0035690,5.803895659417074e-7,0.9999997908797366,39,368,cellular response to drug,BP
GO:0006364,5.955123114544149e-7,0.9999998269051306,27,213,rRNA processing,BP
GO:0016050,5.97450642027492e-7,0.9999997904158854,36,324,vesicle organization,BP
GO:0016817,6.12807705059345e-7,0.9999997925033969,74,906,"hydrolase activity, acting on acid anhydrides",MF
GO:0016818,6.12807705059345e-7,0.9999997925033969,74,906,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",MF
GO:1901214,6.228104432606694e-7,0.9999997847764196,35,311,regulation of neuron death,BP
GO:1903900,6.368468918846205e-7,0.9999998429095871,22,149,regulation of viral life cycle,BP
GO:0032279,6.529818323009668e-7,0.9999997666404681,37,327,asymmetric synapse,CC
GO:0009888,6.54108532813916e-7,0.9999997509179743,134,1962,tissue development,BP
GO:0060322,6.593523695860592e-7,0.9999997829259304,66,768,head development,BP
GO:0051701,7.018678422105452e-7,0.9999997943994761,27,209,interaction with host,BP
GO:0002237,7.194033780545444e-7,0.9999997413713707,37,342,response to molecule of bacterial origin,BP
GO:0032355,7.281405333146427e-7,0.999999826631437,21,134,response to estradiol,BP
GO:0140097,7.437600759837664e-7,0.9999997815649871,27,207,"catalytic activity, acting on DNA",MF
GO:0008134,7.544349108743174e-7,0.9999997597064214,58,656,transcription factor binding,MF
GO:0071826,7.595749206994074e-7,0.9999997586005301,30,257,ribonucleoprotein complex subunit organization,BP
GO:0010638,7.615351324560186e-7,0.9999997611885003,55,619,positive regulation of organelle organization,BP
GO:0032496,7.680978166187504e-7,0.9999997274286556,36,329,response to lipopolysaccharide,BP
GO:0001944,8.102935776156925e-7,0.9999997361589814,62,775,vasculature development,BP
GO:0045069,8.71241815870099e-7,0.9999998292837995,17,95,regulation of viral genome replication,BP
GO:0040008,8.868166665485312e-7,0.9999997163689431,58,667,regulation of growth,BP
GO:0000122,9.116896042583377e-7,0.9999996941651841,69,827,negative regulation of transcription by RNA polymerase II,BP
GO:0070647,9.125311458592863e-7,0.9999996792792407,84,1100,protein modification by small protein conjugation or removal,BP
GO:0072599,9.45135448563794e-7,0.9999998001192765,18,119,establishment of protein localization to endoplasmic reticulum,BP
GO:0050673,9.53664237249497e-7,0.9999996398430201,41,421,epithelial cell proliferation,BP
GO:0044257,9.670259593078787e-7,0.999999681378605,64,768,cellular protein catabolic process,BP
GO:0009790,9.794538975918472e-7,0.999999659089619,80,1010,embryo development,BP
GO:0045666,9.845597751911594e-7,0.9999996307554759,39,367,positive regulation of neuron differentiation,BP
GO:2000116,1.0190333222240325e-6,0.9999996792211528,29,238,regulation of cysteine-type endopeptidase activity,BP
GO:0003725,1.0245842116770069e-6,0.9999998236634352,15,75,double-stranded RNA binding,MF
GO:0022414,1.0276383205707422e-6,0.9999996230698509,103,1417,reproductive process,BP
GO:0099572,1.0341667434526145e-6,0.9999996171033534,38,347,postsynaptic specialization,CC
GO:0003924,1.1137647719339299e-6,0.9999996045731605,35,320,GTPase activity,MF
GO:0000003,1.1198365475445697e-6,0.9999995886703663,103,1420,reproduction,BP
GO:0019080,1.1688993509289583e-6,0.9999996760947087,24,191,viral gene expression,BP
GO:0009617,1.1977646248304256e-6,0.9999996219881344,54,627,response to bacterium,BP
GO:0000723,1.1985130581475696e-6,0.9999996909311362,22,160,telomere maintenance,BP
GO:0043281,1.2122855856662206e-6,0.9999996337388676,27,214,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0052548,1.2400958893111832e-6,0.9999995169073201,41,421,regulation of endopeptidase activity,BP
GO:0048525,1.2705739986443804e-6,0.9999997428196409,17,99,negative regulation of viral process,BP
GO:0070972,1.3125432437503636e-6,0.999999685862444,20,143,protein localization to endoplasmic reticulum,BP
GO:0005844,1.3181096137010256e-6,0.999999784603862,14,72,polysome,CC
GO:0051607,1.3216215530376783e-6,0.9999995783293587,29,238,defense response to virus,BP
GO:1902533,1.3485472740707078e-6,0.9999995249996657,82,1075,positive regulation of intracellular signal transduction,BP
GO:0060284,1.4310649521145105e-6,0.9999995053931413,75,945,regulation of cell development,BP
GO:1902494,1.4341285795555117e-6,0.9999994767583938,97,1355,catalytic complex,CC
GO:0072358,1.4841389562136325e-6,0.9999993753489439,62,784,cardiovascular system development,BP
GO:0032880,1.5053048686763894e-6,0.9999994759040953,77,1002,regulation of protein localization,BP
GO:0010008,1.5199801986913993e-6,0.9999993963556314,44,456,endosome membrane,CC
GO:0030659,1.5999629420032234e-6,0.9999993227419104,63,751,cytoplasmic vesicle membrane,CC
GO:0042254,1.6121695411901461e-6,0.9999994444611787,32,294,ribosome biogenesis,BP
GO:0001558,1.6202650938465504e-6,0.9999993625500966,41,410,regulation of cell growth,BP
GO:0017157,1.6253310205146786e-6,0.9999995008900721,27,215,regulation of exocytosis,BP
GO:0006614,1.696583537224589e-6,0.999999666574479,16,102,SRP-dependent cotranslational protein targeting to membrane,BP
GO:0097153,1.7071874794358922e-6,0.9999999209388946,7,15,cysteine-type endopeptidase activity involved in apoptotic process,MF
GO:0010976,1.7141811831526951e-6,0.999999408784929,32,280,positive regulation of neuron projection development,BP
GO:0048146,1.7374957641295848e-6,0.9999997638058524,12,51,positive regulation of fibroblast proliferation,BP
GO:0051962,1.7506591445561354e-6,0.9999993129270549,50,536,positive regulation of nervous system development,BP
GO:0044459,1.817993947918605e-6,0.9999990441701943,180,2784,plasma membrane part,CC
GO:0019079,1.9508238601722414e-6,0.9999995446133337,19,122,viral genome replication,BP
GO:0044431,2.022820999677652e-6,0.9999990953185123,75,952,Golgi apparatus part,CC
GO:0022604,2.070031305090614e-6,0.999999152354354,46,482,regulation of cell morphogenesis,BP
GO:0022610,2.1002792875497176e-6,0.999998989133398,103,1415,biological adhesion,BP
GO:1901652,2.3095754463777097e-6,0.9999990408088756,47,518,response to peptide,BP
GO:0036293,2.3239317097342306e-6,0.9999991132537519,37,365,response to decreased oxygen levels,BP
GO:0044283,2.346176253317499e-6,0.9999989872654274,65,804,small molecule biosynthetic process,BP
GO:0045047,2.3592093415577035e-6,0.9999994930618975,17,115,protein targeting to ER,BP
GO:0099513,2.4807055501737763e-6,0.9999989763990306,56,637,polymeric cytoskeletal fiber,CC
GO:0052547,2.482013355942912e-6,0.9999989930570692,42,448,regulation of peptidase activity,BP
GO:0071396,2.5105353166937104e-6,0.9999989821123116,53,607,cellular response to lipid,BP
GO:0006979,2.539737296008131e-6,0.9999989689711121,42,444,response to oxidative stress,BP
GO:0034470,2.552493811924673e-6,0.9999990074705584,38,383,ncRNA processing,BP
GO:0051384,2.663836809064979e-6,0.9999993056109131,21,145,response to glucocorticoid,BP
GO:0042995,2.741668530160269e-6,0.9999984479313816,144,2167,cell projection,CC
GO:0043123,2.8348253839435805e-6,0.9999991737138394,24,183,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP
GO:0007155,2.867379669637951e-6,0.9999986145366603,102,1408,cell adhesion,BP
GO:0019900,2.9037975340849153e-6,0.9999986610085487,61,727,kinase binding,MF
GO:0042788,2.913289354614153e-6,0.9999997285255469,9,32,polysomal ribosome,CC
GO:0009611,2.9790335802886265e-6,0.9999987564970492,57,675,response to wounding,BP
GO:0006613,2.988726667627804e-6,0.9999993834763997,16,106,cotranslational protein targeting to membrane,BP
GO:0051656,3.002507975721879e-6,0.9999987528538863,46,500,establishment of organelle localization,BP
GO:0032200,3.086821993637707e-6,0.9999991511476098,22,171,telomere organization,BP
GO:0051248,3.1010079999044926e-6,0.9999985631053883,83,1168,negative regulation of protein metabolic process,BP
GO:2001056,3.183853401042452e-6,0.9999991590039691,21,148,positive regulation of cysteine-type endopeptidase activity,BP
GO:0044281,3.29955824147282e-6,0.9999981438424441,136,2089,small molecule metabolic process,BP
GO:1903901,3.3319667601149358e-6,0.9999993583091958,15,85,negative regulation of viral life cycle,BP
GO:0050770,3.379405642980223e-6,0.9999990047439711,24,182,regulation of axonogenesis,BP
GO:0051338,3.414333739909794e-6,0.9999983153218795,75,966,regulation of transferase activity,BP
GO:0002764,3.464563304260397e-6,0.9999985156773573,49,551,immune response-regulating signaling pathway,BP
GO:0044087,3.4679712288421904e-6,0.9999983008497353,73,943,regulation of cellular component biogenesis,BP
GO:0006325,3.5085416735572505e-6,0.9999984831565124,63,783,chromatin organization,BP
GO:0032101,3.5141061738013124e-6,0.9999984601705942,66,843,regulation of response to external stimulus,BP
GO:0016773,3.5737397135698784e-6,0.9999983605303813,59,693,"phosphotransferase activity, alcohol group as acceptor",MF
GO:0045321,3.5904175763787544e-6,0.9999981504176605,88,1203,leukocyte activation,BP
GO:0060429,3.6588101830254265e-6,0.9999981097601363,89,1195,epithelium development,BP
GO:0071887,3.6644998884006354e-6,0.9999991919246991,17,104,leukocyte apoptotic process,BP
GO:0070482,3.7049985897587018e-6,0.9999985348463143,38,388,response to oxygen levels,BP
GO:0071897,3.827094092755259e-6,0.9999988612357914,24,191,DNA biosynthetic process,BP
GO:0045944,3.859516143352528e-6,0.999998003892529,89,1186,positive regulation of transcription by RNA polymerase II,BP
GO:0034976,3.871181510286414e-6,0.999998630701384,31,284,response to endoplasmic reticulum stress,BP
GO:0005840,3.914611254778095e-6,0.9999986969103354,28,262,ribosome,CC
GO:0016055,3.976955078247934e-6,0.999998316544087,47,516,Wnt signaling pathway,BP
GO:0019058,4.062071788206054e-6,0.9999984786533309,34,328,viral life cycle,BP
GO:0070201,4.2125869956250515e-6,0.9999980454958527,60,737,regulation of establishment of protein localization,BP
GO:0198738,4.404946316906869e-6,0.9999981284121674,47,518,cell-cell signaling by wnt,BP
GO:0071417,4.420953495642341e-6,0.9999980605213175,51,583,cellular response to organonitrogen compound,BP
GO:0097193,4.460415973592317e-6,0.9999984103072196,31,286,intrinsic apoptotic signaling pathway,BP
GO:0007420,4.461824383500133e-6,0.9999979166721016,61,725,brain development,BP
GO:1901699,4.534807166329153e-6,0.9999979534660974,55,646,cellular response to nitrogen compound,BP
GO:0000184,4.571121917385833e-6,0.9999989630719793,17,120,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",BP
GO:0031346,4.589875161724406e-6,0.9999981685537154,38,382,positive regulation of cell projection organization,BP
GO:1903362,4.859260968128272e-6,0.9999983682743534,28,244,regulation of cellular protein catabolic process,BP
GO:0006468,4.897858653722286e-6,0.9999972476235625,130,1970,protein phosphorylation,BP
GO:0080135,4.952409954107171e-6,0.9999976909799402,60,740,regulation of cellular response to stress,BP
GO:0098791,5.026441577509729e-6,0.9999975744057047,67,838,Golgi subcompartment,CC
GO:0006919,5.147349450845728e-6,0.9999989712570325,15,85,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0009636,5.2542216506193175e-6,0.9999977114288545,46,517,response to toxic substance,BP
GO:0005773,5.363048020864651e-6,0.9999974802320223,61,756,vacuole,CC
GO:0097440,5.421865477088802e-6,0.9999996801457558,7,17,apical dendrite,CC
GO:1901654,5.498680309115586e-6,0.9999983271451589,24,191,response to ketone,BP
GO:0070306,5.937924006601104e-6,0.9999993986502801,9,31,lens fiber cell differentiation,BP
GO:0042060,6.0945694329251354e-06,0.9999973362963875,49,562,wound healing,BP
GO:0000790,6.127313650618556e-6,0.9999975836527887,36,362,nuclear chromatin,CC
GO:0044391,6.27434275131058e-6,0.9999981845541408,22,187,ribosomal subunit,CC
GO:0006629,6.498472676894203e-6,0.9999963712768271,98,1399,lipid metabolic process,BP
GO:0016301,6.534570279089199e-6,0.9999968971241535,62,758,kinase activity,MF
GO:0031399,6.5459644646190705e-6,0.9999960695101231,123,1851,regulation of protein modification process,BP
GO:0043280,6.5893366735763705e-6,0.9999983128625958,19,131,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0043487,6.708976535612121e-6,0.9999979941273193,23,183,regulation of RNA stability,BP
GO:0001666,7.175628780256071e-6,0.9999971898079518,35,354,response to hypoxia,BP
GO:0051603,7.191611389936823e-6,0.9999965349098409,58,711,proteolysis involved in cellular protein catabolic process,BP
GO:0120025,7.1918625296058476e-6,0.9999955764491775,138,2092,plasma membrane bounded cell projection,CC
GO:0002429,7.559561467955643e-6,0.9999970332036547,35,350,immune response-activating cell surface receptor signaling pathway,BP
GO:0009895,7.675704285453802e-6,0.9999971317966615,32,306,negative regulation of catabolic process,BP
GO:0001819,8.214880848066434e-6,0.9999964660905714,42,457,positive regulation of cytokine production,BP
GO:0035770,8.232601951603036e-6,0.9999972835261458,26,222,ribonucleoprotein granule,CC
GO:1903050,8.326817574431161e-6,0.9999973211430316,25,211,regulation of proteolysis involved in cellular protein catabolic process,BP
GO:0061013,8.483983273572611e-6,0.9999973431520413,24,199,regulation of mRNA catabolic process,BP
GO:0045136,8.808747526278122e-6,0.9999997970161268,5,8,development of secondary sexual characteristics,BP
GO:1903530,9.125997611827153e-6,0.9999955170831236,60,745,regulation of secretion by cell,BP
GO:0030234,9.224775456168386e-6,0.9999951273019023,76,1028,enzyme regulator activity,MF
GO:0036464,9.639777148880348e-6,0.9999968711028994,25,211,cytoplasmic ribonucleoprotein granule,CC
GO:1901342,1.0004389489371136e-5,0.9999960008841906,35,407,regulation of vasculature development,BP
GO:0001568,1.0033527816715009e-5,0.999995135068815,57,744,blood vessel development,BP
GO:0097199,1.0348129444722783e-5,0.9999997532458446,5,8,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF
GO:0099504,1.0410600259375251e-5,0.9999967038380575,24,192,synaptic vesicle cycle,BP
GO:0048514,1.0645807440114912e-5,0.9999949932909329,52,665,blood vessel morphogenesis,BP
GO:0031349,1.0813209031315235e-5,0.9999951456489956,45,514,positive regulation of defense response,BP
GO:0051098,1.1006801923041256e-5,0.9999955335960199,36,371,regulation of binding,BP
GO:0005938,1.1709078858639934e-5,0.9999955245469477,32,308,cell cortex,CC
GO:0019220,1.1710913620375119e-5,0.9999929289204391,119,1801,regulation of phosphate metabolic process,BP
GO:0006281,1.1868306233229905e-5,0.9999946158849408,47,547,DNA repair,BP
GO:0060560,1.2016477119283421e-5,0.9999958467215674,27,234,developmental growth involved in morphogenesis,BP
GO:0015629,1.2212219699297211e-5,0.999994492966092,45,505,actin cytoskeleton,CC
GO:0005764,1.2254469374364183e-5,0.9999941355225361,54,660,lysosome,CC
GO:0051174,1.2341063909544228e-5,0.9999925400210207,119,1803,regulation of phosphorus metabolic process,BP
GO:0000323,1.2668010975083179e-5,0.9999939304228675,54,661,lytic vacuole,CC
GO:1903706,1.309381404021717e-5,0.9999942273550756,42,470,regulation of hemopoiesis,BP
GO:0016311,1.32553121875517e-5,0.9999941187191078,43,475,dephosphorylation,BP
GO:0099537,1.33102678989884e-5,0.9999933214406906,59,709,trans-synaptic signaling,BP
GO:0002181,1.3322079385407533e-5,0.9999970704958673,15,99,cytoplasmic translation,BP
GO:0031960,1.3393600029870556e-5,0.9999960799076744,21,161,response to corticosteroid,BP
GO:0005200,1.3609423878815113e-5,0.9999968332592978,16,101,structural constituent of cytoskeleton,MF
GO:0072659,1.4362006332674974e-5,0.9999948592151895,28,260,protein localization to plasma membrane,BP
GO:0005769,1.5031536016036728e-5,0.9999939830216014,34,341,early endosome,CC
GO:0009314,1.514459061796096e-5,0.999993357062073,41,447,response to radiation,BP
GO:0009991,1.5430402306268434e-5,0.9999929070269276,46,530,response to extracellular stimulus,BP
GO:0051640,1.5833660009360366e-5,0.9999921438247933,56,695,organelle localization,BP
GO:0005739,1.6332273815000694e-5,0.9999903602012844,103,1548,mitochondrion,CC
GO:0099536,1.6877525174383603e-5,0.999991461021438,59,715,synaptic signaling,BP
GO:0046890,1.696992441766769e-5,0.9999945916659998,23,198,regulation of lipid biosynthetic process,BP
GO:0048144,1.7469397158148055e-5,0.9999963404307791,14,84,fibroblast proliferation,BP
GO:0048661,1.8162072033989752e-5,0.9999958898285202,15,101,positive regulation of smooth muscle cell proliferation,BP
GO:0007268,1.8264534842486675e-5,0.9999907874189298,58,701,chemical synaptic transmission,BP
GO:0098916,1.8264534842486675e-5,0.9999907874189298,58,701,anterograde trans-synaptic signaling,BP
GO:0032608,1.8515440071597074e-5,0.9999970658861197,11,50,interferon-beta production,BP
GO:0048732,1.8548811587114834e-5,0.9999918848558642,40,427,gland development,BP
GO:0061180,1.8952065808171257e-5,0.999996308267595,13,72,mammary gland epithelium development,BP
GO:0044425,1.907918660024271e-5,0.9999858857942497,367,6661,membrane part,CC
GO:0045786,1.9221396931303436e-5,0.9999907101171158,51,635,negative regulation of cell cycle,BP
GO:0006366,1.9438109895724217e-5,0.9999870114197765,173,2786,transcription by RNA polymerase II,BP
GO:0030863,1.967285432899369e-5,0.9999950023485813,17,116,cortical cytoskeleton,CC
GO:0030900,1.9915620917527472e-5,0.9999915668214218,37,379,forebrain development,BP
GO:0010720,2.0536412495544776e-5,0.999990366922831,47,546,positive regulation of cell development,BP
GO:0048489,2.058487085428235e-5,0.9999940106666341,20,151,synaptic vesicle transport,BP
GO:0097480,2.058487085428235e-5,0.9999940106666341,20,151,establishment of synaptic vesicle localization,BP
GO:0044389,2.1121967108282437e-5,0.9999918003304815,31,308,ubiquitin-like protein ligase binding,MF
GO:0090305,2.1271859580850916e-5,0.9999918869875767,30,295,nucleic acid phosphodiester bond hydrolysis,BP
GO:0010631,2.1382456580074522e-5,0.9999916646841807,31,341,epithelial cell migration,BP
GO:1903311,2.1679324185460124e-5,0.9999914240340836,32,324,regulation of mRNA metabolic process,BP
GO:0007163,2.1731449533681762e-5,0.9999927594926232,24,210,establishment or maintenance of cell polarity,BP
GO:0007623,2.304055803520223e-5,0.9999922997252106,24,207,circadian rhythm,BP
GO:0046914,2.319308177368529e-5,0.9999869622580869,78,1068,transition metal ion binding,MF
GO:0048729,2.3947737778338178e-5,0.999987941094907,55,665,tissue morphogenesis,BP
GO:0051046,2.431969840454029e-5,0.9999872242575943,62,803,regulation of secretion,BP
GO:0030684,2.4586778816547357e-5,0.9999950604656445,13,76,preribosome,CC
GO:0098542,2.4725371962127892e-5,0.9999887753611342,42,496,defense response to other organism,BP
GO:0001525,2.4856188057865803e-5,0.9999883648851233,45,574,angiogenesis,BP
GO:0090132,2.554738834113431e-5,0.9999899420081091,31,344,epithelium migration,BP
GO:0044297,2.5838392122965492e-5,0.9999875994748374,48,560,cell body,CC
GO:0051259,2.584185371710278e-5,0.9999877565186641,47,563,protein complex oligomerization,BP
GO:0033002,2.585165516793931e-5,0.9999912508216541,24,233,muscle cell proliferation,BP
GO:0045088,2.600160597877568e-5,0.9999884146995603,40,447,regulation of innate immune response,BP
GO:0043900,2.6390358613936964e-5,0.999988648753146,37,405,regulation of multi-organism process,BP
GO:0001655,2.7332302169979914e-5,0.9999888870763973,33,329,urogenital system development,BP
GO:1905114,2.7767886754039237e-5,0.9999863975372365,51,619,cell surface receptor signaling pathway involved in cell-cell signaling,BP
GO:0007346,2.79440833261055e-5,0.9999862940261928,51,649,regulation of mitotic cell cycle,BP
GO:0030424,2.7952796866414284e-5,0.9999863109565473,51,604,axon,CC
GO:0019901,2.813447185883854e-5,0.999985929128465,53,648,protein kinase binding,MF
GO:0032386,2.8234587440344623e-5,0.9999876620204605,38,420,regulation of intracellular transport,BP
GO:0043542,2.82360423581415e-5,0.9999901149322221,25,263,endothelial cell migration,BP
GO:0050821,2.876624789806985e-5,0.9999910841494566,21,173,protein stabilization,BP
GO:0000186,3.007905572243892e-5,0.9999949283577947,11,53,activation of MAPKK activity,BP
GO:0036473,3.0472846143559518e-5,0.9999932192871662,14,93,cell death in response to oxidative stress,BP
GO:0050851,3.1002863269785435e-5,0.9999891382588723,25,231,antigen receptor-mediated signaling pathway,BP
GO:0001505,3.2314033119374704e-5,0.9999865318351794,34,352,regulation of neurotransmitter levels,BP
GO:0097278,3.257389075200521e-5,0.9999987838399006,5,10,complement-dependent cytotoxicity,BP
GO:0048511,3.260349075888152e-5,0.9999872681377172,30,294,rhythmic process,BP
GO:0071222,3.387208016802167e-5,0.9999886857021216,23,204,cellular response to lipopolysaccharide,BP
GO:0043005,3.533412701318896e-5,0.9999788880922001,92,1307,neuron projection,CC
GO:0010876,3.534589624915617e-5,0.9999847618452189,36,397,lipid localization,BP
GO:0003006,3.5422862446458665e-5,0.9999820050877701,54,668,developmental process involved in reproduction,BP
GO:1903827,3.558644577652034e-5,0.9999832665079698,44,520,regulation of cellular protein localization,BP
GO:0048660,3.574475259008386e-5,0.999989475017491,19,167,regulation of smooth muscle cell proliferation,BP
GO:0042325,3.5966814177883825e-5,0.9999777717953257,106,1602,regulation of phosphorylation,BP
GO:0051262,3.599543097505313e-5,0.999989024012887,20,169,protein tetramerization,BP
GO:0045071,3.647727977235586e-5,0.9999936341901009,11,59,negative regulation of viral genome replication,BP
GO:0090130,3.753389073944371e-5,0.9999849012446017,31,350,tissue migration,BP
GO:0071496,3.7810855480845226e-5,0.9999843456878958,33,339,cellular response to external stimulus,BP
GO:0048589,3.81435647855132e-5,0.9999806893976254,53,663,developmental growth,BP
GO:0048027,3.9103656668042894e-5,0.9999964387966934,7,25,mRNA 5'-UTR binding,MF
GO:0019083,4.017069849335538e-5,0.99998762336869,20,177,viral transcription,BP
GO:1904018,4.0419217660578736e-5,0.9999862780579879,23,226,positive regulation of vasculature development,BP
GO:0043632,4.0425084827323856e-5,0.9999797091878027,51,634,modification-dependent macromolecule catabolic process,BP
GO:0006511,4.052138749801913e-5,0.9999798648133399,50,617,ubiquitin-dependent protein catabolic process,BP
GO:0043488,4.054502524419335e-5,0.9999871087846879,21,177,regulation of mRNA stability,BP
GO:0030100,4.092708234499429e-5,0.9999843869613639,28,280,regulation of endocytosis,BP
GO:0072001,4.159235179778741e-5,0.9999835381663844,30,292,renal system development,BP
GO:0006949,4.189590124923798e-5,0.9999926330504829,11,55,syncytium formation,BP
GO:0034660,4.1946060160604317e-5,0.9999797718075802,46,561,ncRNA metabolic process,BP
GO:0033267,4.202126992318786e-5,0.9999817490357914,36,381,axon part,CC
GO:0043254,4.28605725629488e-5,0.9999804363078498,40,462,regulation of protein complex assembly,BP
GO:0043549,4.310715591294344e-5,0.9999765550060897,65,864,regulation of kinase activity,BP
GO:0007548,4.354128366482528e-5,0.9999833611192478,28,266,sex differentiation,BP
GO:0048659,4.3777231196163706e-5,0.9999869018674331,19,169,smooth muscle cell proliferation,BP
GO:0009612,4.378881004035131e-5,0.9999847342309766,24,210,response to mechanical stimulus,BP
GO:0051099,4.564685406973651e-5,0.999985359169675,21,178,positive regulation of binding,BP
GO:0042542,4.60554369394948e-5,0.9999867715840463,18,144,response to hydrogen peroxide,BP
GO:0001837,4.61105420672541e-5,0.9999867813411321,18,139,epithelial to mesenchymal transition,BP
GO:0051650,4.6574617921023396e-5,0.9999817633587432,29,287,establishment of vesicle localization,BP
GO:0006605,4.748100435065951e-5,0.9999789353854497,37,429,protein targeting,BP
GO:0071216,4.811509737816538e-5,0.9999826540858852,25,235,cellular response to biotic stimulus,BP
GO:2001233,4.864538419620944e-5,0.999978681277321,36,402,regulation of apoptotic signaling pathway,BP
GO:0010564,4.8802902768989966e-5,0.9999741629099359,58,782,regulation of cell cycle process,BP
GO:0016788,4.896877923741771e-5,0.9999742427613086,57,734,"hydrolase activity, acting on ester bonds",MF
GO:0002768,5.007279672193835e-5,0.999978320921661,35,382,immune response-regulating cell surface receptor signaling pathway,BP
GO:0098687,5.0143392284888666e-5,0.9999792071273652,32,345,chromosomal region,CC
GO:0019941,5.053485032054721e-5,0.9999746591178926,50,623,modification-dependent protein catabolic process,BP
GO:0006909,5.058225620176644e-5,0.9999808540164254,27,266,phagocytosis,BP
GO:0003727,5.096212452427318e-5,0.9999881056080366,14,92,single-stranded RNA binding,MF
GO:0003730,5.2187299204867066e-5,0.9999878025143185,14,91,mRNA 3'-UTR binding,MF
GO:0036477,5.2433082869637175e-5,0.9999713044741849,64,839,somatodendritic compartment,CC
GO:0007015,5.286996279968563e-5,0.9999767422122814,36,396,actin filament organization,BP
GO:0061136,5.3159383458282824e-5,0.9999827527370807,21,180,regulation of proteasomal protein catabolic process,BP
GO:0033044,5.325764548595296e-5,0.9999781979025969,31,329,regulation of chromosome organization,BP
GO:0051093,5.351877816873255e-5,0.9999697361086753,71,1022,negative regulation of developmental process,BP
GO:0005543,5.3554982512741056e-5,0.9999758412528614,38,424,phospholipid binding,MF
GO:0043901,5.436102816511244e-5,0.9999829013742313,20,171,negative regulation of multi-organism process,BP
GO:0044451,5.4410629123461106e-5,0.9999684164494147,78,1120,nucleoplasm part,CC
GO:0043434,5.4702742392415506e-5,0.9999752817869754,38,434,response to peptide hormone,BP
GO:0010769,5.570909861010572e-5,0.9999775610206114,30,299,regulation of cell morphogenesis involved in differentiation,BP
GO:0046543,5.6783123734675116e-5,0.9999989454720987,4,6,development of secondary female sexual characteristics,BP
GO:0051347,5.683191843332615e-5,0.9999708776914188,52,649,positive regulation of transferase activity,BP
GO:0006213,5.684669317949391e-5,0.9999906787011743,10,50,pyrimidine nucleoside metabolic process,BP
GO:0097479,5.703187905404405e-5,0.9999820469636059,20,162,synaptic vesicle localization,BP
GO:0017016,5.793807877832707e-5,0.9999737559669308,38,428,Ras GTPase binding,MF
GO:0016197,5.800019820741136e-5,0.999979348274526,24,223,endosomal transport,BP
GO:0071219,5.850876031041134e-5,0.999979693504325,23,211,cellular response to molecule of bacterial origin,BP
GO:0001667,6.004683912638939e-5,0.9999730147376289,37,449,ameboidal-type cell migration,BP
GO:0001932,6.011591271899678e-5,0.9999629205095608,97,1454,regulation of protein phosphorylation,BP
GO:0044437,6.107714849459158e-5,0.9999702433719851,45,549,vacuolar part,CC
GO:0005788,6.170821488039738e-5,0.999974973076709,30,308,endoplasmic reticulum lumen,CC
GO:0030155,6.245958323033982e-5,0.9999677493373665,53,680,regulation of cell adhesion,BP
GO:0000209,6.262383530233824e-5,0.999974580291577,30,308,protein polyubiquitination,BP
GO:0016234,6.368101191506762e-5,0.9999858366840194,13,82,inclusion body,CC
GO:0002088,6.520257987603959e-5,0.9999854939985573,13,80,lens development in camera-type eye,BP
GO:0009411,6.592858574795831e-5,0.9999805357622189,18,141,response to UV,BP
GO:1990778,6.642285139899301e-5,0.9999729381130458,30,311,protein localization to cell periphery,BP
GO:0030198,6.652540443405105e-5,0.9999711647808578,34,368,extracellular matrix organization,BP
GO:0048145,6.680781170110368e-5,0.9999850540632872,13,83,regulation of fibroblast proliferation,BP
GO:0032607,6.74405186048457e-5,0.9999917992393779,8,30,interferon-alpha production,BP
GO:0002191,6.870048680195112e-5,1,3,3,cap-dependent translational initiation,BP
GO:0042177,6.88301139242242e-5,0.9999804726132079,17,130,negative regulation of protein catabolic process,BP
GO:0007264,6.889520046073918e-5,0.999965706181223,47,569,small GTPase mediated signal transduction,BP
GO:0061035,6.89313966183624e-5,0.9999857664843987,12,70,regulation of cartilage development,BP
GO:0032922,7.087699425360365e-5,0.9999865911869243,11,62,circadian regulation of gene expression,BP
GO:0044770,7.121814597312295e-5,0.9999641687029743,48,624,cell cycle phase transition,BP
GO:0051223,7.167078399409368e-5,0.9999626541107811,53,690,regulation of protein transport,BP
GO:0099503,7.211380525102906e-5,0.9999588833298959,70,983,secretory vesicle,CC
GO:0032648,7.25586686171654e-5,0.9999878029828666,10,48,regulation of interferon-beta production,BP
GO:0030879,7.286946964121864e-5,0.9999783123842951,18,141,mammary gland development,BP
GO:0051235,7.500749684317577e-5,0.9999687076644156,31,326,maintenance of location,BP
GO:0019216,7.552819155305648e-5,0.9999661355202134,36,408,regulation of lipid metabolic process,BP
GO:1903320,7.65519548831675e-5,0.9999722209725961,24,226,regulation of protein modification by small protein conjugation or removal,BP
GO:0006612,7.663726119537069e-5,0.999974352062921,21,199,protein targeting to membrane,BP
GO:0015934,7.675127175711148e-5,0.9999800140936906,15,119,large ribosomal subunit,CC
GO:0032103,7.71276357797955e-5,0.999968275499531,30,320,positive regulation of response to external stimulus,BP
GO:0097342,7.723174046934184e-5,0.9999984441996234,4,6,ripoptosome,CC
GO:0000932,7.75998523123707e-5,0.999982356944448,13,84,P-body,CC
GO:0071103,8.168299699636587e-5,0.9999668574543716,29,310,DNA conformation change,BP
GO:0010498,8.258698872152165e-5,0.999961054088368,40,474,proteasomal protein catabolic process,BP
GO:0019218,8.358129130438713e-5,0.9999769545186837,16,124,regulation of steroid metabolic process,BP
GO:0009896,8.381036624316284e-5,0.9999617608454227,37,422,positive regulation of catabolic process,BP
GO:2000278,8.391936158895604e-5,0.9999781024379364,15,108,regulation of DNA biosynthetic process,BP
GO:0061036,8.44164008184198e-5,0.9999892042200209,8,33,positive regulation of cartilage development,BP
GO:0002009,8.581608846560277e-5,0.9999575820826669,45,534,morphogenesis of an epithelium,BP
GO:0098590,8.70669668560437e-5,0.999947468624283,84,1196,plasma membrane region,CC
GO:1902949,8.949916789141649e-5,0.9999974681136916,4,8,positive regulation of tau-protein kinase activity,BP
GO:0031396,8.951949294353067e-5,0.9999688759663737,22,199,regulation of protein ubiquitination,BP
GO:0007520,9.12584757626951e-5,0.9999861074312103,9,41,myoblast fusion,BP
GO:0051241,9.139278055283304e-5,0.999944831959862,84,1286,negative regulation of multicellular organismal process,BP
GO:0007041,9.152214181182157e-5,0.9999759574376548,15,106,lysosomal transport,BP
GO:0043062,9.172210054130526e-5,0.999957958833927,37,422,extracellular structure organization,BP
GO:0044772,9.375460865799476e-5,0.9999533856463223,45,581,mitotic cell cycle phase transition,BP
GO:0050727,9.40686349270593e-5,0.9999578031809271,35,416,regulation of inflammatory response,BP
GO:0034612,9.511929739350054e-5,0.9999610599825217,29,309,response to tumor necrosis factor,BP
GO:1901653,9.720983941942851e-5,0.9999569411690359,34,384,cellular response to peptide,BP
GO:0045860,9.784621061060748e-5,0.9999517364377362,44,532,positive regulation of protein kinase activity,BP
GO:0001822,9.834538949460293e-5,0.9999604723603986,28,277,kidney development,BP
GO:0019882,9.867579964909953e-5,0.9999654169926634,22,204,antigen processing and presentation,BP
GO:0008187,9.899551649004333e-5,0.9999870389784403,8,33,poly-pyrimidine tract binding,MF
GO:0003690,1.0424183339625642e-4,0.9999398409457941,70,951,double-stranded DNA binding,MF
GO:0055085,1.0441890378141223e-4,0.9999334063534634,104,1580,transmembrane transport,BP
GO:0060070,1.0505742271565459e-4,0.9999552973136805,31,332,canonical Wnt signaling pathway,BP
GO:0071560,1.073866528440353e-4,0.9999591344110187,25,248,cellular response to transforming growth factor beta stimulus,BP
GO:1901615,1.0855052853487072e-4,0.9999461973140369,44,534,organic hydroxy compound metabolic process,BP
GO:0034762,1.1190882976348275e-4,0.9999434597591875,46,563,regulation of transmembrane transport,BP
GO:0090087,1.1238986036892695e-4,0.9999398632419113,54,720,regulation of peptide transport,BP
GO:0031267,1.1292622897443946e-4,0.9999470578312507,38,442,small GTPase binding,MF
GO:0000139,1.1297479852521632e-4,0.9999388441752469,56,733,Golgi membrane,CC
GO:0007269,1.1324835138777573e-4,0.9999623876344265,20,168,neurotransmitter secretion,BP
GO:0032508,1.1354877567777515e-4,0.9999695128046547,15,109,DNA duplex unwinding,BP
GO:0071214,1.1518920101671206e-4,0.9999507313541056,31,331,cellular response to abiotic stimulus,BP
GO:0104004,1.1518920101671206e-4,0.9999507313541056,31,331,cellular response to environmental stimulus,BP
GO:2000058,1.152002575308648e-4,0.9999643057115406,18,149,regulation of ubiquitin-dependent protein catabolic process,BP
GO:0008270,1.1530525713339522e-4,0.9999361456933067,60,805,zinc ion binding,MF
GO:0030260,1.161518133340641e-4,0.9999654969639467,17,134,entry into host cell,BP
GO:0044409,1.161518133340641e-4,0.9999654969639467,17,134,entry into host,BP
GO:0051806,1.161518133340641e-4,0.9999654969639467,17,134,entry into cell of other organism involved in symbiotic interaction,BP
GO:0051828,1.161518133340641e-4,0.9999654969639467,17,134,entry into other organism involved in symbiotic interaction,BP
GO:0055086,1.162696237950601e-4,0.999936581022025,57,781,nucleobase-containing small molecule metabolic process,BP
GO:0045596,1.1763907082024052e-4,0.9999365539996684,55,738,negative regulation of cell differentiation,BP
GO:0016485,1.1896784953434431e-4,0.9999533937391801,26,266,protein processing,BP
GO:0032269,1.2120538924622668e-4,0.999928657064875,73,1099,negative regulation of cellular protein metabolic process,BP
GO:0030136,1.2214861249562213e-4,0.9999591051781335,20,176,clathrin-coated vesicle,CC
GO:0043161,1.222139701402826e-4,0.9999437673184239,36,418,proteasome-mediated ubiquitin-dependent protein catabolic process,BP
GO:0099643,1.2374995976279228e-4,0.9999586081104381,20,169,signal release from synapse,BP
GO:0051648,1.2435687785962101e-4,0.9999483000868176,29,303,vesicle localization,BP
GO:0016604,1.2502393642525942e-4,0.9999316201089365,57,775,nuclear body,CC
GO:0072562,1.271010134202553e-4,0.999965378973392,15,116,blood microparticle,CC
GO:0032432,1.2716663057691803e-4,0.9999717985228979,12,74,actin filament bundle,CC
GO:0034599,1.2906283418371323e-4,0.9999471103792251,28,300,cellular response to oxidative stress,BP
GO:0005813,1.293316777202991e-4,0.9999364297566442,42,510,centrosome,CC
GO:0032970,1.298994103623063e-4,0.9999415553441088,34,383,regulation of actin filament-based process,BP
GO:0031647,1.3093871913325846e-4,0.999947348407942,27,278,regulation of protein stability,BP
GO:0045785,1.3095589155744087e-4,0.9999402904616213,35,397,positive regulation of cell adhesion,BP
GO:0003682,1.3200139859783494e-4,0.9999344545489735,43,528,chromatin binding,MF
GO:1990837,1.321494413101142e-4,0.9999246927788349,65,869,sequence-specific double-stranded DNA binding,MF
GO:0021955,1.3221273622647495e-4,0.9999817585147319,8,35,central nervous system neuron axonogenesis,BP
GO:0048675,1.3231588201877294e-4,0.999962077756808,16,120,axon extension,BP
GO:1904951,1.324606981313535e-4,0.9999373624888375,38,451,positive regulation of establishment of protein localization,BP
GO:0120114,1.387090839289727e-4,0.9999686568495961,12,83,Sm-like protein family complex,CC
GO:0006357,1.4314296976238153e-4,0.9998996727380334,161,2652,regulation of transcription by RNA polymerase II,BP
GO:0033674,1.4516777138293564e-4,0.9999257616194553,46,573,positive regulation of kinase activity,BP
GO:0008047,1.4641638430819694e-4,0.9999275808209962,42,517,enzyme activator activity,MF
GO:0035456,1.4697700573283073e-4,0.9999830032913554,7,28,response to interferon-beta,BP
GO:2000052,1.4713922398721914e-4,0.9999912650861009,5,13,positive regulation of non-canonical Wnt signaling pathway,BP
GO:0150034,1.4797417474385322e-4,0.9999389509835931,28,285,distal axon,CC
GO:0030532,1.4845190912117135e-4,0.9999689865534722,11,72,small nuclear ribonucleoprotein complex,CC
GO:0006869,1.486888855608804e-4,0.9999343919289272,32,362,lipid transport,BP
GO:0000792,1.508175068372271e-4,0.9999658451409006,12,76,heterochromatin,CC
GO:0000302,1.5137546311076025e-4,0.9999437217593768,23,228,response to reactive oxygen species,BP
GO:0010657,1.5334814939628146e-4,0.9999647378349479,12,91,muscle cell apoptotic process,BP
GO:0042273,1.551622110440978e-4,0.9999674935801635,11,70,ribosomal large subunit biogenesis,BP
GO:0005518,1.5670836323743975e-4,0.9999672573855729,11,67,collagen binding,MF
GO:0071356,1.5712871539386966e-4,0.9999360083934239,27,288,cellular response to tumor necrosis factor,BP
GO:0007017,1.5912616504027902e-4,0.9999125558806895,56,746,microtubule-based process,BP
GO:0048762,1.5965028573364405e-4,0.9999405270779018,23,218,mesenchymal cell differentiation,BP
GO:0048871,1.6269994316996637e-4,0.999920626194994,40,481,multicellular organismal homeostasis,BP
GO:0007050,1.6394544756356507e-4,0.999937257341531,24,236,cell cycle arrest,BP
GO:0004709,1.6548186388555232e-4,0.9999807606817008,7,26,MAP kinase kinase kinase activity,MF
GO:0030864,1.679458816257964e-4,0.9999584436865417,13,90,cortical actin cytoskeleton,CC
GO:0031099,1.6966678053400688e-4,0.9999398275831156,21,196,regeneration,BP
GO:0061061,1.7095609708210827e-4,0.9999092590005246,50,659,muscle structure development,BP
GO:0071559,1.7152862278247555e-4,0.9999326070321077,25,254,response to transforming growth factor beta,BP
GO:0010608,1.718867854688938e-4,0.9999041983723027,57,1098,posttranscriptional regulation of gene expression,BP
GO:0050852,1.7394876299567515e-4,0.9999400363745219,20,184,T cell receptor signaling pathway,BP
GO:0051129,1.777600612748739e-4,0.9999035260670045,53,723,negative regulation of cellular component organization,BP
GO:0045859,1.8208192523845018e-4,0.9998982671855059,58,788,regulation of protein kinase activity,BP
GO:0002274,1.833518625471375e-4,0.9999029641464288,49,647,myeloid leukocyte activation,BP
GO:0000768,1.8588061950756079e-4,0.9999643642306583,10,54,syncytium formation by plasma membrane fusion,BP
GO:0140253,1.8588061950756079e-4,0.9999643642306583,10,54,cell-cell fusion,BP
GO:0032481,1.8727576083118368e-4,0.9999565173000979,12,77,positive regulation of type I interferon production,BP
GO:0043394,1.8740190096749513e-4,0.9999726456774937,8,36,proteoglycan binding,MF
GO:1901800,1.9100802413729738e-4,0.9999489081206635,14,103,positive regulation of proteasomal protein catabolic process,BP
GO:0032813,1.9849023718872735e-4,0.9999659113657077,9,46,tumor necrosis factor receptor superfamily binding,MF
GO:0062012,1.9871990347367812e-4,0.9999049888258497,37,455,regulation of small molecule metabolic process,BP
GO:0043523,1.997013669978769e-4,0.9999262830768401,22,209,regulation of neuron apoptotic process,BP
GO:0016323,2.0080871083167243e-4,0.9999239838849282,23,217,basolateral plasma membrane,CC
GO:0043025,2.0081825883364388e-4,0.9999000536232495,41,494,neuronal cell body,CC
GO:0070613,2.0249479809996608e-4,0.9999422907234505,15,119,regulation of protein processing,BP
GO:0031331,2.0449266453065698e-4,0.9999081205987963,32,360,positive regulation of cellular catabolic process,BP
GO:0010038,2.0475642425678324e-4,0.999907980792587,32,362,response to metal ion,BP
GO:0042180,2.0487725217941546e-4,0.9999202352884569,24,248,cellular ketone metabolic process,BP
GO:0030665,2.0597779253125951e-4,0.9999444896183627,14,103,clathrin-coated vesicle membrane,CC
GO:0009416,2.0690874113552215e-4,0.9999111855449102,29,313,response to light stimulus,BP
GO:0021954,2.072033312920847e-4,0.9999512976997774,12,78,central nervous system neuron development,BP
GO:1903845,2.0723919726494788e-4,0.9999510995100707,12,82,negative regulation of cellular response to transforming growth factor beta stimulus,BP
GO:0071236,2.09443178263492e-4,0.9999342235901478,17,147,cellular response to antibiotic,BP
GO:0042641,2.107087181009074e-4,0.999950331411081,12,79,actomyosin,CC
GO:0051402,2.112283610028016e-4,0.999917723863911,24,237,neuron apoptotic process,BP
GO:0043269,2.113411885607316e-4,0.9998845499085327,53,693,regulation of ion transport,BP
GO:0050810,2.1204017647533663e-4,0.9999460376949154,13,95,regulation of steroid biosynthetic process,BP
GO:0031901,2.1234487573514987e-4,0.9999333738933431,17,141,early endosome membrane,CC
GO:0097413,2.1380313261139462e-4,0.9999923791235186,4,8,Lewy body,CC
GO:0006417,2.140043406765267e-4,0.9999032626019917,32,410,regulation of translation,BP
GO:0045137,2.1824843220200372e-4,0.9999168600343853,23,219,development of primary sexual characteristics,BP
GO:0002250,2.1844691970714536e-4,0.9998987800628159,34,393,adaptive immune response,BP
GO:1901216,2.236566196484687e-4,0.9999428029791142,13,94,positive regulation of neuron death,BP
GO:0050678,2.2504876013368822e-4,0.9998996146382234,31,366,regulation of epithelial cell proliferation,BP
GO:0010562,2.2645882876283241e-4,0.9998618427160013,77,1132,positive regulation of phosphorus metabolic process,BP
GO:0045937,2.2645882876283241e-4,0.9998618427160013,77,1132,positive regulation of phosphate metabolic process,BP
GO:0070555,2.2727585842494957e-4,0.9999174664162465,21,204,response to interleukin-1,BP
GO:0101031,2.318199760037321e-4,0.9999774437835939,6,21,chaperone complex,CC
GO:0045651,2.3309022606868426e-4,0.9999842625116844,5,14,positive regulation of macrophage differentiation,BP
GO:1903204,2.3601035836154127e-4,0.9999772263338971,6,20,negative regulation of oxidative stress-induced neuron death,BP
GO:0034704,2.376638332956723e-4,0.9999479128732903,11,66,calcium channel complex,CC
GO:1904874,2.3817767292592923e-4,0.9999834715781015,5,15,positive regulation of telomerase RNA localization to Cajal body,BP
GO:0051260,2.4233006930661805e-4,0.9998915757542469,31,349,protein homooligomerization,BP
GO:0003729,2.424835900567421e-4,0.999892217513509,30,475,mRNA binding,MF
GO:0042059,2.443286858190313e-4,0.9999566088975671,9,48,negative regulation of epidermal growth factor receptor signaling pathway,BP
GO:0000791,2.4450016983564656e-4,0.9999692248190122,7,28,euchromatin,CC
GO:0006446,2.476469419890128e-4,0.9999405649706957,12,79,regulation of translational initiation,BP
GO:0008289,2.505584802157644e-4,0.9998612352359075,54,731,lipid binding,MF
GO:0099568,2.5163169896993097e-4,0.9998732859922681,41,505,cytoplasmic region,CC
GO:0004706,2.5248436749862846e-4,0.9999905906901982,4,8,JUN kinase kinase kinase activity,MF
GO:1903317,2.527761065405335e-4,0.9999263569498292,15,121,regulation of protein maturation,BP
GO:0034249,2.5537952527191653e-4,0.9999113642925022,19,215,negative regulation of cellular amide metabolic process,BP
GO:0031625,2.555024127432657e-4,0.9998926264169843,27,290,ubiquitin protein ligase binding,MF
GO:0097305,2.5717473170801947e-4,0.9999006721536814,23,231,response to alcohol,BP
GO:0090261,2.6209558261045717e-4,0.9999972513914446,3,4,positive regulation of inclusion body assembly,BP
GO:0017156,2.625416419456049e-4,0.999912766074629,18,153,calcium ion regulated exocytosis,BP
GO:0032870,2.6323354088978026e-4,0.9998556424712794,52,698,cellular response to hormone stimulus,BP
GO:0030235,2.634063525186613e-4,0.9999900715325327,4,8,nitric-oxide synthase regulator activity,MF
GO:1903844,2.642920461220385e-4,0.999922673708263,15,121,regulation of cellular response to transforming growth factor beta stimulus,BP
GO:0008135,2.69224901880645e-4,0.9999344790960629,12,84,"translation factor activity, RNA binding",MF
GO:0046928,2.6993186041416944e-4,0.999925261815979,14,103,regulation of neurotransmitter secretion,BP
GO:0008610,2.7494350334726235e-4,0.9998489038129402,52,706,lipid biosynthetic process,BP
GO:0032392,2.7750303992127865e-4,0.9999185449786357,15,118,DNA geometric change,BP
GO:0097525,2.798087640495265e-4,0.9999424121328824,10,66,spliceosomal snRNP complex,CC
GO:0044255,2.8027670878035807e-4,0.9998305032861557,72,1064,cellular lipid metabolic process,BP
GO:1904869,2.8119920883072673e-4,0.9999883930656371,4,9,regulation of protein localization to Cajal body,BP
GO:1904871,2.8119920883072673e-4,0.9999883930656371,4,9,positive regulation of protein localization to Cajal body,BP
GO:0003735,2.8498005648039084e-4,0.9999006201255877,19,192,structural constituent of ribosome,MF
GO:0098827,2.863234179350748e-4,0.9998267289152161,72,1057,endoplasmic reticulum subcompartment,CC
GO:1901739,2.891858488507153e-4,0.9999706552322059,6,21,regulation of myoblast fusion,BP
GO:0046596,2.9299759239354744e-4,0.9999615281269012,7,30,regulation of viral entry into host cell,BP
GO:0010565,2.9557261823701597e-4,0.9998968654606266,19,181,regulation of cellular ketone metabolic process,BP
GO:0006470,2.9721259552397273e-4,0.9998694535879424,29,319,protein dephosphorylation,BP
GO:0051015,2.972144969958673e-4,0.9998899710127889,21,198,actin filament binding,MF
GO:0043393,2.9963683336534737e-4,0.9998858849913034,22,216,regulation of protein binding,BP
GO:0016581,3.0257257822609686e-4,0.9999778633734068,5,15,NuRD complex,CC
GO:0090545,3.0257257822609686e-4,0.9999778633734068,5,15,CHD-type complex,CC
GO:0097296,3.0355359892529095e-4,0.9999966497662216,3,4,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP
GO:0031330,3.052710021020573e-4,0.9998751496185497,25,262,negative regulation of cellular catabolic process,BP
GO:0032651,3.132235530368871e-4,0.999922097026387,12,90,regulation of interleukin-1 beta production,BP
GO:0032652,3.146910051639998e-4,0.9999161299004843,13,102,regulation of interleukin-1 production,BP
GO:0032647,3.1470196384794505e-4,0.9999586700532122,7,28,regulation of interferon-alpha production,BP
GO:2000106,3.1555975904608513e-4,0.9999218902712568,12,83,regulation of leukocyte apoptotic process,BP
GO:0046332,3.1664490392959273e-4,0.9999218061529259,12,80,SMAD binding,MF
GO:0006457,3.176254602665741e-4,0.9998784032279772,22,221,protein folding,BP
GO:0009117,3.22327504082638e-4,0.9998237692572584,50,689,nucleotide metabolic process,BP
GO:0006397,3.2559305632650135e-4,0.9998352900746171,40,507,mRNA processing,BP
GO:0004672,3.2609410585529764e-4,0.9998266565635107,46,590,protein kinase activity,MF
GO:0051147,3.27577489930293e-4,0.9998883408297664,18,178,regulation of muscle cell differentiation,BP
GO:0032434,3.2979782418430354e-4,0.9999013906100676,15,122,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP
GO:0000226,3.326104079912086e-4,0.9998271079507913,43,547,microtubule cytoskeleton organization,BP
GO:0043405,3.340161100666956e-4,0.999849874987101,30,335,regulation of MAP kinase activity,BP
GO:0042578,3.3639508918173016e-4,0.9998443249881442,32,366,phosphoric ester hydrolase activity,MF
GO:1900182,3.383198231953126e-4,0.9999219142102249,11,74,positive regulation of protein localization to nucleus,BP
GO:0032535,3.4518556749073905e-4,0.9998399896485444,32,368,regulation of cellular component size,BP
GO:0009792,3.5165340183131426e-4,0.9998083385370735,49,639,embryo development ending in birth or egg hatching,BP
GO:0030099,3.5426374549414423e-4,0.9998311082848595,34,412,myeloid cell differentiation,BP
GO:0009116,3.552173602885158e-4,0.9998930747450244,15,121,nucleoside metabolic process,BP
GO:0071478,3.5667040180462864e-4,0.9998697080605522,20,191,cellular response to radiation,BP
GO:0006906,3.5667765580649257e-4,0.9999041630480278,13,94,vesicle fusion,BP
GO:1901135,3.588314237554988e-4,0.9997745978107455,81,1242,carbohydrate derivative metabolic process,BP
GO:1902803,3.591907357079862e-4,0.9999097822344256,12,83,regulation of synaptic vesicle transport,BP
GO:0030687,3.6122482959218135e-4,0.9999610009930969,6,23,"preribosome, large subunit precursor",CC
GO:0051272,3.629236373106075e-4,0.9998103112918749,43,580,positive regulation of cellular component movement,BP
GO:0051082,3.630348736335924e-4,0.999890251292612,15,126,unfolded protein binding,MF
GO:0045089,3.6328177676155543e-4,0.9998309942146433,32,376,positive regulation of innate immune response,BP
GO:0043202,3.634891755520106e-4,0.9999020665640629,13,95,lysosomal lumen,CC
GO:1903202,3.658405988559869e-4,0.9999302071173943,9,56,negative regulation of oxidative stress-induced cell death,BP
GO:0006403,3.6754958806117387e-4,0.9998575851130047,22,228,RNA localization,BP
GO:0008406,3.6819363321636227e-4,0.9998576749833098,22,213,gonad development,BP
GO:1902187,3.6895968517190535e-4,0.9999717914549089,5,15,negative regulation of viral release from host cell,BP
GO:0010212,3.68980486920592e-4,0.9998782034878106,17,147,response to ionizing radiation,BP
GO:0000151,3.719221544904108e-4,0.9998426351267031,26,282,ubiquitin ligase complex,CC
GO:0016079,3.759688619077861e-4,0.9998863647522366,15,118,synaptic vesicle exocytosis,BP
GO:1904813,3.7632199458331956e-4,0.9998859351887694,15,124,ficolin-1-rich granule lumen,CC
GO:0042327,3.787652040313051e-4,0.999768420134687,72,1061,positive regulation of phosphorylation,BP
GO:0033209,3.803687578568392e-4,0.9998691048105973,18,165,tumor necrosis factor-mediated signaling pathway,BP
GO:0005874,3.8088246243324385e-4,0.9998156324706822,35,415,microtubule,CC
GO:0031401,3.819194673253987e-4,0.9997595121584278,81,1228,positive regulation of protein modification process,BP
GO:0030177,3.831255382806219e-4,0.9998634961594222,19,179,positive regulation of Wnt signaling pathway,BP
GO:0010660,3.850560995598009e-4,0.9999087039865094,11,87,regulation of muscle cell apoptotic process,BP
GO:1900408,3.873604628685973e-4,0.9999253916131905,9,57,negative regulation of cellular response to oxidative stress,BP
GO:0007565,3.887475619137805e-4,0.9998570402892981,20,190,female pregnancy,BP
GO:2000050,3.935043003472568e-4,0.9999568142878443,6,23,regulation of non-canonical Wnt signaling pathway,BP
GO:0060996,3.9982560389141704e-4,0.9998910975076046,13,96,dendritic spine development,BP
GO:0098772,4.025295160144945e-4,0.9997288721527565,110,1799,molecular function regulator,MF
GO:0006753,4.03536313823979e-4,0.9997770823483798,50,696,nucleoside phosphate metabolic process,BP
GO:0031100,4.0551005069846717e-4,0.9999045483102152,11,72,animal organ regeneration,BP
GO:0001934,4.065791329764235e-4,0.9997534477079035,69,1010,positive regulation of protein phosphorylation,BP
GO:0070925,4.13438881222982e-4,0.9997595736301332,59,837,organelle assembly,BP
GO:0005789,4.212764030420337e-4,0.999742291552106,71,1053,endoplasmic reticulum membrane,CC
GO:0060026,4.2173896161426424e-4,0.9999667812448683,5,15,convergent extension,BP
GO:0050808,4.217910942691011e-4,0.9997947537331614,35,407,synapse organization,BP
GO:0000976,4.235248159683529e-4,0.9997525406338014,60,820,transcription regulatory region sequence-specific DNA binding,MF
GO:0030135,4.319426121337668e-4,0.9998188979025626,25,269,coated vesicle,CC
GO:0010821,4.320129624513689e-4,0.9998444657652854,19,181,regulation of mitochondrion organization,BP
GO:0072331,4.366131597531821e-4,0.999816846390486,25,267,signal transduction by p53 class mediator,BP
GO:0044706,4.406222791885736e-4,0.9998271465018866,22,220,multi-multicellular organism process,BP
GO:0098793,4.4258741221608986e-4,0.9997726405731883,40,490,presynapse,CC
GO:1990000,4.436427140592671e-4,0.9999639869928596,5,16,amyloid fibril formation,BP
GO:0048285,4.482946018136548e-4,0.9997783422330737,36,447,organelle fission,BP
GO:0044294,4.492584638920968e-4,0.9999789644655603,4,9,dendritic growth cone,CC
GO:0071363,4.592250337321739e-4,0.9997432158779183,51,698,cellular response to growth factor stimulus,BP
GO:0042175,4.5937880142315926e-4,0.9997170699977467,72,1075,nuclear outer membrane-endoplasmic reticulum membrane network,CC
GO:0097191,4.597900300130176e-4,0.9998189553164276,22,223,extrinsic apoptotic signaling pathway,BP
GO:0034765,4.6182741008646245e-4,0.999764392371204,39,478,regulation of ion transmembrane transport,BP
GO:0007179,4.710559078192288e-4,0.999823790267889,20,198,transforming growth factor beta receptor signaling pathway,BP
GO:0051493,4.7994357138293785e-4,0.9997499642276252,41,527,regulation of cytoskeleton organization,BP
GO:0061684,4.8412943761475474e-4,0.9999599263125059,5,16,chaperone-mediated autophagy,BP
GO:0002183,4.8825386078608815e-4,0.9999287833265531,7,34,cytoplasmic translational initiation,BP
GO:0005815,4.898825352726793e-4,0.9997219380019119,53,734,microtubule organizing center,CC
GO:1903405,4.917659550691006e-4,0.9999751424665995,4,10,protein localization to nuclear body,BP
GO:1904851,4.917659550691006e-4,0.9999751424665995,4,10,positive regulation of establishment of protein localization to telomere,BP
GO:1904867,4.917659550691006e-4,0.9999751424665995,4,10,protein localization to Cajal body,BP
GO:0006958,4.927620330142512e-4,0.9999280131429749,7,34,"complement activation, classical pathway",BP
GO:1901185,4.950922840813532e-4,0.9999019726966798,9,53,negative regulation of ERBB signaling pathway,BP
GO:1901215,4.993739465389745e-4,0.9998072408538293,21,206,negative regulation of neuron death,BP
GO:0004674,5.085298087437007e-4,0.9997469003724987,36,437,protein serine/threonine kinase activity,MF
GO:1903364,5.095515361105739e-4,0.9998334499619059,16,139,positive regulation of cellular protein catabolic process,BP
GO:0048167,5.13157349974236e-4,0.999807145161357,20,187,regulation of synaptic plasticity,BP
GO:1902883,5.219257915173692e-4,0.999894870315659,9,59,negative regulation of response to oxidative stress,BP
GO:0031264,5.269585742819489e-4,0.9999742369893511,4,9,death-inducing signaling complex,CC
GO:1990234,5.351355394749088e-4,0.9996917276889107,55,777,transferase complex,CC
GO:0000165,5.396048260028718e-4,0.9996742121225872,65,952,MAPK cascade,BP
GO:0009986,5.499740582927102e-4,0.9996779896137865,58,804,cell surface,CC
GO:0051427,5.507493215663045e-4,0.9997975178166176,19,184,hormone receptor binding,MF
GO:0033227,5.567585148109348e-4,0.999988873439825,3,5,dsRNA transport,BP
GO:0006066,5.615638725066578e-4,0.9997353512308039,31,363,alcohol metabolic process,BP
GO:0048284,5.673493500872816e-4,0.9998209958267837,15,124,organelle fusion,BP
GO:0017158,5.74711422087956e-4,0.9998273615558703,14,111,regulation of calcium ion-dependent exocytosis,BP
GO:0050772,5.808886193336498e-4,0.9998456127776575,12,85,positive regulation of axonogenesis,BP
GO:0030425,5.843409058699513e-4,0.9996780319059344,47,618,dendrite,CC
GO:2001234,5.866643943014916e-4,0.9997644467568655,22,229,negative regulation of apoptotic signaling pathway,BP
GO:0000987,5.867547915312571e-4,0.9996861821284879,43,543,proximal promoter sequence-specific DNA binding,MF
GO:0040012,5.940590230382643e-4,0.9996353915978077,68,1061,regulation of locomotion,BP
GO:0051054,5.946681208436412e-4,0.9997610211719123,22,228,positive regulation of DNA metabolic process,BP
GO:0097039,6.035998796387672e-4,0.9999875915285271,3,5,protein linear polyubiquitination,BP
GO:0035637,6.072944602561283e-4,0.9997621643916118,21,201,multicellular organismal signaling,BP
GO:0000784,6.084745125995899e-4,0.9998152780833722,14,121,"nuclear chromosome, telomeric region",CC
GO:0075522,6.109672590333943e-4,0.9999672473531167,4,10,IRES-dependent viral translational initiation,BP
GO:0044003,6.201320339823422e-4,0.9998880316772373,8,46,modification by symbiont of host morphology or physiology,BP
GO:0034504,6.247647683057426e-4,0.9997363056049601,24,261,protein localization to nucleus,BP
GO:0097447,6.283182905726687e-4,0.999652563517447,47,620,dendritic tree,CC
GO:1904872,6.288304534711297e-4,0.9999431441312104,5,18,regulation of telomerase RNA localization to Cajal body,BP
GO:0030512,6.439257374668481e-4,0.999838388882151,11,80,negative regulation of transforming growth factor beta receptor signaling pathway,BP
GO:0007034,6.51655028630134e-4,0.999781849164154,16,141,vacuolar transport,BP
GO:0048872,6.543053563351307e-4,0.999728830458712,23,245,homeostasis of number of cells,BP
GO:0071902,6.550411154632944e-4,0.999697059119545,29,334,positive regulation of protein serine/threonine kinase activity,BP
GO:0101002,6.577459505081042e-4,0.9997544781004148,19,185,ficolin-1-rich granule,CC
GO:0006302,6.631411552464714e-4,0.99972485552206,23,246,double-strand break repair,BP
GO:0043565,6.669685564694285e-4,0.9995779260004348,76,1118,sequence-specific DNA binding,MF
GO:0032956,6.680021814776762e-4,0.9996905725722788,29,338,regulation of actin cytoskeleton organization,BP
GO:0051588,6.729734450056827e-4,0.9997742556161862,16,138,regulation of neurotransmitter transport,BP
GO:0000280,6.772906098176145e-4,0.999668467756299,33,407,nuclear division,BP
GO:0090174,6.865987167616826e-4,0.9998011904204656,13,100,organelle membrane fusion,BP
GO:2000573,6.882042510938679e-4,0.9998406336651758,10,67,positive regulation of DNA biosynthetic process,BP
GO:2001235,6.935343503565413e-4,0.9997478793132336,18,176,positive regulation of apoptotic signaling pathway,BP
GO:0007265,6.958911766516691e-4,0.9996472846637134,36,446,Ras protein signal transduction,BP
GO:0045926,6.994053924137722e-4,0.9997086089372358,23,247,negative regulation of growth,BP
GO:0070848,7.023915083024543e-4,0.9995969783226123,52,727,response to growth factor,BP
GO:0030141,7.049687759801831e-4,0.9995844824967912,57,831,secretory granule,CC
GO:0150011,7.062452383203233e-4,0.9999606179174796,4,10,regulation of neuron projection arborization,BP
GO:0006335,7.07253638706047e-4,0.9999087896370595,6,31,DNA replication-dependent nucleosome assembly,BP
GO:0034723,7.07253638706047e-4,0.9999087896370595,6,31,DNA replication-dependent nucleosome organization,BP
GO:0017015,7.090620534795461e-4,0.9997814835517295,14,119,regulation of transforming growth factor beta receptor signaling pathway,BP
GO:0070203,7.153350998438064e-4,0.9999583811302506,4,11,regulation of establishment of protein localization to telomere,BP
GO:0043621,7.160525954808654e-4,0.9998500882256803,9,55,protein self-association,MF
GO:0046649,7.225419978312012e-4,0.9995948525309991,48,656,lymphocyte activation,BP
GO:0072332,7.275910816037412e-4,0.9998149511607968,11,78,intrinsic apoptotic signaling pathway by p53 class mediator,BP
GO:0023061,7.298871609915465e-4,0.9996253024370909,37,459,signal release,BP
GO:0019049,7.331852483919422e-4,0.9999838635803339,3,5,evasion or tolerance of host defenses by virus,BP
GO:0044413,7.331852483919422e-4,0.9999838635803339,3,5,avoidance of host defenses,BP
GO:0044415,7.331852483919422e-4,0.9999838635803339,3,5,evasion or tolerance of host defenses,BP
GO:0051832,7.331852483919422e-4,0.9999838635803339,3,5,avoidance of defenses of other organism involved in symbiotic interaction,BP
GO:0051834,7.331852483919422e-4,0.9999838635803339,3,5,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP
GO:0023014,7.345355977121217e-4,0.9995508015540141,65,963,signal transduction by protein phosphorylation,BP
GO:0061448,7.354954769414625e-4,0.9996797483146794,25,271,connective tissue development,BP
GO:0044463,7.448266421424554e-4,0.999505205829889,93,1459,cell projection part,CC
GO:0120038,7.448266421424554e-4,0.999505205829889,93,1459,plasma membrane bounded cell projection part,CC
GO:0050729,7.449324299298833e-4,0.9997467155713401,16,150,positive regulation of inflammatory response,BP
GO:0002758,7.462084186923772e-4,0.99966833747139106,26,296,innate immune response-activating signal transduction,BP
GO:0010256,7.46265322890153e-4,0.99962416079078,35,435,endomembrane system organization,BP
GO:0007610,7.472956154195476e-4,0.999589028799287,45,592,behavior,BP
GO:0006338,7.482899739677342e-4,0.9997260242315058,18,178,chromatin remodeling,BP
GO:0007568,7.527449706862662e-4,0.9996593436602972,27,313,aging,BP
GO:0005123,7.531367683456191e-4,0.9999300449354833,5,17,death receptor binding,MF
GO:0042695,7.545707525523069e-4,0.9999832242655258,3,5,thelarche,BP
GO:0060744,7.545707525523069e-4,0.9999832242655258,3,5,mammary gland branching involved in thelarche,BP
GO:0001649,7.546867814716894e-4,0.9996984361954627,21,217,osteoblast differentiation,BP
GO:0006836,7.574762680090146e-4,0.9996695957730956,25,268,neurotransmitter transport,BP
GO:1990138,7.655491099171012e-4,0.9997198690766711,18,167,neuron projection extension,BP
GO:1903265,7.669000154680919e-4,0.9999562640828344,4,10,positive regulation of tumor necrosis factor-mediated signaling pathway,BP
GO:0005522,7.759800349507867e-4,0.9999538418103396,4,11,profilin binding,MF
GO:0002224,7.776136188939612e-4,0.9997348364113969,16,146,toll-like receptor signaling pathway,BP
GO:0075525,7.828989073046742e-4,0.9999823674277779,3,5,viral translational termination-reinitiation,BP
GO:0005774,7.883684118892808e-4,0.9996152123521174,32,394,vacuolar membrane,CC
GO:0050806,7.931081563130294e-4,0.9997088012908933,18,168,positive regulation of synaptic transmission,BP
GO:0060968,0.00079311915921445055,0.9997397723521341,15,140,regulation of gene silencing,BP
GO:0006898,7.981360135415572e-4,0.9996638088786299,23,255,receptor-mediated endocytosis,BP
GO:0051047,8.017855512630305e-4,0.9995988845690106,34,423,positive regulation of secretion,BP
GO:0060751,8.079914024326096e-4,0.999981599153832,3,5,branch elongation involved in mammary gland duct branching,BP
GO:0032594,8.088360111247891e-4,0.9998713404560453,7,34,protein transport within lipid bilayer,BP
GO:0032552,8.096718891786869e-4,0.9999815473934036,3,5,deoxyribonucleotide binding,MF
GO:0008630,8.098415518228955e-4,0.9997606589313748,13,104,intrinsic apoptotic signaling pathway in response to DNA damage,BP
GO:0045185,8.20630221281142e-4,0.9997569841095434,13,105,maintenance of protein location,BP
GO:0030308,8.207520487291905e-4,0.9996877331584049,19,186,negative regulation of cell growth,BP
GO:0048568,8.211970905058269e-4,0.9995843308967584,35,425,embryonic organ development,BP
GO:0046661,8.222705821242785e-4,0.9997073595098025,17,156,male sex differentiation,BP
GO:0019637,8.306675405507502e-4,0.9994728506065944,74,1154,organophosphate metabolic process,BP
GO:0045787,8.314394211011228e-4,0.9995978416103548,31,386,positive regulation of cell cycle,BP
GO:0001968,8.329779055893528e-4,0.9998912734203017,6,27,fibronectin binding,MF
GO:0051270,8.358009871009068e-4,0.9994799131552644,68,1072,regulation of cellular component movement,BP
GO:1903052,8.404064162319637e-4,0.9997363620457566,14,119,positive regulation of proteolysis involved in cellular protein catabolic process,BP
GO:0010954,8.423942200160122e-4,0.9998886223994277,6,29,positive regulation of protein processing,BP
GO:0032092,8.44221845361647e-4,0.9997643098461968,12,93,positive regulation of protein binding,BP
GO:0060330,8.44258900222067e-4,0.9998909061067489,6,25,regulation of response to interferon-gamma,BP
GO:0060334,8.44258900222067e-4,0.9998909061067489,6,25,regulation of interferon-gamma-mediated signaling pathway,BP
GO:0051604,8.512959708365293e-4,0.999604998824785,28,335,protein maturation,BP
GO:0071706,8.605184066577867e-4,0.9996915814748454,17,167,tumor necrosis factor superfamily cytokine production,BP
GO:0051020,8.620779268091283e-4,0.999536575288562,41,540,GTPase binding,MF
GO:0090670,8.634237726982434e-4,0.9999151477715943,5,19,RNA localization to Cajal body,BP
GO:0090671,8.634237726982434e-4,0.9999151477715943,5,19,telomerase RNA localization to Cajal body,BP
GO:0090672,8.634237726982434e-4,0.9999151477715943,5,19,telomerase RNA localization,BP
GO:0090685,8.634237726982434e-4,0.9999151477715943,5,19,RNA localization to nucleus,BP
GO:0032436,8.677799507045934e-4,0.9997738407077771,11,81,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP
GO:0001725,8.724705338421862e-4,0.9997915127394209,10,67,stress fiber,CC
GO:0097517,8.724705338421862e-4,0.9997915127394209,10,67,contractile actin filament bundle,CC
GO:0030111,8.734054463025141e-4,0.9995821718602587,30,360,regulation of Wnt signaling pathway,BP
GO:0004527,8.747430752542341e-4,0.9997719907611163,11,80,exonuclease activity,MF
GO:0006665,8.765497008663362e-4,0.9996860234323688,17,158,sphingolipid metabolic process,BP
GO:0150063,8.808714031140882e-4,0.9995729364112854,31,366,visual system development,BP
GO:0014916,8.980634420165328e-4,0.9999748322679409,3,6,regulation of lung blood pressure,BP
GO:0030662,8.996428303286197e-4,0.9996766347641077,17,162,coated vesicle membrane,CC
GO:0031983,9.056041633153065e-4,0.9995779205233636,28,339,vesicle lumen,CC
GO:0060828,9.057414118044467e-4,0.9995991531348875,25,283,regulation of canonical Wnt signaling pathway,BP
GO:0036465,9.066441910363714e-4,0.9997819857270017,10,68,synaptic vesicle recycling,BP
GO:0008637,9.097398800617077e-4,0.9997117428779898,14,123,apoptotic mitochondrial changes,BP
GO:1903201,9.101379117809684e-4,0.9997794830463435,10,75,regulation of oxidative stress-induced cell death,BP
GO:0043687,9.116713749429256e-4,0.9995626274095614,30,361,post-translational protein modification,BP
GO:0090066,9.140573519021436e-4,0.9995155595188405,39,502,regulation of anatomical structure size,BP
GO:0046165,9.214790508214513e-4,0.9996566333036616,18,174,alcohol biosynthetic process,BP
GO:1903532,9.315600140829508e-4,0.9995406035225597,32,394,positive regulation of secretion by cell,BP
GO:1902041,9.317198517469071e-4,0.9997964867094636,9,58,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP
GO:1902903,9.401662980580815e-4,0.9995543460903024,29,347,regulation of supramolecular fiber organization,BP
GO:0090201,9.422542998283851e-4,0.9999055497893872,5,19,negative regulation of release of cytochrome c from mitochondria,BP
GO:0051668,9.425033586181546e-4,0.9996724198737134,16,148,localization within membrane,BP
GO:2001269,9.537036166908439e-4,0.9999399838291481,4,11,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP
GO:0060589,9.564547106779835e-4,0.9995462456864906,29,343,nucleoside-triphosphatase regulator activity,MF
GO:0005509,9.591741183437941e-4,0.9994448894935839,51,701,calcium ion binding,MF
GO:0002218,9.638209409861551e-4,0.9995562046135492,27,317,activation of innate immune response,BP
GO:0001836,9.748607765216195e-4,0.9997853631692455,9,59,release of cytochrome c from mitochondria,BP
GO:1900019,9.795653432750533e-4,0.9999761243754036,3,5,regulation of protein kinase C activity,BP
GO:1900020,9.795653432750533e-4,0.9999761243754036,3,5,positive regulation of protein kinase C activity,BP
GO:0034644,9.79824098651039e-4,0.999740536446171,11,82,cellular response to UV,BP
GO:0043112,9.806429149967824e-4,0.9996206904611923,19,192,receptor metabolic process,BP
GO:1903203,9.820379236281068e-4,0.9998684158830092,6,26,regulation of oxidative stress-induced neuron death,BP
GO:0032612,9.886589195172608e-4,0.9996998057220231,13,114,interleukin-1 production,BP
GO:0032611,9.939378292913648e-4,0.9997158012615021,12,101,interleukin-1 beta production,BP
GO:0060749,0.0010086764859838057,0.9998985212081901,5,18,mammary gland alveolus development,BP
GO:0061377,0.0010086764859838057,0.9998985212081901,5,18,mammary gland lobule development,BP
GO:0009306,0.0010089038520968967,0.9994441981852107,43,586,protein secretion,BP
GO:0022616,0.001015254331747753,0.9998622446936909,6,27,DNA strand elongation,BP
GO:0043044,0.001020992800852442,0.999727219995831,11,87,ATP-dependent chromatin remodeling,BP
GO:0035196,0.0010242301543646522,0.9997999901576615,8,46,production of miRNAs involved in gene silencing by miRNA,BP
GO:0031967,0.0010252205369011478,0.9993459294874589,73,1158,organelle envelope,CC
GO:0031975,0.0010252205369011478,0.9993459294874589,73,1158,envelope,CC
GO:1901987,0.0010291784068269525,0.9994708163500657,35,474,regulation of cell cycle phase transition,BP
GO:0097237,0.0010294182965325353,0.9995672103332307,22,246,cellular response to toxic substance,BP
GO:0016504,0.0010306703696346027,0.9998271644262496,7,37,peptidase activator activity,MF
GO:0010803,0.0010307065529550003,0.9997712357065174,9,59,regulation of tumor necrosis factor-mediated signaling pathway,BP
GO:0048193,0.0010340354275898615,0.9994996547774029,30,367,Golgi vesicle transport,BP
GO:0031098,0.001036360175740656,0.9995205650317827,27,313,stress-activated protein kinase signaling cascade,BP
GO:0045652,0.0010379598360837354,0.9997438386854766,10,76,regulation of megakaryocyte differentiation,BP
GO:0099632,0.001040702626588853,0.999858955369005,6,26,protein transport within plasma membrane,BP
GO:0099637,0.001040702626588853,0.999858955369005,6,26,neurotransmitter receptor transport,BP
GO:0030335,0.0010438540563017782,0.9994418647063659,39,541,positive regulation of cell migration,BP
GO:0003714,0.0010442190763253253,0.9995609508125404,22,238,transcription corepressor activity,MF
GO:0005891,0.00105254505308898,0.9997950491338994,8,43,voltage-gated calcium channel complex,CC
GO:1903829,0.0010652744833445531,0.9995058724282033,27,322,positive regulation of cellular protein localization,BP
GO:0048306,0.0010655693911945372,0.9997617157642205,9,61,calcium-dependent protein binding,MF
GO:0032182,0.001067708302126243,0.9996930075320265,12,96,ubiquitin-like protein binding,MF
GO:1905288,0.0010729051029819932,0.9999263634486707,4,13,vascular associated smooth muscle cell apoptotic process,BP
GO:1905459,0.0010729051029819932,0.9999263634486707,4,13,regulation of vascular associated smooth muscle cell apoptotic process,BP
GO:0070202,0.0010745293132975093,0.9999279892307305,4,12,regulation of establishment of protein localization to chromosome,BP
GO:0048066,0.0010803835824623402,0.9997867801344168,8,47,developmental pigmentation,BP
GO:1904816,0.0010969516417913446,0.9999260692028874,4,12,"positive regulation of protein localization to chromosome, telomeric region",BP
GO:0048880,0.0011051387772626903,0.999456236179634,31,371,sensory system development,BP
GO:0051052,0.0011146831521206598,0.999437261895482,33,417,regulation of DNA metabolic process,BP
GO:0043009,0.00111842261765979,0.9993675023049787,46,622,chordate embryonic development,BP
GO:1990173,0.0011188355331104498,0.9999241846643427,4,12,protein localization to nucleoplasm,BP
GO:0061337,0.0011189950304503467,0.9996051608951338,16,143,cardiac conduction,BP
GO:2000059,0.0011452143463147855,0.999771424819862,8,48,negative regulation of ubiquitin-dependent protein catabolic process,BP
GO:0090181,0.0011483567857195804,0.999739755525238,9,63,regulation of cholesterol metabolic process,BP
GO:0019048,0.0011497498996432636,0.999802288175399,7,39,modulation by virus of host morphology or physiology,BP
GO:0070169,0.0011556349121576975,0.9997694869480709,8,47,positive regulation of biomineral tissue development,BP
GO:0030855,0.0011569795120576012,0.999331868999571,49,682,epithelial cell differentiation,BP
GO:0060338,0.0011575944410886405,0.9998032502169091,7,35,regulation of type I interferon-mediated signaling pathway,BP
GO:0005791,0.0011590540959999676,0.9996858238451966,11,85,rough endoplasmic reticulum,CC
GO:0046718,0.001163235287272088,0.9996220051217801,14,121,viral entry into host cell,BP
GO:0034250,0.0011751963676202564,0.999582347091999,16,151,positive regulation of cellular amide metabolic process,BP
GO:0008253,0.0012014094149388629,0.999916981748364,4,12,5'-nucleotidase activity,MF
GO:0035257,0.0012049979695617048,0.9995707083874295,16,151,nuclear hormone receptor binding,MF
GO:0044843,0.0012062544295441773,0.9994638092692859,24,291,cell cycle G1/S phase transition,BP
GO:0007256,0.0012117977026087762,0.9999185581180164,4,11,activation of JNKK activity,BP
GO:0045765,0.0012148559746681348,0.9994293937565764,27,370,regulation of angiogenesis,BP
GO:0036475,0.0012191304836879579,0.9998285063527873,6,27,neuron death in response to oxidative stress,BP
GO:2000108,0.001220817875576176,0.999827275850525,6,28,positive regulation of leukocyte apoptotic process,BP
GO:0016358,0.0012211359561607885,0.9994805887644231,22,232,dendrite development,BP
GO:0003743,0.0012459897522697208,0.9997465510445275,8,51,translation initiation factor activity,MF
GO:0070087,0.0012471316216296163,0.999960763013161,3,6,chromo shadow domain binding,MF
GO:1902947,0.0012472754634434368,0.9999107880216335,4,13,regulation of tau-protein kinase activity,BP
GO:0051150,0.0012548026073112028,0.9997772614729084,7,46,regulation of smooth muscle cell differentiation,BP
GO:0070382,0.0012551706987547159,0.9994901456847499,20,206,exocytic vesicle,CC
GO:0004842,0.001264990482915426,0.9993717162012457,31,382,ubiquitin-protein transferase activity,MF
GO:0050853,0.0012652364782065704,0.9997099263418339,9,61,B cell receptor signaling pathway,BP
GO:0002244,0.0012674665836975244,0.999529162211714,17,166,hematopoietic progenitor cell differentiation,BP
GO:0048260,0.0012681422666894796,0.9997417824096384,8,50,positive regulation of receptor-mediated endocytosis,BP
GO:0035567,0.0012701490079795996,0.9995452910972106,16,150,non-canonical Wnt signaling pathway,BP
GO:0019042,0.001272356130679283,0.9999133309353074,4,11,viral latency,BP
GO:0008584,0.0012750291429635967,0.9995619839068709,15,134,male gonad development,BP
GO:1901617,0.001284836813096206,0.9994273619605555,24,270,organic hydroxy compound biosynthetic process,BP
GO:0007167,0.0012858597114156888,0.9991860858683655,68,1036,enzyme linked receptor protein signaling pathway,BP
GO:0034220,0.0012889449109052809,0.9991632248533479,76,1164,ion transmembrane transport,BP
GO:2000379,0.0012890326210311346,0.9996207837507496,12,97,positive regulation of reactive oxygen species metabolic process,BP
GO:0043001,0.0012976388492210954,0.9997720744290766,7,39,Golgi to plasma membrane protein transport,BP
GO:0072527,0.0013182074452628098,0.9996111666579092,12,97,pyrimidine-containing compound metabolic process,BP
GO:0071074,0.0013317825194215547,1,2,2,eukaryotic initiation factor eIF2 binding,MF
GO:0002443,0.0013355298429202338,0.9992096107817953,52,761,leukocyte mediated immunity,BP
GO:2000147,0.0013374447779804753,0.9992686417024055,40,565,positive regulation of cell motility,BP
GO:0031012,0.0013376446059439613,0.9992695054550024,40,526,extracellular matrix,CC
GO:2001238,0.0013475821982147432,0.9997234578597446,8,49,positive regulation of extrinsic apoptotic signaling pathway,BP
GO:1901998,0.0013543817913067432,0.9997603110148234,7,39,toxin transport,BP
GO:1903319,0.001355020847832966,0.9998015361541431,6,31,positive regulation of protein maturation,BP
GO:0046546,0.001361635086211395,0.999528912038088,15,135,development of primary male sexual characteristics,BP
GO:0044212,0.0013677467733732547,0.999144940852298,64,934,transcription regulatory region DNA binding,MF
GO:0000470,0.0013694457534032755,0.9998475776759558,5,21,maturation of LSU-rRNA,BP
GO:0045351,0.0013701902728967812,0.9999047380861208,4,11,type I interferon biosynthetic process,BP
GO:0098644,0.0013735001044443973,0.9998499637030327,5,19,complex of collagen trimers,CC
GO:0045732,0.0013773859363259344,0.9994354291031365,20,213,positive regulation of protein catabolic process,BP
GO:0050817,0.001399348089721507,0.9993281241239472,28,340,coagulation,BP
GO:0006271,0.0014046092648411792,0.9998441796277625,5,20,DNA strand elongation involved in DNA replication,BP
GO:0001067,0.0014063709325889944,0.9991197371878798,64,935,regulatory region nucleic acid binding,MF
GO:0002263,0.0014087801810068023,0.9991780680377371,49,706,cell activation involved in immune response,BP
GO:0055038,0.001423011208412974,0.9996345578139668,10,73,recycling endosome membrane,CC
GO:1901741,0.0014262676424419349,0.9998428451918397,5,19,positive regulation of myoblast fusion,BP
GO:0016064,0.0014429143400432258,0.9995431116914493,13,113,immunoglobulin mediated immune response,BP
GO:0140014,0.0014648115623139037,0.9993528645674362,23,264,mitotic nuclear division,BP
GO:0001736,0.0014750482603116952,0.9995077360472603,14,124,establishment of planar polarity,BP
GO:0007164,0.0014750482603116952,0.9995077360472603,14,124,establishment of tissue polarity,BP
GO:0034698,0.001491154487407049,0.9997804928109301,6,28,response to gonadotropin,BP
GO:0000819,0.0015036469170428034,0.9994126729722773,18,188,sister chromatid segregation,BP
GO:0032482,0.0015048844503304216,0.9996102222982978,10,74,Rab protein signal transduction,BP
GO:0043010,0.001506888252645732,0.999284288807666,27,314,camera-type eye development,BP
GO:0004518,0.0015138736094094337,0.9993910320594699,19,199,nuclease activity,MF
GO:0001654,0.0015175830157673196,0.99924716717438955,30,362,eye development,BP
GO:0030133,0.0015214206994039056,0.9992446932667474,30,371,transport vesicle,CC
GO:0042058,0.0015233645308014813,0.9995722378874423,11,86,regulation of epidermal growth factor receptor signaling pathway,BP
GO:0048013,0.0015314067526822077,0.9995696912603447,11,86,ephrin receptor signaling pathway,BP
GO:0032507,0.001531585288525477,0.9996023560141305,10,74,maintenance of protein location in cell,BP
GO:0042110,0.0015415395993559392,0.9991886040455341,35,456,T cell activation,BP
GO:0006790,0.001573372793909801,0.9992171544664882,30,371,sulfur compound metabolic process,BP
GO:0021537,0.0015751429565927567,0.9993012853347977,23,250,telencephalon development,BP
GO:0007183,0.001591927524021827,0.9998782179582069,4,13,SMAD protein complex assembly,BP
GO:0035458,0.0016018650850154717,0.9998168478353724,5,20,cellular response to interferon-beta,BP
GO:1903055,0.0016041611171686986,0.9998148514874332,5,21,positive regulation of extracellular matrix organization,BP
GO:0050661,0.0016166594782109028,0.9996572114648068,8,51,NADP binding,MF
GO:1903555,0.0016245891038482027,0.9994022750606653,16,162,regulation of tumor necrosis factor superfamily cytokine production,BP
GO:0008201,0.0016352045299936157,0.9993774357915005,17,168,heparin binding,MF
GO:0032640,0.0016438931294179226,0.9993944646524782,16,162,tumor necrosis factor production,BP
GO:0071900,0.001648284290076513,0.99910381917211,38,511,regulation of protein serine/threonine kinase activity,BP
GO:0010763,0.0016617687644356815,0.9998713560149233,4,13,positive regulation of fibroblast migration,BP
GO:0009887,0.001663168181852988,0.998929023179858,70,1059,animal organ morphogenesis,BP
GO:0018209,0.0016659790514969458,0.99920260387338,27,321,peptidyl-serine modification,BP
GO:0051897,0.0016824682419512155,0.999356845318252,17,174,positive regulation of protein kinase B signaling,BP
GO:1904674,0.001689194018134842,1,2,2,positive regulation of somatic stem cell population maintenance,BP
GO:0042752,0.0016892241339937172,0.9994554568212131,13,113,regulation of circadian rhythm,BP
GO:0007257,0.0016962358988278747,0.9996876309095235,7,39,activation of JUN kinase activity,BP
GO:0021953,0.0016982488508243848,0.999330414457341,18,179,central nervous system neuron differentiation,BP
GO:0019724,0.001705471148925992,0.9994491411754555,13,115,B cell mediated immunity,BP
GO:0043406,0.0017057268639562339,0.9992378867512003,23,258,positive regulation of MAP kinase activity,BP
GO:0019103,0.0017093180820445233,0.9999398593216611,3,6,pyrimidine nucleotide binding,MF
GO:1900121,0.0017217384609937406,0.9998653983327146,4,13,negative regulation of receptor binding,BP
GO:0004197,0.0017222803149825557,0.9994433280495576,13,114,cysteine-type endopeptidase activity,MF
GO:0051258,0.0017307400131114086,0.9992100382973631,24,281,protein polymerization,BP
GO:0072529,0.0017318217773438368,0.9996798994102324,7,39,pyrimidine-containing compound catabolic process,BP
GO:0061462,0.0017342199424800933,0.9996785044071034,7,40,protein localization to lysosome,BP
GO:0060998,0.0017351831382570984,0.9995421746159231,10,73,regulation of dendritic spine development,BP
GO:0019200,0.0017512326743141324,0.9997937494149822,5,21,carbohydrate kinase activity,MF
GO:0060142,0.0017651424140005295,0.9997299175395872,6,29,regulation of syncytium formation by plasma membrane fusion,BP
GO:0038061,0.0017658026222017915,0.9993208985229941,17,181,NIK/NF-kappaB signaling,BP
GO:0001085,0.0017690358822713575,0.9993447444624423,16,155,RNA polymerase II transcription factor binding,MF
GO:0044448,0.0017740961039560072,0.9992969756528918,18,184,cell cortex part,CC
GO:0061741,0.0017863497645903988,1,2,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP
GO:0060205,0.0017868654651631817,0.9991393517393201,27,338,cytoplasmic vesicle lumen,CC
GO:0000786,0.0017878388411392636,0.999520059618955,10,91,nucleosome,CC
GO:0030501,0.001789784329222903,0.9996672438281385,7,39,positive regulation of bone mineralization,BP
GO:0034774,0.0017929490287990945,0.9991497638494433,26,321,secretory granule lumen,CC
GO:0090288,0.0017940335754389359,0.9993338816802227,16,159,negative regulation of cellular response to growth factor stimulus,BP
GO:0031667,0.001802228902776346,0.9990235824653154,37,498,response to nutrient levels,BP
GO:1901990,0.0018068721296428066,0.9990686100317588,32,438,regulation of mitotic cell cycle phase transition,BP
GO:0030544,0.001822188067724146,0.999657507871164,7,42,Hsp70 protein binding,MF
GO:0045778,0.0018226066587366811,0.9994752773274752,11,89,positive regulation of ossification,BP
GO:2001252,0.0018306174547054299,0.9992946940952341,17,173,positive regulation of chromosome organization,BP
GO:0043130,0.0018339677465145105,0.9995111170423565,10,76,ubiquitin binding,MF
GO:0032731,0.0018365025651455795,0.9996018669430102,8,52,positive regulation of interleukin-1 beta production,BP
GO:0098693,0.0018452711737209733,0.9993996533899466,13,111,regulation of synaptic vesicle cycle,BP
GO:0070059,0.0018731626106629278,0.9995445047359426,9,62,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP
GO:0030176,0.0018733776563813077,0.9993565517892731,14,132,integral component of endoplasmic reticulum membrane,CC
GO:0007611,0.0018757266046242054,0.9991559056370961,23,255,learning or memory,BP
GO:0022409,0.0018906000371235708,0.9991651954183131,22,249,positive regulation of cell-cell adhesion,BP
GO:0002683,0.0018919113305450434,0.9990011554820729,34,454,negative regulation of immune system process,BP
GO:0031265,0.001901606306242612,0.9999305029120049,3,6,CD95 death-inducing signaling complex,CC
GO:0044292,0.0019055426947433716,0.9998467758861462,4,13,dendrite terminus,CC
GO:0050708,0.0019076644119531794,0.9989822359327157,35,467,regulation of protein secretion,BP
GO:0000354,0.0019196825903157833,1,2,2,cis assembly of pre-catalytic spliceosome,BP
GO:0002480,0.0019232369378224033,1,2,2,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",BP
GO:0031638,0.001923667046575225,0.9995791660524305,8,53,zymogen activation,BP
GO:1900180,0.0019292273493064405,0.9993677514467599,13,116,regulation of protein localization to nucleus,BP
GO:0002428,0.0019316166075403313,1,2,2,antigen processing and presentation of peptide antigen via MHC class Ib,BP
GO:0097110,0.0019460679098533863,0.9995259305259245,9,59,scaffold protein binding,MF
GO:0043021,0.0019586044374948486,0.9993237825917263,14,133,ribonucleoprotein complex binding,MF
GO:0031050,0.0019867775766718335,0.9995645150598624,8,51,dsRNA processing,BP
GO:0070918,0.0019867775766718335,0.9995645150598624,8,51,production of small RNA involved in gene silencing by RNA,BP
GO:0008022,0.0020011186343341595,0.9991976642299186,18,187,protein C-terminus binding,MF
GO:0071383,0.0020013191510138252,0.999112297833961,22,248,cellular response to steroid hormone stimulus,BP
GO:0000978,0.002025811486686396,0.9988673691880701,40,528,RNA polymerase II proximal promoter sequence-specific DNA binding,MF
GO:0070234,0.002054211871280844,0.9998279854187001,4,14,positive regulation of T cell apoptotic process,BP
GO:0030139,0.0020556841207520077,0.9990489115753863,24,284,endocytic vesicle,CC
GO:1990454,0.0020574750772792,0.9998349876951187,4,12,L-type voltage-gated calcium channel complex,CC
GO:0035455,0.002068412533888116,0.9997468249398616,5,21,response to interferon-alpha,BP
GO:0097617,0.002079788194360333,0.999828642496042,4,13,annealing activity,MF
GO:1904814,0.0020814659572360476,0.9998250630036911,4,14,"regulation of protein localization to chromosome, telomeric region",BP
GO:0008252,0.0020838934426237704,0.9998248021770401,4,14,nucleotidase activity,MF
GO:0098609,0.0020856745543174388,0.9987085628593678,57,833,cell-cell adhesion,BP
GO:0002366,0.0020865810574087064,0.9987650231704606,48,702,leukocyte activation involved in immune response,BP
GO:0030016,0.002089660133183,0.999091200305699,21,224,myofibril,CC
GO:0051582,0.0020950283802452035,0.9999207377400295,3,6,positive regulation of neurotransmitter uptake,BP
GO:1902737,0.002116143851852278,1,2,2,dendritic filopodium,CC
GO:0031380,0.002117301466607475,1,2,2,nuclear RNA-directed RNA polymerase complex,CC
GO:0050878,0.002121982181469459,0.9988391529581766,37,497,regulation of body fluid levels,BP
GO:0062023,0.002128498774169287,0.9988928570922329,32,406,collagen-containing extracellular matrix,CC
GO:0040017,0.0021325740486421033,0.9987929939719112,41,595,positive regulation of locomotion,BP
GO:0042089,0.002139159909184407,0.9992886427519629,13,123,cytokine biosynthetic process,BP
GO:0009650,0.0021408402647275526,0.9998221837716277,4,13,UV protection,BP
GO:0008202,0.0021443510312952455,0.9989540635074211,27,331,steroid metabolic process,BP
GO:1901558,0.002159499598082671,1,2,2,response to metformin,BP
GO:0008266,0.0021860246192364876,0.9996492347680984,6,30,poly(U) RNA binding,MF
GO:0060485,0.0021862975809719704,0.9989844162836912,24,276,mesenchyme development,BP
GO:0051056,0.0021957626809078422,0.9989121547936032,28,338,regulation of small GTPase mediated signal transduction,BP
GO:0030426,0.0022191269200198677,0.9991293770226028,17,171,growth cone,CC
GO:0003684,0.0022220343246996867,0.9994438479976785,9,65,damaged DNA binding,MF
GO:0045930,0.002230180650623319,0.9989243345413195,26,333,negative regulation of mitotic cell cycle,BP
GO:0005765,0.0022410121286673334,0.9989030222286964,27,336,lysosomal membrane,CC
GO:0030148,0.0022667486886254794,0.999284239179202,12,102,sphingolipid biosynthetic process,BP
GO:1903305,0.0022681933959466938,0.9991380067084357,16,158,regulation of regulated secretory pathway,BP
GO:1901522,0.0022688256002162187,0.999713974414974,5,22,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP
GO:0140058,0.002285412452078512,0.9997136983345527,5,21,neuron projection arborization,BP
GO:0006163,0.002290991467123012,0.9987183362059777,39,556,purine nucleotide metabolic process,BP
GO:0009147,0.0022933383339149953,0.9997101602509153,5,22,pyrimidine nucleoside triphosphate metabolic process,BP
GO:0045649,0.0022966076495630643,0.9997096508067697,5,22,regulation of macrophage differentiation,BP
GO:0007596,0.00229695642060631,0.9988737845755713,27,334,blood coagulation,BP
GO:0044420,0.00229816335569078,0.999484217511004,8,51,extracellular matrix component,CC
GO:0007178,0.0023099896325929907,0.9988507106425222,28,347,transmembrane receptor protein serine/threonine kinase signaling pathway,BP
GO:0000082,0.0023103456012421087,0.998960414997628,22,272,G1/S transition of mitotic cell cycle,BP
GO:0009163,0.0023107451143629673,0.9995468525785284,7,42,nucleoside biosynthetic process,BP
GO:0030619,0.0023128790874006274,0.9999000665629535,3,7,U1 snRNA binding,MF
GO:0086067,0.0023132746575957076,0.9998082922040302,4,12,AV node cell to bundle of His cell communication,BP
GO:0098852,0.0023156081946185906,0.9988637292683668,27,337,lytic vacuole membrane,CC
GO:0010656,0.0023222087020082403,0.9995344378011778,7,54,negative regulation of muscle cell apoptotic process,BP
GO:0006012,0.0023331445820432154,0.9998014990856924,4,13,galactose metabolic process,BP
GO:1901657,0.0023351693035061436,0.9991428477487699,15,145,glycosyl compound metabolic process,BP
GO:1903313,0.0023412197835141688,0.9993534453219278,10,78,positive regulation of mRNA metabolic process,BP
GO:1902416,0.002350421541835559,0.9998978584212647,3,7,positive regulation of mRNA binding,BP
GO:0042692,0.00235342952702734,0.9988105196589396,29,377,muscle cell differentiation,BP
GO:0045667,0.0023555294256274676,0.9992088014671874,13,120,regulation of osteoblast differentiation,BP
GO:0034399,0.0023602260154054425,0.9991688045795701,14,131,nuclear periphery,CC
GO:0060147,0.0023612668458943215,0.9992468840094143,12,113,regulation of posttranscriptional gene silencing,BP
GO:0060966,0.0023612668458943215,0.9992468840094143,12,113,regulation of gene silencing by RNA,BP
GO:0006637,0.002361484675557442,0.9992494669481801,12,105,acyl-CoA metabolic process,BP
GO:0035383,0.002361484675557442,0.9992494669481801,12,105,thioester metabolic process,BP
GO:0039694,0.002361637138504112,0.999611955165913,6,32,viral RNA genome replication,BP
GO:0007000,0.002363598862259946,0.9998970803090755,3,7,nucleolus organization,BP
GO:0045004,0.0023664059987325656,1,2,2,DNA replication proofreading,BP
GO:0086014,0.0023711294899659186,0.9997030772998184,5,20,atrial cardiac muscle cell action potential,BP
GO:0086026,0.0023711294899659186,0.9997030772998184,5,20,atrial cardiac muscle cell to AV node cell signaling,BP
GO:0086066,0.0023711294899659186,0.9997030772998184,5,20,atrial cardiac muscle cell to AV node cell communication,BP
GO:0042107,0.0023718896581574585,0.9992014926637518,13,124,cytokine metabolic process,BP
GO:0038003,0.002372401176347724,0.9998019966091048,4,12,opioid receptor signaling pathway,BP
GO:0006284,0.002399629996535578,0.9995262189212514,7,42,base-excision repair,BP
GO:0034404,0.0024014977369973176,0.9989654627103457,20,225,nucleobase-containing small molecule biosynthetic process,BP
GO:0006513,0.0024092776144955556,0.9993889920702986,9,66,protein monoubiquitination,BP
GO:0060529,0.0024122567081786253,1,2,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP
GO:0044452,0.0024151103245804496,0.9990434677654395,17,177,nucleolar part,CC
GO:1902186,0.0024151211090757433,0.9996029233618421,6,31,regulation of viral release from host cell,BP
GO:0005215,0.0024152471043629403,0.998405691005702,73,1130,transporter activity,MF
GO:0010755,0.0024189986644343,0.9997879934115614,4,14,regulation of plasminogen activation,BP
GO:0051403,0.002419583031072324,0.998866237523585,24,284,stress-activated MAPK cascade,BP
GO:0032655,0.002420461499309868,0.9994503782221064,8,53,regulation of interleukin-12 production,BP
GO:0051153,0.002452925590831515,0.9992136783473872,12,114,regulation of striated muscle cell differentiation,BP
GO:0002121,0.0024560053449639773,1,2,2,inter-male aggressive behavior,BP
GO:0071541,0.002460150890155715,0.9998913310821691,3,7,"eukaryotic translation initiation factor 3 complex, eIF3m",CC
GO:0019081,0.0024627534042039,0.9997830740418056,4,14,viral translation,BP
GO:0052173,0.002475815933944001,0.9998903904374485,3,7,response to defenses of other organism involved in symbiotic interaction,BP
GO:0052200,0.002475815933944001,0.9998903904374485,3,7,response to host defenses,BP
GO:0075136,0.002475815933944001,0.9998903904374485,3,7,response to host,BP
GO:0010921,0.002482700742628328,0.9990146546173219,17,174,regulation of phosphatase activity,BP
GO:1902806,0.002485975826417652,0.9990092432422724,17,196,regulation of cell cycle G1/S phase transition,BP
GO:0008285,0.0024940043371712408,0.9985090026796647,48,739,negative regulation of cell proliferation,BP
GO:0006914,0.0024989539398375285,0.9986309034638213,36,495,autophagy,BP
GO:0061919,0.0024989539398375285,0.9986309034638213,36,495,process utilizing autophagic mechanism,BP
GO:0035258,0.0025069264559473845,0.9992469380880877,11,91,steroid hormone receptor binding,MF
GO:0051289,0.0025151614207618257,0.9992432407939649,11,93,protein homotetramerization,BP
GO:2000300,0.002531149541933799,0.9992939374259291,10,77,regulation of synaptic vesicle exocytosis,BP
GO:0007173,0.002534461111032736,0.9991417575424684,13,119,epidermal growth factor receptor signaling pathway,BP
GO:0032728,0.002536726901292746,0.9995805288442289,6,30,positive regulation of interferon-beta production,BP
GO:0008631,0.0025680286478723963,0.999485573001034,7,43,intrinsic apoptotic signaling pathway in response to oxidative stress,BP
GO:1903786,0.002570825264521338,1,2,2,regulation of glutathione biosynthetic process,BP
GO:0045653,0.0025710137557437163,0.999760939218153,4,17,negative regulation of megakaryocyte differentiation,BP
GO:0060090,0.0025805369254644304,0.9988554367259974,21,237,molecular adaptor activity,MF
GO:0018105,0.002585675402977069,0.9987610508405618,25,298,peptidyl-serine phosphorylation,BP
GO:0031428,0.0025970079464916565,0.9998830403726252,3,7,box C/D snoRNP complex,CC
GO:0045807,0.0026177777661751636,0.9990256162662879,15,152,positive regulation of endocytosis,BP
GO:0006643,0.0026193238902436937,0.9988919813294488,19,206,membrane lipid metabolic process,BP
GO:0006811,0.0026314277976014423,0.9981450522147459,101,1676,ion transport,BP
GO:0032570,0.0026680702301159973,0.9994606768854905,7,44,response to progesterone,BP
GO:0008203,0.002672451378368224,0.9990035934527526,15,150,cholesterol metabolic process,BP
GO:0006925,0.0026754234703046604,0.9996494874622935,5,22,inflammatory cell apoptotic process,BP
GO:0045637,0.0026822611845135767,0.9988048210202874,21,248,regulation of myeloid cell differentiation,BP
GO:0071425,0.002696975297523189,0.9996434577155753,5,23,hematopoietic stem cell proliferation,BP
GO:0002791,0.0026998442152664512,0.9985137744810403,36,495,regulation of peptide secretion,BP
GO:0003401,0.002703540498805787,0.9995452197865727,6,31,axis elongation,BP
GO:0051651,0.0027038660461193957,0.9991787419156338,11,93,maintenance of location in cell,BP
GO:0098910,0.0027082702104617596,0.999876181186713,3,7,regulation of atrial cardiac muscle cell action potential,BP
GO:0061900,0.002710191087561594,0.9993703649651783,8,56,glial cell activation,BP
GO:0005262,0.0027134913189509604,0.9990322531829522,14,123,calcium channel activity,MF
GO:0006260,0.002732459676401836,0.9987301797225537,23,274,DNA replication,BP
GO:0097300,0.0027352322072850465,0.999441368662133,7,47,programmed necrotic cell death,BP
GO:0035303,0.002736913465000887,0.998837232361439,19,208,regulation of dephosphorylation,BP
GO:0032147,0.002753665654542107,0.9986319413310808,27,333,activation of protein kinase activity,BP
GO:0008015,0.002763129178803325,0.9984380612054177,39,536,blood circulation,BP
GO:0071353,0.0027694842450876325,0.9995300135547794,6,32,cellular response to interleukin-4,BP
GO:0061133,0.002780171047952748,0.9998716931879971,3,7,endopeptidase activator activity,MF
GO:0051301,0.00278603046936292,0.9983881779400093,42,597,cell division,BP
GO:0002790,0.002788922579915228,0.9983750515695499,43,619,peptide secretion,BP
GO:0031668,0.0027931330572766883,0.9987004445380889,23,268,cellular response to extracellular stimulus,BP
GO:0034775,0.002796356996698628,1,2,2,glutathione transmembrane transport,BP
GO:0035443,0.002796356996698628,1,2,2,tripeptide transmembrane transport,BP
GO:0003712,0.002826563837214471,0.99838730183534,40,560,transcription coregulator activity,MF
GO:0007599,0.002827302700841667,0.9985920358111902,27,339,hemostasis,BP
GO:0005114,0.002829895159938369,0.9998685644365108,3,7,type II transforming growth factor beta receptor binding,MF
GO:1901184,0.0028306388605342722,0.9991350607760197,11,93,regulation of ERBB signaling pathway,BP
GO:0022612,0.00283740700088568,0.9990267938595067,13,118,gland morphogenesis,BP
GO:0046339,0.0028416334510519827,0.9996224159916773,5,22,diacylglycerol metabolic process,BP
GO:0030695,0.0028741374120064777,0.9986109842685317,25,303,GTPase regulator activity,MF
GO:0002756,0.0028896748095314497,0.9995035686857477,6,33,MyD88-independent toll-like receptor signaling pathway,BP
GO:0016235,0.0028904777657591733,0.999408464063787,7,43,aggresome,CC
GO:0060340,0.002899628569947749,0.9997377845798384,4,13,positive regulation of type I interferon-mediated signaling pathway,BP
GO:0030278,0.002909876553093916,0.9987896616420817,18,196,regulation of ossification,BP
GO:0002221,0.0029235693372471018,0.9987832233838427,18,197,pattern recognition receptor signaling pathway,BP
GO:0022624,0.0029252965554946012,0.9996032932506124,5,24,proteasome accessory complex,CC
GO:0002064,0.002933770753896549,0.9987464281680958,19,204,epithelial cell development,BP
GO:0016125,0.0029728838891360763,0.9988365371114584,16,166,sterol metabolic process,BP
GO:1900407,0.0029750370500028823,0.9991451075993619,10,87,regulation of cellular response to oxidative stress,BP
GO:0099173,0.002979510271442911,0.9988347207275806,16,162,postsynapse organization,BP
GO:0006333,0.003006603751719514,0.9988197965999162,16,175,chromatin assembly or disassembly,BP
GO:0005802,0.00300913136798141,0.9986776207682229,20,225,trans-Golgi network,CC
GO:0071260,0.0030266081461462957,0.9991329656822312,10,79,cellular response to mechanical stimulus,BP
GO:0043408,0.0030396776805881104,0.9981354051739162,51,762,regulation of MAPK cascade,BP
GO:0045766,0.0030534678023255435,0.9987575602928822,17,200,positive regulation of angiogenesis,BP
GO:0070841,0.0030713644055309548,0.9995813944118337,5,23,inclusion body assembly,BP
GO:0048708,0.0030811622421147043,0.999114450602813,10,80,astrocyte differentiation,BP
GO:0060028,0.0030902794197595314,0.9998518553743326,3,7,convergent extension involved in axis elongation,BP
GO:0015085,0.0031005492375072775,0.9988291279392936,15,139,calcium ion transmembrane transporter activity,MF
GO:0030427,0.0031018410053248514,0.998741208815978,17,176,site of polarized growth,CC
GO:0110053,0.003105108647063647,0.9985700605373529,22,258,regulation of actin filament organization,BP
GO:1903039,0.0031129884419572734,0.9986609559330275,19,212,positive regulation of leukocyte cell-cell adhesion,BP
GO:0019787,0.0031462348841917757,0.9983377128118753,31,407,ubiquitin-like protein transferase activity,MF
GO:0032615,0.0031504498194399695,0.9992507876631452,8,55,interleukin-12 production,BP
GO:0005096,0.0031662571474979726,0.9985111195766074,23,272,GTPase activator activity,MF
GO:0098876,0.003175049679832964,0.9990134140671215,11,96,vesicle-mediated transport to the plasma membrane,BP
GO:0046835,0.003178234344578714,0.9995605157601956,5,24,carbohydrate phosphorylation,BP
GO:0033688,0.0031803920474519514,0.9995629626392081,5,23,regulation of osteoblast proliferation,BP
GO:0060603,0.0031811639911704034,0.9994426756192506,6,33,mammary gland duct morphogenesis,BP
GO:0070199,0.0031943950069116293,0.9995577537436932,5,24,establishment of protein localization to chromosome,BP
GO:0098642,0.0032051670950405927,0.999844314228284,3,7,network-forming collagen trimer,CC
GO:0098645,0.0032051670950405927,0.999844314228284,3,7,collagen network,CC
GO:0007423,0.0032066701077237115,0.9981575868943735,40,546,sensory organ development,BP
GO:2001171,0.0032075266705338668,0.9994352148298072,6,34,positive regulation of ATP biosynthetic process,BP
GO:0035497,0.0032119518136230064,0.9996951665538591,4,14,cAMP response element binding,MF
GO:0051222,0.0032219026808755005,0.9982944581747581,31,413,positive regulation of protein transport,BP
GO:0016528,0.0032252485346427016,0.9990670508554932,10,80,sarcoplasm,CC
GO:2000060,0.003228308181374302,0.9989952046934453,11,95,positive regulation of ubiquitin-dependent protein catabolic process,BP
GO:0003678,0.0032285319184493996,0.9990659670262317,10,80,DNA helicase activity,MF
GO:1901655,0.003237822407772719,0.998992980803011,11,93,cellular response to ketone,BP
GO:1901988,0.0032386393604175983,0.9985309932195695,21,263,negative regulation of cell cycle phase transition,BP
GO:0002455,0.003246565769363796,0.9993172740791416,7,46,humoral immune response mediated by circulating immunoglobulin,BP
GO:0031227,0.0032515277138096326,0.9988100437025658,14,140,intrinsic component of endoplasmic reticulum membrane,CC
GO:0014902,0.0032621654664549537,0.9989190457427781,12,109,myotube differentiation,BP
GO:0098797,0.003269340188865047,0.9981193154881159,40,548,plasma membrane protein complex,CC
GO:0008380,0.003272031924105641,0.998246404723208,32,435,RNA splicing,BP
GO:0097441,0.0033037441535493,0.999837763825988,3,7,basal dendrite,CC
GO:0000781,0.0033278786416109604,0.9987276192322896,15,157,"chromosome, telomeric region",CC
GO:0008287,0.003333599197111647,0.9992969386621688,7,45,protein serine/threonine phosphatase complex,CC
GO:1903293,0.003333599197111647,0.9992969386621688,7,45,phosphatase complex,CC
GO:0014074,0.003334439799909517,0.9987276827701683,15,148,response to purine-containing compound,BP
GO:0017148,0.0033422413597152026,0.9987125348119859,15,195,negative regulation of translation,BP
GO:0070227,0.0033485257287268625,0.999104877648945,9,69,lymphocyte apoptotic process,BP
GO:0043292,0.0033802045182433635,0.9984660330670557,21,234,contractile fiber,CC
GO:0006261,0.003380532379514933,0.9987065412872443,15,153,DNA-dependent DNA replication,BP
GO:0045824,0.00338426242152136,0.9991844766959899,8,56,negative regulation of innate immune response,BP
GO:2000027,0.003389741381748179,0.9984282578033947,22,253,regulation of animal organ morphogenesis,BP
GO:0035091,0.0033970778555024233,0.9984560316541402,21,243,phosphatidylinositol binding,MF
GO:0006839,0.0034241105381520773,0.9984407779374808,21,254,mitochondrial transport,BP
GO:0030001,0.0034494592097647075,0.9978024110252504,58,875,metal ion transport,BP
GO:1905461,0.0034521734188162484,0.9998164835233938,3,8,positive regulation of vascular associated smooth muscle cell apoptotic process,BP
GO:0017134,0.0034593076129757283,0.9995151169392255,5,23,fibroblast growth factor binding,MF
GO:0048488,0.0034728603386110527,0.9991606939747572,8,55,synaptic vesicle endocytosis,BP
GO:0140238,0.0034728603386110527,0.9991606939747572,8,55,presynaptic endocytosis,BP
GO:0032680,0.0034761797959308753,0.9986640559232574,15,159,regulation of tumor necrosis factor production,BP
GO:0017053,0.0035106441514349968,0.9989700646966072,10,83,transcriptional repressor complex,CC
GO:2000637,0.003515152766473688,0.9995054211000167,5,23,positive regulation of gene silencing by miRNA,BP
GO:0060412,0.0035229834336653943,0.99925599037921,7,41,ventricular septum morphogenesis,BP
GO:0046135,0.0035475108069485768,0.9994965754348648,5,24,pyrimidine nucleoside catabolic process,BP
GO:0032409,0.003562878739060144,0.998307336558095,23,278,regulation of transporter activity,BP
GO:2000377,0.0035845834550441774,0.9985207312871871,17,189,regulation of reactive oxygen species metabolic process,BP
GO:2000145,0.0035958113941481924,0.997684142861772,60,989,regulation of cell motility,BP
GO:0098943,0.0035960000507283523,0.9998179229564037,3,7,"neurotransmitter receptor transport, postsynaptic endosome to lysosome",BP
GO:1905216,0.0036046934537250276,0.9998053675960383,3,8,positive regulation of RNA binding,BP
GO:0045475,0.0036156542329167296,0.9996393787822075,4,15,locomotor rhythm,BP
GO:0060071,0.0036194032977162234,0.9987855306078731,12,108,"Wnt signaling pathway, planar cell polarity pathway",BP
GO:0051100,0.0036196784014096827,0.9985537626036349,16,168,negative regulation of binding,BP
GO:0061951,0.003626831246283308,0.9991136353881157,8,58,establishment of protein localization to plasma membrane,BP
GO:1903051,0.003631606777721887,0.9990162158481388,9,70,negative regulation of proteolysis involved in cellular protein catabolic process,BP
GO:0097327,0.0036337773501332496,0.9988511360750859,11,95,response to antineoplastic agent,BP
GO:0030911,0.003644090706645771,0.9998024677235057,3,8,TPR domain binding,MF
GO:0031623,0.0036493256568612712,0.998772655414617,12,111,receptor internalization,BP
GO:1905906,0.003649425474860092,0.9998020741620973,3,8,regulation of amyloid fibril formation,BP
GO:0031965,0.0036662933689177307,0.9982225655257911,24,296,nuclear membrane,CC
GO:0010332,0.0036858725829464105,0.9990991247805607,8,56,response to gamma radiation,BP
GO:0032727,0.0036872217792160347,0.999479013111868,5,22,positive regulation of interferon-alpha production,BP
GO:0048588,0.003698474061116875,0.9983431212227564,20,231,developmental cell growth,BP
GO:0032732,0.0037114731406117977,0.9990894668198603,8,58,positive regulation of interleukin-1 production,BP
GO:0003013,0.003713460616271135,0.9978627826203176,39,546,circulatory system process,BP
GO:1902652,0.0037151743963926907,0.9985632505685232,15,155,secondary alcohol metabolic process,BP
GO:0044089,0.003737359012380987,0.9978645601247016,38,535,positive regulation of cellular component biogenesis,BP
GO:0044815,0.0037446827794192727,0.9988813363697798,10,99,DNA packaging complex,CC
GO:0070670,0.0037617634617333855,0.9993156203278794,6,34,response to interleukin-4,BP
GO:0051817,0.0037678171714183866,0.9987271944732197,12,112,modification of morphology or physiology of other organism involved in symbiotic interaction,BP
GO:0001732,0.0037774929794592823,0.999613267960523,4,16,formation of cytoplasmic translation initiation complex,BP
GO:0086019,0.003793691844820582,0.9993133717736682,6,32,cell-cell signaling involved in cardiac conduction,BP
GO:0060009,0.003793990819222447,0.9996225501842484,4,14,Sertoli cell development,BP
GO:1904589,0.0038185634439383345,0.9990587511749252,8,58,regulation of protein import,BP
GO:0032226,0.0038348565882710727,0.9998012565830037,3,7,"positive regulation of synaptic transmission, dopaminergic",BP
GO:0010830,0.0038591838676349955,0.9990458975152879,8,59,regulation of myotube differentiation,BP
GO:1903363,0.0038680330580446796,0.9988487188873784,10,84,negative regulation of cellular protein catabolic process,BP
GO:0008013,0.003920708049409295,0.998832369177096,10,82,beta-catenin binding,MF
GO:2001236,0.003923348057182587,0.9984741134478338,15,154,regulation of extrinsic apoptotic signaling pathway,BP
GO:0035336,0.00393559496351679,0.9994242864633713,5,25,long-chain fatty-acyl-CoA metabolic process,BP
GO:0061025,0.003945364897380656,0.9984649882950143,15,153,membrane fusion,BP
GO:0099188,0.003955560440840906,0.999601786356723,4,14,postsynaptic cytoskeleton organization,BP
GO:0070200,0.00396468591305893,0.9995885051375691,4,16,establishment of protein localization to telomere,BP
GO:0010595,0.003984113142096679,0.9986378773152405,12,126,positive regulation of endothelial cell migration,BP
GO:0048259,0.0039981580648519015,0.9987152325221645,11,102,regulation of receptor-mediated endocytosis,BP
GO:0090385,0.004001551204443885,0.9997756367975478,3,8,phagosome-lysosome fusion,BP
GO:0043631,0.004004077272347177,0.9991250451760119,7,46,RNA polyadenylation,BP
GO:0006336,0.004011375164097838,0.9991158585790072,7,51,DNA replication-independent nucleosome assembly,BP
GO:0009259,0.004027149650889369,0.997705550432981,37,538,ribonucleotide metabolic process,BP
GO:0050679,0.004035015254326221,0.9982660945498013,18,204,positive regulation of epithelial cell proliferation,BP
GO:0010634,0.004035090681993345,0.9984207268839017,15,169,positive regulation of epithelial cell migration,BP
GO:0070231,0.004042818163833999,0.9991134063330944,7,47,T cell apoptotic process,BP
GO:0071241,0.00407543273791028,0.9982013124610181,19,217,cellular response to inorganic substance,BP
GO:0022898,0.004083776873429812,0.9980742209325579,22,263,regulation of transmembrane transporter activity,BP
GO:0010715,0.004092675633370596,0.9995663059132818,4,17,regulation of extracellular matrix disassembly,BP
GO:0032993,0.004129909625635289,0.9983217513178988,16,185,protein-DNA complex,CC
GO:0022411,0.004146207460806527,0.9976151057491637,38,544,cellular component disassembly,BP
GO:0042575,0.004155989366004363,0.9995628439531324,4,16,DNA polymerase complex,CC
GO:1903321,0.00417776983047315,0.9987427891388538,10,84,negative regulation of protein modification by small protein conjugation or removal,BP
GO:0060148,0.0041788248334174456,0.9993835086153182,5,24,positive regulation of posttranscriptional gene silencing,BP
GO:0060444,0.0041838503871417755,0.9993790192380412,5,25,branching involved in mammary gland duct morphogenesis,BP
GO:0034109,0.004185458388101358,0.9987427193814958,10,81,homotypic cell-cell adhesion,BP
GO:0072521,0.004193054514699198,0.9975487415057401,40,593,purine-containing compound metabolic process,BP
GO:0001890,0.004197962455355983,0.9983568572322274,15,150,placenta development,BP
GO:0022843,0.004201019145823788,0.9983590557036224,15,142,voltage-gated cation channel activity,MF
GO:1901659,0.004213472709986739,0.9990706076829338,7,46,glycosyl compound biosynthetic process,BP
GO:0042119,0.004216801726156903,0.997632165635943,35,496,neutrophil activation,BP
GO:0019076,0.004227855463428568,0.9992096111913009,6,35,viral release from host cell,BP
GO:0035890,0.004227855463428568,0.9992096111913009,6,35,exit from host,BP
GO:0035891,0.004227855463428568,0.9992096111913009,6,35,exit from host cell,BP
GO:0052126,0.004227855463428568,0.9992096111913009,6,35,movement in host environment,BP
GO:0052192,0.004227855463428568,0.9992096111913009,6,35,movement in environment of other organism involved in symbiotic interaction,BP
GO:0002446,0.004241773042215074,0.9976171474743145,35,497,neutrophil mediated immunity,BP
GO:0090199,0.004252359237659759,0.9990571111292006,7,48,regulation of release of cytochrome c from mitochondria,BP
GO:0002460,0.004253253558780541,0.9980269378391918,21,250,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP
GO:0034330,0.00425856192036038,0.9979113323780757,24,290,cell junction organization,BP
GO:1902905,0.00427816816570196,0.9981519861771869,18,201,positive regulation of supramolecular fiber organization,BP
GO:0090175,0.004308169949426769,0.998521084066463,12,110,regulation of establishment of planar polarity,BP
GO:0033260,0.004319030879984726,0.9989106741460664,8,60,nuclear DNA replication,BP
GO:0009150,0.004320137658133099,0.9975481403904741,36,523,purine ribonucleotide metabolic process,BP
GO:0099590,0.004337720313450021,0.9993543563322086,5,24,neurotransmitter receptor internalization,BP
GO:0038127,0.004340507567430288,0.9983577579874512,14,142,ERBB signaling pathway,BP
GO:0019693,0.004342502508303068,0.9974939967324189,38,558,ribose phosphate metabolic process,BP
GO:0032760,0.004357341051852624,0.9986799762983836,10,85,positive regulation of tumor necrosis factor production,BP
GO:0065004,0.004385052744532407,0.9980476328547762,19,232,protein-DNA complex assembly,BP
GO:1903659,0.0043889720759883325,0.9997455408665243,3,8,regulation of complement-dependent cytotoxicity,BP
GO:1902036,0.00439080888605368,0.9987732479742519,9,72,regulation of hematopoietic stem cell differentiation,BP
GO:0031232,0.004425399527670163,0.9997426587233155,3,8,extrinsic component of external side of plasma membrane,CC
GO:0071385,0.0044491773349707615,0.9988763466604913,8,57,cellular response to glucocorticoid stimulus,BP
GO:0002483,0.00448804272418249,0.9997376818053105,3,8,antigen processing and presentation of endogenous peptide antigen,BP
GO:0019885,0.00448804272418249,0.9997376818053105,3,8,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP
GO:0035259,0.004507370327519198,0.9995148122667069,4,16,glucocorticoid receptor binding,MF
GO:0034724,0.004517800450205503,0.9989807441538511,7,52,DNA replication-independent nucleosome organization,BP
GO:0030168,0.004555366121888992,0.9981996190631542,15,153,platelet activation,BP
GO:0034508,0.004644365296418224,0.9989453794819223,7,53,centromere complex assembly,BP
GO:0099576,0.004653875247119009,0.999936456277258,2,3,"regulation of protein catabolic process at postsynapse, modulating synaptic transmission",BP
GO:0000775,0.004663770734612813,0.9980225335251488,17,193,"chromosome, centromeric region",CC
GO:0032874,0.004670742170571742,0.998081876653046,16,172,positive regulation of stress-activated MAPK cascade,BP
GO:0048210,0.0046794053716000695,0.9999359253735005,2,3,Golgi vesicle fusion to target membrane,BP
GO:0072384,0.004687408051435133,0.9985659407973229,10,84,organelle transport along microtubule,BP
GO:0055008,0.004694492794627439,0.9986795126959098,9,68,cardiac muscle tissue morphogenesis,BP
GO:0071347,0.004727680275591752,0.9980538104928717,16,178,cellular response to interleukin-1,BP
GO:0042383,0.004745090569732619,0.9981893066150098,14,136,sarcolemma,CC
GO:0032480,0.004770507262411551,0.9989232976129098,7,46,negative regulation of type I interferon production,BP
GO:0150012,0.004774227635350166,0.9997146191938692,3,8,positive regulation of neuron projection arborization,BP
GO:0035088,0.004788411653201074,0.9989185051509009,7,46,establishment or maintenance of apical/basal cell polarity,BP
GO:0061245,0.004788411653201074,0.9989185051509009,7,46,establishment or maintenance of bipolar cell polarity,BP
GO:0030865,0.004802239365113796,0.9989109791780302,7,48,cortical cytoskeleton organization,BP
GO:0005577,0.00481465423857178,0.9997113189993844,3,8,fibrinogen complex,CC
GO:0008625,0.004817069920854966,0.9985185922766869,10,86,extrinsic apoptotic signaling pathway via death domain receptors,BP
GO:0009409,0.004839056710578912,0.9989010745724722,7,48,response to cold,BP
GO:0009299,0.004842330129853271,0.9992557964201887,5,25,mRNA transcription,BP
GO:0071375,0.004843653446860146,0.997557976245308,25,320,cellular response to peptide hormone stimulus,BP
GO:0045091,0.004843951614725479,0.9994614971541603,4,17,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP
GO:2000736,0.004849049993865862,0.998307507344725,12,114,regulation of stem cell differentiation,BP
GO:0021952,0.004860310637512775,0.9992523704738708,5,25,central nervous system projection neuron axonogenesis,BP
GO:0050867,0.004866126091099368,0.9975462641874013,25,317,positive regulation of cell activation,BP
GO:0043312,0.004872358755209388,0.997262640912388,34,483,neutrophil degranulation,BP
GO:0001738,0.004902623956595379,0.998119485245692,14,141,morphogenesis of a polarized epithelium,BP
GO:0006900,0.004923084514331905,0.9983739328900777,11,101,vesicle budding from membrane,BP
GO:0070838,0.0049392126180469835,0.9971992830914823,35,481,divalent metal ion transport,BP
GO:1903522,0.004946610398293748,0.9975431579350964,24,294,regulation of blood circulation,BP
GO:0032872,0.0049568991312716505,0.9977183001970902,20,235,regulation of stress-activated MAPK cascade,BP
GO:0086065,0.004969221793199516,0.9987230891695958,8,56,cell communication involved in cardiac conduction,BP
GO:0070304,0.004974115266947333,0.997943277487667,16,173,positive regulation of stress-activated protein kinase signaling cascade,BP
GO:0010717,0.004979951547532913,0.9984583941149641,10,89,regulation of epithelial to mesenchymal transition,BP
GO:0042307,0.004982353136268527,0.9990308512721572,6,37,positive regulation of protein import into nucleus,BP
GO:0098651,0.004998654467506943,0.9996961685555783,3,8,basement membrane collagen trimer,CC
GO:0090083,0.005004648921600459,0.999444950385152,4,16,regulation of inclusion body assembly,BP
GO:0048598,0.00501103191857361,0.9970204862534309,41,582,embryonic morphogenesis,BP
GO:0032354,0.0050113811137137265,0.9994439900206177,4,16,response to follicle-stimulating hormone,BP
GO:0018193,0.005015094345367489,0.9965564760058045,76,1254,peptidyl-amino acid modification,BP
GO:1900120,0.005017540339346422,0.9992222794237351,5,25,regulation of receptor binding,BP
GO:0016570,0.005039597193784129,0.9971907719381485,33,450,histone modification,BP
GO:0016282,0.005050097561776401,0.9994318601492644,4,17,eukaryotic 43S preinitiation complex,CC
GO:0045921,0.005059433104126385,0.998432043801434,10,87,positive regulation of exocytosis,BP
GO:0019722,0.005065601358705207,0.9977182725124867,19,216,calcium-mediated signaling,BP
GO:0071248,0.005078370730686748,0.9978290879094736,17,190,cellular response to metal ion,BP
GO:0045182,0.005078694634017578,0.9986852172820794,8,59,translation regulator activity,MF
GO:0036230,0.005081560552165151,0.997111024849788,35,502,granulocyte activation,BP
GO:0033643,0.0050837623143416034,0.999433640696108,4,16,host cell part,CC
GO:0090501,0.005089462664860021,0.9980353646025787,14,149,RNA phosphodiester bond hydrolysis,BP
GO:0000110,0.0051050558117217,0.9999268509619473,2,3,nucleotide-excision repair factor 1 complex,CC
GO:0060027,0.00511820308701684,0.999686212552686,3,8,convergent extension involved in gastrulation,BP
GO:0050931,0.00512826963610619,0.9989991664720786,6,36,pigment cell differentiation,BP
GO:0045444,0.0051412971998278465,0.9976787894669166,19,223,fat cell differentiation,BP
GO:0032201,0.005143551587804206,0.9991899457755302,5,27,telomere maintenance via semi-conservative replication,BP
GO:0005635,0.0051457883588772665,0.9971261215517175,33,462,nuclear envelope,CC
GO:0060964,0.005152385208822248,0.9982817854124911,11,109,regulation of gene silencing by miRNA,BP
GO:1902275,0.005153052801986312,0.9978608913597429,16,174,regulation of chromatin organization,BP
GO:1903557,0.005159701985318241,0.9983964268888722,10,87,positive regulation of tumor necrosis factor superfamily cytokine production,BP
GO:0060395,0.005183753091326213,0.9985165262693374,9,70,SMAD protein signal transduction,BP
GO:0106027,0.005186622683471912,0.9983868462371535,10,87,neuron projection organization,BP
GO:0098796,0.0051893328075293225,0.9964982255384537,69,1128,membrane protein complex,CC
GO:0031397,0.0051939224579861335,0.9985093717173714,9,73,negative regulation of protein ubiquitination,BP
GO:0061614,0.005196487387007683,0.9988062139976095,7,47,pri-miRNA transcription by RNA polymerase II,BP
GO:0010566,0.005203337845499791,0.9994164481328017,4,16,regulation of ketone biosynthetic process,BP
GO:0051087,0.0052045734274591025,0.9982671688102991,11,102,chaperone binding,MF
GO:0050890,0.005211171804772399,0.9974006311264068,24,294,cognition,BP
GO:1990841,0.005240494062149931,0.9987921491632697,7,48,promoter-specific chromatin binding,MF
GO:0016233,0.00524883547585708,0.9987807865633044,7,53,telomere capping,BP
GO:0016569,0.005254935080224914,0.9970341838307358,34,470,covalent chromatin modification,BP
GO:2000096,0.00526818226566478,0.9996587276289589,3,9,"positive regulation of Wnt signaling pathway, planar cell polarity pathway",BP
GO:2000045,0.005270271111864318,0.9978725720189744,15,178,regulation of G1/S transition of mitotic cell cycle,BP
GO:1902415,0.005274731313084681,0.9996581489272935,3,9,regulation of mRNA binding,BP
GO:0031905,0.005288790219171989,0.9999228064100945,2,3,early endosome lumen,CC
GO:0090263,0.005301162480054309,0.9979449894817898,14,147,positive regulation of canonical Wnt signaling pathway,BP
GO:0008537,0.005309520718426613,0.9999223453281971,2,3,proteasome activator complex,CC
GO:0034046,0.005318087909883609,0.9996693720918415,3,8,poly(G) binding,MF
GO:0002283,0.005322500646537579,0.9969917011608862,34,486,neutrophil activation involved in immune response,BP
GO:0051032,0.005330084529884901,0.9999218870099226,2,3,nucleic acid transmembrane transporter activity,MF
GO:0051033,0.005330084529884901,0.9999218870099226,2,3,RNA transmembrane transporter activity,MF
GO:0005911,0.005356687832878754,0.9969741643235881,34,459,cell-cell junction,CC
GO:0006812,0.005357527160932163,0.9963596852789584,71,1142,cation transport,BP
GO:0000977,0.005361603771729949,0.9965969050717627,52,769,RNA polymerase II regulatory region sequence-specific DNA binding,MF
GO:0031000,0.0053818464509429375,0.9993834170636976,4,17,response to caffeine,BP
GO:0036270,0.0053818464509429375,0.9993834170636976,4,17,response to diuretic,BP
GO:0031053,0.0053927702374894325,0.9996476728208489,3,9,primary miRNA processing,BP
GO:0032677,0.005397732740236771,0.99844031724912,9,74,regulation of interleukin-8 production,BP
GO:0070302,0.005406396917392675,0.9974908247894849,20,237,regulation of stress-activated protein kinase signaling cascade,BP
GO:0006342,0.005430939450889469,0.9981789112052254,11,105,chromatin silencing,BP
GO:0006893,0.005447780361966087,0.9985665573206891,8,63,Golgi to plasma membrane transport,BP
GO:0035494,0.005505393874165231,0.9999179418429649,2,3,SNARE complex disassembly,BP
GO:0016540,0.005506367028882296,0.9993723582403377,4,16,protein autoprocessing,BP
GO:0003181,0.005518374012483735,0.9991298652979758,5,24,atrioventricular valve morphogenesis,BP
GO:1902037,0.005521416340260254,0.9999175779050613,2,3,negative regulation of hematopoietic stem cell differentiation,BP
GO:0072666,0.005538644772670517,0.9987101844566251,7,48,establishment of protein localization to vacuole,BP
GO:0097067,0.005549190546576526,0.9993660684916552,4,16,cellular response to thyroid hormone stimulus,BP
GO:2001267,0.005549465173910752,0.9993585999720853,4,17,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP
GO:0046519,0.005554916394394104,0.9993652264090171,4,16,sphingoid metabolic process,BP
GO:0001664,0.0055642889956110525,0.9973010062095163,22,279,G protein-coupled receptor binding,MF
GO:0005516,0.005579171426221646,0.9975267943388226,18,200,calmodulin binding,MF
GO:0046598,0.005626778990123439,0.9996266516166707,3,9,positive regulation of viral entry into host cell,BP
GO:2000625,0.005642846389614553,0.99991480153105,2,3,regulation of miRNA catabolic process,BP
GO:0002696,0.005660649065691242,0.9971550111925677,24,303,positive regulation of leukocyte activation,BP
GO:0005640,0.005671651160756044,0.9990899112775369,5,26,nuclear outer membrane,CC
GO:0001504,0.005702367468064762,0.9986694505044914,7,46,neurotransmitter uptake,BP
GO:0030515,0.005716897515045953,0.9990808942222044,5,26,snoRNA binding,MF
GO:0030219,0.005745642766535642,0.9981801900567193,10,93,megakaryocyte differentiation,BP
GO:0061740,0.0057601656177055024,0.999912088831797,2,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP
GO:0016791,0.00576410002598581,0.9971979523362013,22,269,phosphatase activity,MF
GO:0097010,0.0057655612185199675,0.9999119633605642,2,3,eukaryotic translation initiation factor 4F complex assembly,BP
GO:1902369,0.0057792793568558366,0.9984706951086806,8,59,negative regulation of RNA catabolic process,BP
GO:0034390,0.005781618510421377,0.9990521355341759,5,30,smooth muscle cell apoptotic process,BP
GO:0034391,0.005781618510421377,0.9990521355341759,5,30,regulation of smooth muscle cell apoptotic process,BP
GO:0010761,0.005806059727447379,0.9988309803595378,6,38,fibroblast migration,BP
GO:0033687,0.00580704999492636,0.9990628747929513,5,26,osteoblast proliferation,BP
GO:0045669,0.005809551479326475,0.9984545938980085,8,63,positive regulation of osteoblast differentiation,BP
GO:0043507,0.005827871516983902,0.9982957225274268,9,74,positive regulation of JUN kinase activity,BP
GO:0043235,0.005830444060436973,0.9968180638213141,30,395,receptor complex,CC
GO:0002275,0.005840539406091389,0.9965925232468719,37,542,myeloid cell activation involved in immune response,BP
GO:0001503,0.005855587141264919,0.9968380527401822,29,389,ossification,BP
GO:0003223,0.005927528823158378,0.9996165768036959,3,8,ventricular compact myocardium morphogenesis,BP
GO:0032557,0.005928503293203659,0.9999081449580796,2,3,pyrimidine ribonucleotide binding,MF
GO:0006700,0.005933294913122385,0.9990375236494077,5,26,C21-steroid hormone biosynthetic process,BP
GO:0032412,0.005935188949486694,0.9971621303071703,21,255,regulation of ion transmembrane transporter activity,BP
GO:0071392,0.005952390851014466,0.9988015159348057,6,36,cellular response to estradiol stimulus,BP
GO:0071824,0.005960154727041608,0.9971448185043155,21,271,protein-DNA complex subunit organization,BP
GO:0022627,0.005966045589783962,0.9987789095082207,6,43,cytosolic small ribosomal subunit,CC
GO:0055106,0.005975108958706183,0.999294589344763,4,17,ubiquitin-protein transferase regulator activity,MF
GO:0001818,0.005992437197516276,0.9970717684139602,22,290,negative regulation of cytokine production,BP
GO:0072511,0.005993909769272509,0.9965566917464421,35,487,divalent inorganic cation transport,BP
GO:0004724,0.006001633782016759,0.9992905544180501,4,17,magnesium-dependent protein serine/threonine phosphatase activity,MF
GO:0032545,0.00601417226847283,0.9999061147821342,2,3,CURI complex,CC
GO:0034456,0.00601417226847283,0.9999061147821342,2,3,UTP-C complex,CC
GO:0033979,0.006017788643901134,0.999906028741074,2,3,box H/ACA snoRNA metabolic process,BP
GO:0097325,0.00606152401827366,0.9999049860090095,2,3,melanocyte proliferation,BP
GO:0090493,0.0060868696916960485,0.9992858939421846,4,16,catecholamine uptake,BP
GO:0071604,0.006122895375494562,0.9987533593100396,6,38,transforming growth factor beta production,BP
GO:0071384,0.006134073343228641,0.9983583530932079,8,60,cellular response to corticosteroid stimulus,BP
GO:0022407,0.006136792565744996,0.9966733029653645,29,397,regulation of cell-cell adhesion,BP
GO:0070588,0.006155800207575897,0.9968373750575753,25,313,calcium ion transmembrane transport,BP
GO:0006892,0.006172214979277548,0.9978948026393046,11,104,post-Golgi vesicle-mediated transport,BP
GO:0039692,0.006211175062162196,0.999250983144474,4,18,single stranded viral RNA replication via double stranded DNA intermediate,BP
GO:0001012,0.006211224264624766,0.9960263140788553,52,775,RNA polymerase II regulatory region DNA binding,MF
GO:0043506,0.006278584274290197,0.9979909808205113,10,88,regulation of JUN kinase activity,BP
GO:0060571,0.0062824530648316855,0.9989720399910333,5,25,morphogenesis of an epithelial fold,BP
GO:0070993,0.006287955404824094,0.9992390376425093,4,18,translation preinitiation complex,CC
GO:0034080,0.0063019908130927975,0.9986952465078517,6,43,CENP-A containing nucleosome assembly,BP
GO:0061641,0.0063019908130927975,0.9986952465078517,6,43,CENP-A containing chromatin organization,BP
GO:0005483,0.006318821659046683,0.9998987707248417,2,3,soluble NSF attachment protein activity,MF
GO:0061107,0.006339558018260979,0.9998982638454386,2,3,seminal vesicle development,BP
GO:0033574,0.00634095805856932,0.9986994197914524,6,38,response to testosterone,BP
GO:0070230,0.006350144454095641,0.9992293303977335,4,18,positive regulation of lymphocyte apoptotic process,BP
GO:0048813,0.006358075459637102,0.9974857386801107,14,142,dendrite morphogenesis,BP
GO:0098792,0.00636598537933423,0.9995581229476315,3,9,xenophagy,BP
GO:0008021,0.006371944045209842,0.9972118813743295,17,190,synaptic vesicle,CC
GO:0001701,0.00646910549383518,0.9965226081717533,28,372,in utero embryonic development,BP
GO:1904591,0.006486588751439903,0.9986599894761187,6,39,positive regulation of protein import,BP
GO:0032206,0.006505986178650984,0.9984312038541334,7,51,positive regulation of telomere maintenance,BP
GO:0019043,0.006510338070937361,0.9995443773322368,3,9,establishment of viral latency,BP
GO:1902882,0.006594794427829966,0.9978656113759528,10,96,regulation of response to oxidative stress,BP
GO:0031032,0.006634622764662895,0.9970829194308719,17,194,actomyosin structure organization,BP
GO:1903053,0.0066444823226351315,0.9986143676678791,6,41,regulation of extracellular matrix organization,BP
GO:0045927,0.006650527360794674,0.9967846382681596,21,263,positive regulation of growth,BP
GO:0030500,0.006701469731985333,0.9979951720973435,9,75,regulation of bone mineralization,BP
GO:0070266,0.006712902769408318,0.9985942567328655,6,42,necroptotic process,BP
GO:0030010,0.006786230878199656,0.9974006947476058,13,135,establishment of cell polarity,BP
GO:0006352,0.006796387172576692,0.9967745847421712,20,246,"DNA-templated transcription, initiation",BP
GO:0030666,0.006798666039450207,0.9972861852864447,14,148,endocytic vesicle membrane,CC
GO:0002475,0.006804307735924006,0.9995160308447002,3,9,antigen processing and presentation via MHC class Ib,BP
GO:0030540,0.006822358342198036,0.9991631589165271,4,17,female genitalia development,BP
GO:0006694,0.006864468858178488,0.9969702395509069,17,196,steroid biosynthetic process,BP
GO:0072655,0.006874744065847542,0.9973611392934437,13,137,establishment of protein localization to mitochondrion,BP
GO:0032233,0.006905456719544536,0.9981119423016345,8,61,positive regulation of actin filament bundle assembly,BP
GO:0002444,0.006911717988460688,0.9959226448914279,37,548,myeloid leukocyte mediated immunity,BP
GO:0030705,0.006917360252747834,0.9970343465956799,16,178,cytoskeleton-dependent intracellular transport,BP
GO:0030901,0.006930867843187072,0.9977473167103943,10,90,midbrain development,BP
GO:0062013,0.0069327491049648825,0.9972243437092192,14,151,positive regulation of small molecule metabolic process,BP
GO:0048878,0.006937957036635816,0.995229138400364,71,1179,chemical homeostasis,BP
GO:0034189,0.00693941395850949,0.9998832229165111,2,3,very-low-density lipoprotein particle binding,MF
GO:0003025,0.006951353677918711,0.9998829162200231,2,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP
GO:0071225,0.006965886854867234,0.9995002515972387,3,9,cellular response to muramyl dipeptide,BP
GO:1990182,0.00696895076925582,0.9991235460776309,4,19,exosomal secretion,BP
GO:0031095,0.0069852726581247715,0.9994983491031204,3,9,platelet dense tubular network membrane,CC
GO:0051216,0.006986114331950189,0.9968296126299528,18,207,cartilage development,BP
GO:0014731,0.006986976323348848,0.9994981818127066,3,9,spectrin-associated cytoskeleton,CC
GO:0004386,0.006995626213316383,0.9970942282768714,15,162,helicase activity,MF
GO:0060143,0.007005204377553092,0.9988114189267084,5,27,positive regulation of syncytium formation by plasma membrane fusion,BP
GO:0003951,0.0070105572826971736,0.9991332740822878,4,17,NAD+ kinase activity,MF
GO:0044839,0.007012604882359641,0.9965922158830289,21,266,cell cycle G2/M phase transition,BP
GO:0043299,0.007015540594916939,0.995889757591299,36,531,leukocyte degranulation,BP
GO:0045861,0.007027683775395438,0.9962912170206971,26,358,negative regulation of proteolysis,BP
GO:0043524,0.0070367586336836175,0.9971810978827242,14,146,negative regulation of neuron apoptotic process,BP
GO:0034635,0.007040658391236106,0.9998806133190995,2,3,glutathione transport,BP
GO:0042939,0.007040658391236106,0.9998806133190995,2,3,tripeptide transport,BP
GO:0017038,0.007050831540744262,0.9968783654864135,17,198,protein import,BP
GO:0051155,0.007061267520110032,0.9980457026520798,8,70,positive regulation of striated muscle cell differentiation,BP
GO:0050870,0.007077839225653106,0.9968660895373394,17,196,positive regulation of T cell activation,BP
GO:1902042,0.007088312927365951,0.9985079858662226,6,39,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP
GO:0006610,0.007100550156377035,0.9998299719476008,2,4,ribosomal protein import into nucleus,BP
GO:0046051,0.007104011375258744,0.9994694205648939,3,10,UTP metabolic process,BP
GO:0005261,0.007108440658446137,0.9962543391559252,26,319,cation channel activity,MF
GO:0045780,0.007123865056007916,0.9991062452606433,4,18,positive regulation of bone resorption,BP
GO:0046852,0.007123865056007916,0.9991062452606433,4,18,positive regulation of bone remodeling,BP
GO:0009410,0.0071398724902973065,0.9963994660723516,23,289,response to xenobiotic stimulus,BP
GO:0006732,0.0071457078514108735,0.9960810187781267,29,402,coenzyme metabolic process,BP
GO:0051251,0.007150560832598533,0.9965212470279657,21,259,positive regulation of lymphocyte activation,BP
GO:0048546,0.007169522739465707,0.998247305663396,7,48,digestive tract morphogenesis,BP
GO:0005832,0.007209140907243445,0.9994586600225913,3,10,chaperonin-containing T-complex,CC
GO:0072595,0.007245651956736625,0.9984677572043904,6,39,maintenance of protein localization in organelle,BP
GO:0046134,0.007247280633651585,0.9987547789154217,5,28,pyrimidine nucleoside biosynthetic process,BP
GO:0003281,0.007255378619464995,0.9978071460912549,9,72,ventricular septum development,BP
GO:0008360,0.007300167400339482,0.9970600505513936,14,150,regulation of cell shape,BP
GO:0044729,0.007361095368827478,0.9998722217218665,2,3,hemi-methylated DNA-binding,MF
GO:0046873,0.007363019449098503,0.9957887842822829,33,438,metal ion transmembrane transporter activity,MF
GO:0036498,0.007402723714756474,0.9979453247098002,8,64,IRE1-mediated unfolded protein response,BP
GO:0070265,0.007417352595888969,0.9981505615025852,7,58,necrotic cell death,BP
GO:0060086,0.007418626847734479,0.9998706940053783,2,3,circadian temperature homeostasis,BP
GO:0009260,0.007423637194547687,0.9963039321677152,22,287,ribonucleotide biosynthetic process,BP
GO:0044092,0.007428016390729408,0.9949174166995327,68,1143,negative regulation of molecular function,BP
GO:0030334,0.007453436150980667,0.9951166658292514,55,927,regulation of cell migration,BP
GO:0005220,0.007541011470445522,0.9998674230076335,2,3,"inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity",MF
GO:1901796,0.007541545867042686,0.9967351501754723,16,180,regulation of signal transduction by p53 class mediator,BP
GO:0019752,0.007575542976871982,0.9948577551781056,65,1080,carboxylic acid metabolic process,BP
GO:0005539,0.00759182836583551,0.9964394257764618,19,227,glycosaminoglycan binding,MF
GO:0010575,0.007602688449483697,0.9986731376068825,5,29,positive regulation of vascular endothelial growth factor production,BP
GO:0023026,0.00760879107019408,0.9994172174202844,3,10,MHC class II protein complex binding,MF
GO:0006323,0.0076122812837296034,0.9966938549342499,16,194,DNA packaging,BP
GO:2000628,0.007621187738349929,0.9994159185211359,3,10,regulation of miRNA metabolic process,BP
GO:0010632,0.0076244250815163065,0.9963307138617936,20,281,regulation of epithelial cell migration,BP
GO:0098641,0.00764129037846542,0.9990130242698283,4,19,cadherin binding involved in cell-cell adhesion,MF
GO:1902176,0.0076436482620468316,0.9990126313655362,4,19,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP
GO:0097061,0.00771456158934777,0.9976332909010831,9,79,dendritic spine organization,BP
GO:0098655,0.00776186014664449,0.9949289969794859,54,839,cation transmembrane transport,BP
GO:0030449,0.007854011973496292,0.9980295309649252,7,54,regulation of complement activation,BP
GO:0003171,0.007898633548859935,0.9986264928631674,5,26,atrioventricular valve development,BP
GO:1901137,0.007929929932822455,0.9949260133130269,49,764,carbohydrate derivative biosynthetic process,BP
GO:0048194,0.007941662798507578,0.9975523279256086,9,79,Golgi vesicle budding,BP
GO:1905475,0.007960137925388518,0.9965295881626514,16,187,regulation of protein localization to membrane,BP
GO:0035666,0.007984438882621741,0.9985897605718848,5,29,TRIF-dependent toll-like receptor signaling pathway,BP
GO:0032757,0.008003075322756254,0.9979989897219338,7,49,positive regulation of interleukin-8 production,BP
GO:0031055,0.008045284093107917,0.9982399361917844,6,45,chromatin remodeling at centromere,BP
GO:0033598,0.008056190426033142,0.9985796111140484,5,28,mammary gland epithelial cell proliferation,BP
GO:0048021,0.00809994130766261,0.9993651524747289,3,10,regulation of melanin biosynthetic process,BP
GO:0044449,0.008107194108377548,0.9961759181051404,19,221,contractile fiber part,CC
GO:0032836,0.008115778051026173,0.9993634533337736,3,10,glomerular basement membrane development,BP
GO:0007612,0.00811622212847991,0.996693971209785,14,145,learning,BP
GO:0090679,0.008119661857418995,0.999758469648455,2,5,cell differentiation involved in phenotypic switching,BP
GO:1905420,0.008119661857418995,0.999758469648455,2,5,vascular smooth muscle cell differentiation involved in phenotypic switching,BP
GO:1905915,0.008119661857418995,0.999758469648455,2,5,regulation of cell differentiation involved in phenotypic switching,BP
GO:1905930,0.008119661857418995,0.999758469648455,2,5,regulation of vascular smooth muscle cell differentiation involved in phenotypic switching,BP
GO:0046460,0.008158030794767996,0.998216213019518,6,43,neutral lipid biosynthetic process,BP
GO:0046463,0.008158030794767996,0.998216213019518,6,43,acylglycerol biosynthetic process,BP
GO:0035338,0.008184970782961667,0.9989214799971593,4,19,long-chain fatty-acyl-CoA biosynthetic process,BP
GO:0031400,0.008185975413743869,0.9950112313918554,40,609,negative regulation of protein modification process,BP
GO:0070828,0.008217961723381339,0.9989253052680093,4,18,heterochromatin organization,BP
GO:0098632,0.008225760742495852,0.9979293624290652,7,50,cell-cell adhesion mediator activity,MF
GO:0043410,0.008297906803379638,0.9950462549114607,37,544,positive regulation of MAPK cascade,BP
GO:0044262,0.008298391793277037,0.995827980833306,22,284,cellular carbohydrate metabolic process,BP
GO:0071229,0.00832027468584455,0.9961557174220881,18,209,cellular response to acid chemical,BP
GO:0010878,0.008321903901621379,0.9989077189105044,4,18,cholesterol storage,BP
GO:0070228,0.008378176880940766,0.9978747217134964,7,53,regulation of lymphocyte apoptotic process,BP
GO:0043489,0.008390384206011663,0.9978799114942691,7,50,RNA stabilization,BP
GO:0032026,0.008420963193348351,0.9988811631384202,4,19,response to magnesium ion,BP
GO:1901224,0.008449360841321281,0.9973735058379809,9,77,positive regulation of NIK/NF-kappaB signaling,BP
GO:0090568,0.008461120101947512,0.99848422140214,5,29,nuclear transcriptional repressor complex,CC
GO:0009152,0.008480246918870369,0.995803409575216,21,274,purine ribonucleotide biosynthetic process,BP
GO:0050714,0.008524304301780184,0.9957828707183275,21,265,positive regulation of protein secretion,BP
GO:2001135,0.008536603917801935,0.9993178468702405,3,10,regulation of endocytic recycling,BP
GO:1905330,0.008548383774940419,0.9962482082425876,16,180,regulation of morphogenesis of an epithelium,BP
GO:0090287,0.008571092894335455,0.9956779653726245,22,285,regulation of cellular response to growth factor stimulus,BP
GO:0070585,0.008579576705728422,0.9966112059223537,13,141,protein localization to mitochondrion,BP
GO:0051101,0.008614735877875437,0.9967502386405821,12,123,regulation of DNA binding,BP
GO:0007032,0.008625908492625232,0.9973060588692169,9,79,endosome organization,BP
GO:0042035,0.008627621413393283,0.9969057107513415,11,114,regulation of cytokine biosynthetic process,BP
GO:0023023,0.008648133397203163,0.9988420299762911,4,19,MHC protein complex binding,MF
GO:2000257,0.00865430914823519,0.9977854940303423,7,55,regulation of protein activation cascade,BP
GO:0097734,0.00871460225778699,0.9988214659959578,4,20,extracellular exosome biogenesis,BP
GO:0010762,0.008748299244894253,0.9984141230502126,5,30,regulation of fibroblast migration,BP
GO:0005245,0.008758259545103762,0.9977756143466796,7,48,voltage-gated calcium channel activity,MF
GO:0060562,0.008761381056242723,0.995363588565827,25,319,epithelial tube morphogenesis,BP
GO:0010664,0.008768377107399144,0.9983749136096668,5,38,negative regulation of striated muscle cell apoptotic process,BP
GO:0000290,0.00878624798923703,0.9992903834371952,3,10,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP
GO:0051146,0.00880038040204271,0.9955510550085518,22,287,striated muscle cell differentiation,BP
GO:0010390,0.008819195979201078,0.9984039329326688,5,29,histone monoubiquitination,BP
GO:0035384,0.0088468862612072,0.9977294491967874,7,54,thioester biosynthetic process,BP
GO:0071616,0.0088468862612072,0.9977294491967874,7,54,acyl-CoA biosynthetic process,BP
GO:0033238,0.008849106119489024,0.9972214295143752,9,81,regulation of cellular amine metabolic process,BP
GO:0010811,0.008852106502949693,0.9966507946475363,12,121,positive regulation of cell-substrate adhesion,BP
GO:0045121,0.008868056861224525,0.9953669547225037,24,315,membrane raft,CC
GO:0051131,0.008875856802636065,0.998802488487025,4,19,chaperone-mediated protein complex assembly,BP
GO:1904016,0.008882695156072826,0.9997607932772842,2,4,response to Thyroglobulin triiodothyronine,BP
GO:0071797,0.008884559920733268,0.9997607166463647,2,4,LUBAC complex,CC
GO:0051783,0.008893593784209865,0.9960745814959162,16,188,regulation of nuclear division,BP
GO:0032387,0.00891865900095334,0.9974385408474251,8,66,negative regulation of intracellular transport,BP
GO:0098662,0.008932592339254548,0.994274370270577,48,736,inorganic cation transmembrane transport,BP
GO:0033865,0.008945984340996981,0.9964487574384391,13,140,nucleoside bisphosphate metabolic process,BP
GO:0033875,0.008945984340996981,0.9964487574384391,13,140,ribonucleoside bisphosphate metabolic process,BP
GO:0034032,0.008945984340996981,0.9964487574384391,13,140,purine nucleoside bisphosphate metabolic process,BP
GO:0003007,0.008947955261629163,0.9955569893238861,21,256,heart morphogenesis,BP
GO:0035304,0.008968136465061099,0.9964406683618935,13,138,regulation of protein dephosphorylation,BP
GO:0097035,0.008975711135156592,0.9977025228231794,7,50,regulation of membrane lipid distribution,BP
GO:0070207,0.008976196021359704,0.9983569688908159,5,31,protein homotrimerization,BP
GO:0035337,0.008986219673229408,0.9980018365746876,6,41,fatty-acyl-CoA metabolic process,BP
GO:0031345,0.009005215430458222,0.9960204663688005,16,187,negative regulation of cell projection organization,BP
GO:0051321,0.009034310677396904,0.995594141496998,20,248,meiotic cell cycle,BP
GO:0033194,0.009039208446015167,0.9987739342395665,4,19,response to hydroperoxide,BP
GO:0006997,0.009049655622419057,0.996559678596038,12,127,nucleus organization,BP
GO:0035865,0.009051515379088444,0.9992608746838465,3,10,cellular response to potassium ion,BP
GO:0005126,0.00905188967135264,0.9954125820687965,22,286,cytokine receptor binding,MF
GO:0050773,0.009077928436936432,0.9962496212849741,14,148,regulation of dendrite development,BP
GO:0070167,0.009080627808723356,0.9969229461328147,10,93,regulation of biomineral tissue development,BP
GO:0070301,0.009095362570243546,0.996908548514027,10,99,cellular response to hydrogen peroxide,BP
GO:0001228,0.009115246368821467,0.9947532590167202,32,433,"DNA-binding transcription activator activity, RNA polymerase II-specific",MF
GO:0072089,0.009136523041946428,0.9965297833564111,12,120,stem cell proliferation,BP
GO:1903800,0.009161778019031844,0.9992485112069102,3,10,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP
GO:0031307,0.009168827088712979,0.9987415154715523,4,20,integral component of mitochondrial outer membrane,CC
GO:0001889,0.009173693965208092,0.9963525644979175,13,134,liver development,BP
GO:0042116,0.00918101504457344,0.9968837978327046,10,93,macrophage activation,BP
GO:0031342,0.009249811813657404,0.9987368891770847,4,19,negative regulation of cell killing,BP
GO:0005544,0.009262803547340565,0.9976047196344213,7,53,calcium-dependent phospholipid binding,MF
GO:0030672,0.009284621951096757,0.9966484105490974,11,104,synaptic vesicle membrane,CC
GO:0099501,0.009284621951096757,0.9966484105490974,11,104,exocytic vesicle membrane,CC
GO:0038094,0.009286045271709372,0.9970615418505004,9,81,Fc-gamma receptor signaling pathway,BP
GO:0034058,0.009293634211937461,0.9992336519735289,3,10,endosomal vesicle fusion,BP
GO:0002673,0.009309888092027183,0.9968273945086776,10,97,regulation of acute inflammatory response,BP
GO:1902532,0.009310029258566518,0.9944371039732046,36,555,negative regulation of intracellular signal transduction,BP
GO:0098857,0.009319147920349814,0.9951101295807093,24,316,membrane microdomain,CC
GO:0046597,0.00932323223217113,0.99872391399234,4,19,negative regulation of viral entry into host cell,BP
GO:1903708,0.00933010827757806,0.995862693379949,16,184,positive regulation of hemopoiesis,BP
GO:0004985,0.009342742119704373,0.9992529900416475,3,9,opioid receptor activity,MF
GO:0061635,0.00941125628698851,0.9992203288250753,3,10,regulation of protein complex stability,BP
GO:0002793,0.00941553080001007,0.9952115815443822,22,285,positive regulation of peptide secretion,BP
GO:0051186,0.009416038180449393,0.9942474422740836,39,599,cofactor metabolic process,BP
GO:0010665,0.00941835664379091,0.9978479745032097,6,52,regulation of cardiac muscle cell apoptotic process,BP
GO:0086056,0.009432307276472464,0.9998133491543036,2,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF
GO:0001907,0.009441289665993904,0.9997374568394436,2,4,killing by symbiont of host cells,BP
GO:0044004,0.009441289665993904,0.9997374568394436,2,4,disruption by symbiont of host cell,BP
GO:0006639,0.00946098443702381,0.9963820119348329,12,127,acylglycerol metabolic process,BP
GO:0071549,0.00950095031438548,0.9982423946038852,5,30,cellular response to dexamethasone stimulus,BP
GO:0043620,0.009516767829705345,0.9963578318532333,12,127,regulation of DNA-templated transcription in response to stress,BP
GO:0000727,0.009544195707610151,0.9991847497927886,3,11,double-strand break repair via break-induced replication,BP
GO:0007584,0.009545986209746428,0.9955217499861551,18,218,response to nutrient,BP
GO:0051302,0.009550017251992223,0.9958857424912687,15,167,regulation of cell division,BP
GO:0007051,0.00955848013021278,0.9958793839125097,15,170,spindle organization,BP
GO:0043436,0.009591255422732616,0.9933389569564545,69,1167,oxoacid metabolic process,BP
GO:0031379,0.009615317623654055,0.9997300318284568,2,4,RNA-directed RNA polymerase complex,CC
GO:0005775,0.009627453049048076,0.9958447127514568,15,172,vacuolar lumen,CC
GO:0002062,0.009647348013826489,0.996307930310209,12,121,chondrocyte differentiation,BP
GO:0098900,0.009658895653315725,0.9974820969240404,7,53,regulation of action potential,BP
GO:0031491,0.009672119310711597,0.9971730781051004,8,70,nucleosome binding,MF
GO:0061572,0.009763801051588339,0.995925245754518,14,154,actin filament bundle organization,BP
GO:0044429,0.009773512145213036,0.9933863458052492,60,1013,mitochondrial part,CC
GO:0046390,0.009785009401621022,0.9950027965214817,22,294,ribose phosphate biosynthetic process,BP
GO:0043679,0.009816950900802462,0.9962367404713945,12,119,axon terminus,CC
GO:0035821,0.009829724948933484,0.9958861848805016,14,164,modification of morphology or physiology of other organism,BP
GO:0048638,0.009848047112023688,0.9947300428532572,25,340,regulation of developmental growth,BP
GO:0043491,0.009852428929732187,0.9951472621675722,20,265,protein kinase B signaling,BP
GO:0046640,0.00988322040540328,0.9981604905153582,5,29,regulation of alpha-beta T cell proliferation,BP
GO:0031122,0.009900212144485311,0.9974068858869629,7,53,cytoplasmic microtubule organization,BP
GO:1902993,0.009906708423848401,0.9986090763506573,4,20,positive regulation of amyloid precursor protein catabolic process,BP
GO:0007005,0.009921095812207528,0.9941409428580062,34,519,mitochondrion organization,BP
GO:1905063,0.009950215058753192,0.9985554525999233,4,26,regulation of vascular smooth muscle cell differentiation,BP
GO:0098981,0.01000253508141141,0.9991523990553736,3,10,cholinergic synapse,CC
GO:0000793,0.010004096041141969,0.9952813219620971,18,223,condensed chromosome,CC
GO:0042482,0.01001033842580723,0.9991296971259476,3,11,positive regulation of odontogenesis,BP
GO:0090101,0.010010402356548712,0.9961452634154624,12,125,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP
GO:0055114,0.010023797183319852,0.9932323193737899,59,978,oxidation-reduction process,BP
GO:0034138,0.010067907354855717,0.9985905828826084,4,19,toll-like receptor 3 signaling pathway,BP
GO:0097421,0.010073111334177,0.9981094726284282,5,30,liver regeneration,BP
GO:0006638,0.010080382205789485,0.996111297753986,12,128,neutral lipid metabolic process,BP
GO:1905908,0.010093831689035429,0.9997092438185392,2,4,positive regulation of amyloid fibril formation,BP
GO:0006816,0.010095665007224182,0.9941972494967531,31,432,calcium ion transport,BP
GO:0042108,0.01009819395993326,0.9970334297009741,8,67,positive regulation of cytokine biosynthetic process,BP
GO:0010977,0.010103137534637078,0.9957652784888236,14,155,negative regulation of neuron projection development,BP
GO:0043625,0.010127574587742424,0.9997077575467084,2,4,delta DNA polymerase complex,CC
GO:0002090,0.010129914444669853,0.9973283320133002,7,55,regulation of receptor internalization,BP
GO:1905214,0.010154913357065573,0.9991124206784433,3,11,regulation of RNA binding,BP
GO:0010800,0.010172939714255716,0.9980929946699898,5,29,positive regulation of peptidyl-threonine phosphorylation,BP
GO:0010661,0.01021187057289461,0.9980588004511395,5,33,positive regulation of muscle cell apoptotic process,BP
GO:0000910,0.010248144787074262,0.9955455214895901,15,171,cytokinesis,BP
GO:0019838,0.010254680108150734,0.9958615181932711,13,137,growth factor binding,MF
GO:0042306,0.010304605125852732,0.9972732700735897,7,55,regulation of protein import into nucleus,BP
GO:0010644,0.010344719008322144,0.9980527391982121,5,29,cell communication by electrical coupling,BP
GO:0072593,0.010366672865371386,0.9947714240678185,21,277,reactive oxygen species metabolic process,BP
GO:0045589,0.010376669720292992,0.9980315584562237,5,31,regulation of regulatory T cell differentiation,BP
GO:0071636,0.010390417258113356,0.9985206003161728,4,20,positive regulation of transforming growth factor beta production,BP
GO:0140029,0.010401137726041051,0.9966498599938277,9,80,exocytic process,BP
GO:0030686,0.010415195259015549,0.9980224383599501,5,31,90S preribosome,CC
GO:0046886,0.010417947273750035,0.9990807475851452,3,11,positive regulation of hormone biosynthetic process,BP
GO:0008332,0.010423418577638585,0.9997824936628948,2,3,low voltage-gated calcium channel activity,MF
GO:0046889,0.010444618399564677,0.9966254589343613,9,84,positive regulation of lipid biosynthetic process,BP
GO:0035035,0.010465915190071368,0.998024233183858,5,29,histone acetyltransferase binding,MF
GO:0036019,0.0104715383587372,0.998505637316398,4,20,endolysosome,CC
GO:0046320,0.01050046137110578,0.9980089076057919,5,30,regulation of fatty acid oxidation,BP
GO:0008408,0.010577044525343613,0.997187018888282,7,55,3'-5' exonuclease activity,MF
GO:0060544,0.01058770813184092,0.9984482626712531,4,24,regulation of necroptotic process,BP
GO:0031306,0.010591884718071069,0.9984730078974253,4,21,intrinsic component of mitochondrial outer membrane,CC
GO:0001094,0.010596353486918965,0.9990590897483552,3,11,TFIID-class transcription factor complex binding,MF
GO:1903312,0.010604566711577678,0.9965757689003153,9,79,negative regulation of mRNA metabolic process,BP
GO:0070044,0.010637935836375335,0.9996849548506991,2,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC
GO:0032588,0.010649726368619572,0.996554442467589,9,81,trans-Golgi network membrane,CC
GO:0032797,0.010689357045564833,0.9990477438712678,3,11,SMN complex,CC
GO:0032341,0.010711883184361722,0.9990688585811789,3,10,aldosterone metabolic process,BP
GO:0032342,0.010711883184361722,0.9990688585811789,3,10,aldosterone biosynthetic process,BP
GO:1903046,0.010714571345400725,0.9951721153528392,16,188,meiotic cell cycle process,BP
GO:0007296,0.010719949949934646,0.9996812344946588,2,4,vitellogenesis,BP
GO:0032637,0.010734873390852157,0.9965202754281011,9,82,interleukin-8 production,BP
GO:0030674,0.010764975515380021,0.9952948857491201,15,170,"protein binding, bridging",MF
GO:0003143,0.01076937148106698,0.9968029675016232,8,66,embryonic heart tube morphogenesis,BP
GO:0035739,0.010800247197703124,0.9990341664724015,3,11,"CD4-positive, alpha-beta T cell proliferation",BP
GO:2000561,0.010800247197703124,0.9990341664724015,3,11,"regulation of CD4-positive, alpha-beta T cell proliferation",BP
GO:0010506,0.010804814384209938,0.9942536857459177,24,326,regulation of autophagy,BP
GO:0071480,0.010825900883430403,0.997931608588022,5,30,cellular response to gamma radiation,BP
GO:0016082,0.01084948174104305,0.9984473736776016,4,19,synaptic vesicle priming,BP
GO:0051194,0.010853653645587472,0.9979180334274682,5,31,positive regulation of cofactor metabolic process,BP
GO:0051149,0.010885039669047036,0.9961867175576506,10,107,positive regulation of muscle cell differentiation,BP
GO:1901681,0.010897342178368291,0.9945877407783096,20,249,sulfur compound binding,MF
GO:0016605,0.010904185443798758,0.9961910957728426,10,99,PML body,CC
GO:0042330,0.010918917247554673,0.9931384850578241,42,642,taxis,BP
GO:0034703,0.010943089351038184,0.9946824284971937,19,220,cation channel complex,CC
GO:0014002,0.010953034781982906,0.9974441351142782,6,44,astrocyte development,BP
GO:0061008,0.010975932827743048,0.9955318885090481,13,137,hepaticobiliary system development,BP
GO:0042118,0.010984119924180497,0.9989913749449093,3,12,endothelial cell activation,BP
GO:0000375,0.011042902103287688,0.9940302033259316,25,348,"RNA splicing, via transesterification reactions",BP
GO:0019884,0.011058309133418973,0.9953090381594234,14,160,antigen processing and presentation of exogenous antigen,BP
GO:0003179,0.01114339288756289,0.9970175551334866,7,52,heart valve morphogenesis,BP
GO:0001920,0.011168684955168413,0.9996606079989665,2,4,negative regulation of receptor recycling,BP
GO:0097749,0.011171077934089065,0.9996604967844968,2,4,membrane tubulation,BP
GO:0030043,0.01121432530353332,0.9996584846339018,2,4,actin filament fragmentation,BP
GO:0032554,0.011280697626116097,0.9996553884055139,2,4,purine deoxyribonucleotide binding,MF
GO:0150076,0.011282016947566378,0.9966044633890799,8,73,neuroinflammatory response,BP
GO:0005884,0.011316708188695589,0.9957871078469441,11,111,actin filament,CC
GO:0002449,0.011342992386893616,0.9944558198234706,19,240,lymphocyte mediated immunity,BP
GO:0030866,0.011346822884369794,0.9973365698346172,6,43,cortical actin cytoskeleton organization,BP
GO:0071364,0.011363577653836186,0.9973317821647304,6,43,cellular response to epidermal growth factor stimulus,BP
GO:0042181,0.011380427795627219,0.9973319002277015,6,42,ketone biosynthetic process,BP
GO:1904978,0.011392798563103627,0.9996501366054719,2,4,regulation of endosome organization,BP
GO:0043325,0.011398430915684642,0.9977941589925615,5,30,"phosphatidylinositol-3,4-bisphosphate binding",MF
GO:0070498,0.011418348469272865,0.9959817840548498,10,100,interleukin-1-mediated signaling pathway,BP
GO:0036146,0.011436527398893923,0.999648080365058,2,4,cellular response to mycotoxin,BP
GO:0044306,0.011445981353980087,0.9953154541375252,13,137,neuron projection terminus,CC
GO:0060218,0.011497690288888768,0.9962288238854603,9,83,hematopoietic stem cell differentiation,BP
GO:0032231,0.011511999029366927,0.9959527857142917,10,95,regulation of actin filament bundle assembly,BP
GO:0060389,0.011532564413288395,0.996537752841963,8,65,pathway-restricted SMAD protein phosphorylation,BP
GO:0009266,0.011565386046830427,0.9943371762364741,19,238,response to temperature stimulus,BP
GO:0042391,0.01159281476625739,0.9932671447467294,31,432,regulation of membrane potential,BP
GO:0008154,0.01159992183968322,0.9945781388416307,17,208,actin polymerization or depolymerization,BP
GO:1990812,0.011644668627721887,0.9996382348680308,2,4,growth cone filopodium,CC
GO:0050685,0.011650056806057262,0.9977256042657667,5,31,positive regulation of mRNA processing,BP
GO:1901222,0.011669747516553274,0.9956276732531323,11,117,regulation of NIK/NF-kappaB signaling,BP
GO:0021761,0.011674737031815083,0.9956409467182087,11,107,limbic system development,BP
GO:0044106,0.011696333457504612,0.9953955626621663,12,129,cellular amine metabolic process,BP
GO:0001935,0.011713784199261352,0.9949779940681146,14,181,endothelial cell proliferation,BP
GO:0033197,0.011717230851720654,0.9988978835003183,3,12,response to vitamin E,BP
GO:0010770,0.011741050446482132,0.9949899866664057,14,153,positive regulation of cell morphogenesis involved in differentiation,BP
GO:0010662,0.011753368628633935,0.9971768132211645,6,54,regulation of striated muscle cell apoptotic process,BP
GO:2000182,0.011858199088591571,0.9996280350989746,2,4,regulation of progesterone biosynthetic process,BP
GO:0035877,0.01188208859058641,0.9996268877371987,2,4,death effector domain binding,MF
GO:0051865,0.011882151447968007,0.9964016412680081,8,69,protein autoubiquitination,BP
GO:0006379,0.011937832348739599,0.9982063308166121,4,22,mRNA cleavage,BP
GO:0021766,0.011943026218274692,0.9960654521789228,9,80,hippocampus development,BP
GO:0061387,0.011944241257553799,0.9955223032452022,11,109,regulation of extent of cell growth,BP
GO:0009119,0.011949064254211274,0.9957732256791986,10,96,ribonucleoside metabolic process,BP
GO:0030225,0.01195153990975477,0.9971627631305569,6,43,macrophage differentiation,BP
GO:1903779,0.011983105687913026,0.996362768192002,8,70,regulation of cardiac conduction,BP
GO:0071211,0.011984454070621441,0.999621957212997,2,4,protein targeting to vacuole involved in autophagy,BP
GO:0022857,0.011989124764236813,0.9917026590415975,64,1035,transmembrane transporter activity,MF
GO:0002605,0.011990953330434347,0.9996216433980873,2,4,negative regulation of dendritic cell antigen processing and presentation,BP
GO:2001259,0.011994193846504724,0.9963645826617045,8,68,positive regulation of cation channel activity,BP
GO:0031624,0.011998311623906488,0.9976330470805246,5,32,ubiquitin conjugating enzyme binding,MF
GO:0006356,0.012046812935642474,0.9976210882863266,5,32,regulation of transcription by RNA polymerase I,BP
GO:0050840,0.012050197649816177,0.996705514149175,7,57,extracellular matrix binding,MF
GO:0002431,0.012061127383729404,0.9960106282340818,9,84,Fc receptor mediated stimulatory signaling pathway,BP
GO:0007507,0.012063871170689085,0.9925596188342417,38,576,heart development,BP
GO:0001976,0.012089815668267086,0.998872419064061,3,11,neurological system process involved in regulation of systemic arterial blood pressure,BP
GO:0044786,0.01216214490622773,0.9962958777200164,8,71,cell cycle DNA replication,BP
GO:0001659,0.012186843599402593,0.9945926747200429,15,173,temperature homeostasis,BP
GO:2001251,0.012211636523775115,0.9951594082558878,12,133,negative regulation of chromosome organization,BP
GO:1900365,0.012251473304593417,0.9996089886579146,2,4,positive regulation of mRNA polyadenylation,BP
GO:0060391,0.012271963244715335,0.9988256244184327,3,12,positive regulation of SMAD protein signal transduction,BP
GO:1902562,0.01228109786226636,0.9970671840077195,6,43,H4 histone acetyltransferase complex,CC
GO:0016796,0.012283585621071083,0.9966291076865328,7,57,"exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters",MF
GO:0071482,0.012296366051084442,0.9951264485404666,12,129,cellular response to light stimulus,BP
GO:0033962,0.012306216878606887,0.9981455676957419,4,21,cytoplasmic mRNA processing body assembly,BP
GO:0061630,0.012323648541738619,0.9940609952318472,18,221,ubiquitin protein ligase activity,MF
GO:0046467,0.012326349755048663,0.994900549674049,13,142,membrane lipid biosynthetic process,BP
GO:0019902,0.012340114152554187,0.9943532652925665,16,185,phosphatase binding,MF
GO:0031094,0.01239283635399757,0.9988334106004867,3,11,platelet dense tubular network,CC
GO:0006622,0.012394989871359985,0.9981282090226251,4,21,protein targeting to lysosome,BP
GO:1905897,0.01239825435605299,0.9958828737926386,9,83,regulation of response to endoplasmic reticulum stress,BP
GO:0030810,0.012430463473432483,0.997018469445749,6,44,positive regulation of nucleotide biosynthetic process,BP
GO:1900373,0.012430463473432483,0.997018469445749,6,44,positive regulation of purine nucleotide biosynthetic process,BP
GO:0043279,0.012460151533749818,0.9952970115091463,11,111,response to alkaloid,BP
GO:0007088,0.012491941711573876,0.9946171555970219,14,164,regulation of mitotic nuclear division,BP
GO:0000086,0.012502629004830712,0.9938242494800255,19,247,G2/M transition of mitotic cell cycle,BP
GO:0006931,0.012504004943485586,0.9995965819617892,2,4,"substrate-dependent cell migration, cell attachment to substrate",BP
GO:0005719,0.012553232332981524,0.9981099928889535,4,20,nuclear euchromatin,CC
GO:0015850,0.012563911386737556,0.9936659079168558,20,260,organic hydroxy compound transport,BP
GO:2001257,0.01256517486004452,0.9944037509508717,15,174,regulation of cation channel activity,BP
GO:0034124,0.012577541928899866,0.9995929434052764,2,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP
GO:0046949,0.012597810238061845,0.9974843564303181,5,32,fatty-acyl-CoA biosynthetic process,BP
GO:1903077,0.012602674729655376,0.9980758302250985,4,22,negative regulation of protein localization to plasma membrane,BP
GO:0030516,0.012611545525541662,0.9955039643299004,10,95,regulation of axon extension,BP
GO:0043153,0.012631023019516664,0.9980818689231988,4,21,entrainment of circadian clock by photoperiod,BP
GO:0005164,0.012634361271896063,0.9974830105606195,5,31,tumor necrosis factor receptor binding,MF
GO:0002576,0.012643094147787172,0.9949714576119393,12,128,platelet degranulation,BP
GO:0098973,0.0127145636284984,0.9995861328608547,2,4,structural constituent of postsynaptic actin cytoskeleton,MF
GO:1903580,0.012735966318622251,0.9969238510384886,6,45,positive regulation of ATP metabolic process,BP
GO:0060750,0.012741518357136846,0.9995847883916263,2,4,epithelial cell proliferation involved in mammary gland duct elongation,BP
GO:0045834,0.012745997791771695,0.9946992411429095,13,146,positive regulation of lipid metabolic process,BP
GO:0006956,0.012748225606828222,0.9960818361488445,8,72,complement activation,BP
GO:0140112,0.012778981249588404,0.9980408614221028,4,22,extracellular vesicle biogenesis,BP
GO:0021543,0.012858478970717253,0.9942604681422214,15,171,pallium development,BP
GO:0035101,0.012868863121463917,0.9995784157256045,2,4,FACT complex,CC
GO:0038093,0.012887745302472787,0.9942381753787036,15,179,Fc receptor signaling pathway,BP
GO:0034614,0.012926278905558686,0.9944044857658682,14,166,cellular response to reactive oxygen species,BP
GO:1901991,0.012981679017995087,0.9936945566064022,18,244,negative regulation of mitotic cell cycle phase transition,BP
GO:0051148,0.01300480089181175,0.9963669263789711,7,64,negative regulation of muscle cell differentiation,BP
GO:0070232,0.01301605175086434,0.9973719763025345,5,33,regulation of T cell apoptotic process,BP
GO:0060602,0.013046117014402914,0.9980131802585099,4,20,branch elongation of an epithelium,BP
GO:1901532,0.01307300695797376,0.9956158358550791,9,85,regulation of hematopoietic progenitor cell differentiation,BP
GO:0140110,0.013148601908874737,0.989977569630073,115,2028,transcription regulator activity,MF
GO:0098978,0.013192747992217882,0.9926702880468695,26,349,glutamatergic synapse,CC
GO:0061001,0.013200192860118632,0.9967975374937483,6,43,regulation of dendritic spine morphogenesis,BP
GO:0072111,0.013206847439479967,0.9979676994671418,4,21,cell proliferation involved in kidney development,BP
GO:0009303,0.01321621500180717,0.9973213467302287,5,33,rRNA transcription,BP
GO:0004003,0.013220860330639878,0.9979649015990698,4,21,ATP-dependent DNA helicase activity,MF
GO:0008026,0.013220860330639878,0.9979649015990698,4,21,ATP-dependent helicase activity,MF
GO:0070035,0.013220860330639878,0.9979649015990698,4,21,purine NTP-dependent helicase activity,MF
GO:0007059,0.013243351157626787,0.9929301390460817,23,319,chromosome segregation,BP
GO:0010659,0.013261096760976344,0.9967264439000846,6,55,cardiac muscle cell apoptotic process,BP
GO:0006378,0.013263781164989418,0.996773112176132,6,44,mRNA polyadenylation,BP
GO:0003229,0.013267877866765136,0.996316316200066,7,54,ventricular cardiac muscle tissue development,BP
GO:1901136,0.013295572126696943,0.9938588664055011,16,191,carbohydrate derivative catabolic process,BP
GO:0048016,0.013306905145658491,0.9962989335460066,7,55,inositol phosphate-mediated signaling,BP
GO:0090114,0.013316982189285757,0.9958780028731626,8,71,COPII-coated vesicle budding,BP
GO:0032388,0.013322171411817858,0.9936747092603065,17,213,positive regulation of intracellular transport,BP
GO:0043034,0.013335909211758428,0.9979711501974077,4,19,costamere,CC
GO:0014855,0.013343936685981952,0.9958566186651431,8,75,striated muscle cell proliferation,BP
GO:1902107,0.013355029513325824,0.9944161038243706,13,143,positive regulation of leukocyte differentiation,BP
GO:0045197,0.013393550126172445,0.9967402458654918,6,43,establishment or maintenance of epithelial cell apical/basal polarity,BP
GO:0044703,0.013405081712906943,0.9907511083316479,61,1009,multi-organism reproductive process,BP
GO:0016529,0.013448727864925328,0.9958298814845328,8,71,sarcoplasmic reticulum,CC
GO:0046039,0.013463948841040182,0.9972746499051248,5,31,GTP metabolic process,BP
GO:0007169,0.013466347730292878,0.9912809552840832,45,712,transmembrane receptor protein tyrosine kinase signaling pathway,BP
GO:0030658,0.013468449518704689,0.9937725991089388,16,188,transport vesicle membrane,CC
GO:0015267,0.013482539126533417,0.9919396603747115,33,456,channel activity,MF
GO:0090092,0.013485773187211687,0.993291503728791,19,240,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP
GO:0086002,0.013523130291419848,0.9962313468503043,7,54,cardiac muscle cell action potential involved in contraction,BP
GO:0098685,0.013549984652953363,0.9954366847352724,9,82,Schaffer collateral - CA1 synapse,CC
GO:0045066,0.01355993736082655,0.9972339356613455,5,33,regulatory T cell differentiation,BP
GO:1904666,0.01356954551332886,0.9978822437673341,4,22,regulation of ubiquitin protein ligase activity,BP
GO:0030667,0.013573620176355806,0.9928540518578309,22,296,secretory granule membrane,CC
GO:0071985,0.013583064221178432,0.9972280332282044,5,33,multivesicular body sorting pathway,BP
GO:0015855,0.013587446499515154,0.9995418164309395,2,4,pyrimidine nucleobase transport,BP
GO:0036499,0.01360372187110075,0.9978881047043543,4,21,PERK-mediated unfolded protein response,BP
GO:0010574,0.013603783900426597,0.9972152965467543,5,34,regulation of vascular endothelial growth factor production,BP
GO:0048863,0.013624522429529757,0.9930795655889961,20,254,stem cell differentiation,BP
GO:0048156,0.013641213845433894,0.996655277715046,6,45,tau protein binding,MF
GO:0071398,0.013652265713258798,0.9961751137218212,7,57,cellular response to fatty acid,BP
GO:0032456,0.01367589099256001,0.9966449056371973,6,45,endocytic recycling,BP
GO:0002920,0.013695514585243942,0.9957333853619291,8,73,regulation of humoral immune response,BP
GO:0099186,0.01369723597087153,0.9986613296907485,3,11,structural constituent of postsynapse,MF
GO:0042255,0.013784384041039661,0.9961152406220811,7,61,ribosome assembly,BP
GO:0097060,0.013785039264442064,0.9918879009589135,31,431,synaptic membrane,CC
GO:0098901,0.013788942631716178,0.9971834489530609,5,32,regulation of cardiac muscle cell action potential,BP
GO:0031369,0.013796147234089045,0.9971816074019525,5,32,translation initiation factor binding,MF
GO:0060415,0.013815091813688719,0.9953352367603348,9,81,muscle tissue morphogenesis,BP
GO:0019903,0.013847481399081521,0.994187023859099,13,140,protein phosphatase binding,MF
GO:0098589,0.013877888678526433,0.992453640609042,24,328,membrane region,CC
GO:0036021,0.013878960959987557,0.9994524975850008,2,5,endolysosome lumen,CC
GO:0097242,0.013902363982547294,0.9971247046565141,5,36,amyloid-beta clearance,BP
GO:1901798,0.013908757440023962,0.9978132925978693,4,22,positive regulation of signal transduction by p53 class mediator,BP
GO:0022803,0.013926265577921666,0.99165407890038,33,457,passive transmembrane transporter activity,MF
GO:0060997,0.013962527393120037,0.9960708418895733,7,57,dendritic spine morphogenesis,BP
GO:0006082,0.013963254021831706,0.9901231140469754,69,1187,organic acid metabolic process,BP
GO:0000070,0.013964242853796034,0.994117188944083,13,151,mitotic sister chromatid segregation,BP
GO:0001776,0.013990552091670827,0.9952552150575682,9,85,leukocyte homeostasis,BP
GO:1902916,0.013991726760735726,0.9985936812694399,3,12,positive regulation of protein polyubiquitination,BP
GO:0031663,0.014000185646302959,0.9960539839883654,7,58,lipopolysaccharide-mediated signaling pathway,BP
GO:0030315,0.014024817923727811,0.9960733157908614,7,52,T-tubule,CC
GO:0030950,0.014025662456833038,0.9985889876927696,3,12,establishment or maintenance of actin cytoskeleton polarity,BP
GO:0016491,0.01404491974879631,0.9908800916828647,45,728,oxidoreductase activity,MF
GO:0007219,0.014073115804808474,0.9934556088784858,16,193,Notch signaling pathway,BP
GO:0005684,0.01409730512222844,0.9952030541237278,9,89,U2-type spliceosomal complex,CC
GO:0016574,0.014117888160367915,0.9965121727479505,6,45,histone ubiquitination,BP
GO:0001101,0.014160104407190706,0.9921816959025573,25,342,response to acid chemical,BP
GO:0006809,0.014201443747013062,0.9955379962503725,8,76,nitric oxide biosynthetic process,BP
GO:0060008,0.014203589635608827,0.9977813936004931,4,20,Sertoli cell differentiation,BP
GO:0034205,0.01421028255538585,0.9970591114399805,5,34,amyloid-beta formation,BP
GO:0006297,0.014224157193053918,0.9977364609957344,4,23,"nucleotide-excision repair, DNA gap filling",BP
GO:0071479,0.014283582994995877,0.99552288292216,8,71,cellular response to ionizing radiation,BP
GO:0000777,0.014285615436977709,0.9947868226628165,10,105,condensed chromosome kinetochore,CC
GO:0043194,0.014293897857258464,0.9977798783500552,4,19,axon initial segment,CC
GO:0050706,0.014337222130911043,0.9964403741440038,6,46,regulation of interleukin-1 beta secretion,BP
GO:0045773,0.01434002477312395,0.9964570761832627,6,43,positive regulation of axon extension,BP
GO:0099175,0.014351397967476462,0.9947760447131244,10,97,regulation of postsynapse organization,BP
GO:0060292,0.01435522191555742,0.99704700074809,5,31,long-term synaptic depression,BP
GO:0002067,0.014370981593890785,0.9964415892789019,6,44,glandular epithelial cell differentiation,BP
GO:0032722,0.014375576126510924,0.9959269800661966,7,58,positive regulation of chemokine production,BP
GO:0032793,0.014424940808087153,0.9977363788295206,4,20,positive regulation of CREB transcription factor activity,BP
GO:0016042,0.014444752968943184,0.9921153943212134,24,332,lipid catabolic process,BP
GO:0051290,0.0144607173550505,0.9963739717251968,6,52,protein heterotetramerization,BP
GO:0031429,0.01446427806105414,0.9994167543798648,2,5,box H/ACA snoRNP complex,CC
GO:0034513,0.01446427806105414,0.9994167543798648,2,5,box H/ACA snoRNA binding,MF
GO:0043388,0.014550062974056123,0.9958677093464655,7,58,positive regulation of DNA binding,BP
GO:0002262,0.014562289778595658,0.9938368328455169,13,147,myeloid cell homeostasis,BP
GO:0071888,0.014562972528399307,0.9985140899581099,3,12,macrophage apoptotic process,BP
GO:0043666,0.014605120602249859,0.9943497216278765,11,116,regulation of phosphoprotein phosphatase activity,BP
GO:0045665,0.014606629374312615,0.9928305876286186,18,224,negative regulation of neuron differentiation,BP
GO:0051896,0.014633007871135043,0.9928037985252364,18,241,regulation of protein kinase B signaling,BP
GO:0045918,0.014635219597266996,0.9994061652798814,2,5,negative regulation of cytolysis,BP
GO:0034061,0.014664919630340615,0.9969490163323635,5,33,DNA polymerase activity,MF
GO:0016281,0.014692011765401816,0.9984711689301506,3,13,eukaryotic translation initiation factor 4F complex,CC
GO:0032469,0.014703671270508891,0.9976496727105643,4,22,endoplasmic reticulum calcium ion homeostasis,BP
GO:0031398,0.014730032040820188,0.9942943283496399,11,116,positive regulation of protein ubiquitination,BP
GO:1902750,0.014806044078637063,0.9945669016621159,10,105,negative regulation of cell cycle G2/M phase transition,BP
GO:0034308,0.014828408750222205,0.994922238155621,9,85,primary alcohol metabolic process,BP
GO:0006695,0.014898932329829776,0.9952813429617319,8,75,cholesterol biosynthetic process,BP
GO:0031334,0.014916033138842821,0.9923468704813746,20,266,positive regulation of protein complex assembly,BP
GO:0031536,0.014949005969233393,0.9993865524877992,2,5,positive regulation of exit from mitosis,BP
GO:0042771,0.014949472413254793,0.9962598387956728,6,45,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP
GO:0043178,0.014952609135109835,0.9948725898982482,9,85,alcohol binding,MF
GO:0051412,0.014956585567810649,0.9976114200359609,4,21,response to corticosterone,BP
GO:0019418,0.014961902947733785,0.9993857415528037,2,5,sulfide oxidation,BP
GO:0070221,0.014961902947733785,0.9993857415528037,2,5,"sulfide oxidation, using sulfide:quinone oxidoreductase",BP
GO:0000109,0.014968472494210407,0.9984568479902676,3,12,nucleotide-excision repair complex,CC
GO:0046633,0.014991533573720824,0.9968726114105062,5,32,alpha-beta T cell proliferation,BP
GO:0010960,0.01499204861176106,0.9984535011302336,3,12,magnesium ion homeostasis,BP
GO:1900376,0.015004508520675877,0.9984517314962549,3,12,regulation of secondary metabolite biosynthetic process,BP
GO:0060390,0.015009730360927075,0.9975859291559405,4,22,regulation of SMAD protein signal transduction,BP
GO:1990948,0.015054074140527493,0.9993799349693929,2,5,ubiquitin ligase inhibitor activity,MF
GO:0002474,0.015080986806768976,0.9948105117150091,9,89,antigen processing and presentation of peptide antigen via MHC class I,BP
GO:0070542,0.015154958586670278,0.9947887610982248,9,86,response to fatty acid,BP
GO:0051457,0.015170983354794804,0.9975521806905252,4,22,maintenance of protein location in nucleus,BP
GO:0001786,0.015212224786267596,0.9956460153764215,7,57,phosphatidylserine binding,MF
GO:0019725,0.015264182730811796,0.9894958726289044,58,964,cellular homeostasis,BP
GO:1902914,0.015269756245651543,0.9975314531622024,4,22,regulation of protein polyubiquitination,BP
GO:0050435,0.015304304946124125,0.9961394152973531,6,47,amyloid-beta metabolic process,BP
GO:0060762,0.015308415966710042,0.9993638117406354,2,5,regulation of branching involved in mammary gland duct morphogenesis,BP
GO:0005770,0.015309062525395935,0.9922778127219283,19,249,late endosome,CC
GO:1905907,0.015317258136186875,0.9993632485795296,2,5,negative regulation of amyloid fibril formation,BP
GO:0045540,0.015384762155583398,0.99609877552468,6,50,regulation of cholesterol biosynthetic process,BP
GO:0106118,0.015384762155583398,0.99609877552468,6,50,regulation of sterol biosynthetic process,BP
GO:0044272,0.015402622057961292,0.9927637994282138,16,192,sulfur compound biosynthetic process,BP
GO:0002698,0.015414564291214527,0.9939875749252872,11,117,negative regulation of immune effector process,BP
GO:0046128,0.015431837615455381,0.9950950312390137,8,71,purine ribonucleoside metabolic process,BP
GO:0048002,0.015435269582588059,0.993168339716896,14,167,antigen processing and presentation of peptide antigen,BP
GO:0002697,0.01545444620138695,0.991183793652902,27,388,regulation of immune effector process,BP
GO:0017124,0.015465204398038893,0.9936733109702185,12,130,SH3 domain binding,MF
GO:0016328,0.015473190957643795,0.9955563526899531,7,57,lateral plasma membrane,CC
GO:0042136,0.015481600050584321,0.9942795166708019,10,105,neurotransmitter biosynthetic process,BP
GO:0010948,0.015526314197257255,0.9914589527783968,24,356,negative regulation of cell cycle process,BP
GO:0072522,0.015561698583850633,0.9916949995436161,22,307,purine-containing compound biosynthetic process,BP
GO:0005686,0.015562291577102195,0.9974436315634125,4,24,U2 snRNP,CC
GO:0045080,0.015578807045521293,0.9983695489862605,3,12,positive regulation of chemokine biosynthetic process,BP
GO:1901203,0.01558856026301108,0.999345883479223,2,5,positive regulation of extracellular matrix assembly,BP
GO:0086016,0.015599469826720731,0.9983988374784175,3,11,AV node cell action potential,BP
GO:0086027,0.015599469826720731,0.9983988374784175,3,11,AV node cell to bundle of His cell signaling,BP
GO:0086070,0.015606830956399373,0.9984373509284227,3,10,SA node cell to atrial cardiac muscle cell communication,BP
GO:0001650,0.015631179215001487,0.9935942812084446,12,131,fibrillar center,CC
GO:0042982,0.015748541434065302,0.9954433549041541,7,61,amyloid precursor protein metabolic process,BP
GO:0071896,0.015777242667413597,0.9994237828772726,2,4,protein localization to adherens junction,BP
GO:0034329,0.015826841130922142,0.991995058140966,19,241,cell junction assembly,BP
GO:0046520,0.015857174344036922,0.998329284252725,3,12,sphingoid biosynthetic process,BP
GO:0032091,0.01589620822271608,0.994108824067513,10,102,negative regulation of protein binding,BP
GO:0098562,0.015931520854645727,0.9926963147956309,15,178,cytoplasmic side of membrane,CC
GO:0031904,0.015940508483301974,0.9966039850906159,5,34,endosome lumen,CC
GO:0030017,0.01594521330450209,0.9922861533630171,17,204,sarcomere,CC
GO:0016779,0.015998906319111692,0.9934207451367709,12,132,nucleotidyltransferase activity,MF
GO:0030618,0.016008187758294296,0.9993186994221068,2,5,"transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity",MF
GO:0060443,0.0160092313813399,0.9959271803453248,6,46,mammary gland morphogenesis,BP
GO:0044321,0.01602899204630904,0.997370739630152,4,22,response to leptin,BP
GO:0034643,0.016069729220050014,0.9973620478615834,4,22,"establishment of mitochondrion localization, microtubule-mediated",BP
GO:0047497,0.016069729220050014,0.9973620478615834,4,22,mitochondrion transport along microtubule,BP
GO:0042555,0.016081310099119776,0.9982966623209476,3,12,MCM complex,CC
GO:0043277,0.016087013979528338,0.9959029893678659,6,46,apoptotic cell clearance,BP
GO:0000287,0.016092926437694256,0.9921999436449107,17,211,magnesium ion binding,MF
GO:0033567,0.016107448372054262,0.9993122118099382,2,5,"DNA replication, Okazaki fragment processing",BP
GO:0046040,0.01610794616832062,0.9982647518009977,3,13,IMP metabolic process,BP
GO:0022838,0.016124597638467048,0.9903964095927126,31,428,substrate-specific channel activity,MF
GO:0004758,0.01614823321788534,0.9993095398058374,2,5,serine C-palmitoyltransferase activity,MF
GO:0016454,0.01614823321788534,0.9993095398058374,2,5,C-palmitoyltransferase activity,MF
GO:0001103,0.01620560920293956,0.9965244313696107,5,35,RNA polymerase II repressing transcription factor binding,MF
GO:0010658,0.01621065758045139,0.9958095037022177,6,57,striated muscle cell apoptotic process,BP
GO:1902653,0.016211477852557613,0.9947833405717348,8,76,secondary alcohol biosynthetic process,BP
GO:0035306,0.0162371804094066,0.9952871145495047,7,58,positive regulation of dephosphorylation,BP
GO:0005319,0.01624939740150865,0.9933050532917107,12,131,lipid transporter activity,MF
GO:0097038,0.016297496589820423,0.9973133238871782,4,22,perinuclear endoplasmic reticulum,CC
GO:0006935,0.01633151481335789,0.98952347040105,41,640,chemotaxis,BP
GO:0045814,0.016365244305642387,0.9935528048669704,11,121,"negative regulation of gene expression, epigenetic",BP
GO:0050431,0.016396938850373518,0.9972919839225779,4,22,transforming growth factor beta binding,MF
GO:0070545,0.01640432847539614,0.999292677816007,2,5,PeBoW complex,CC
GO:0010799,0.016428564014603932,0.995790215951907,6,47,regulation of peptidyl-threonine phosphorylation,BP
GO:0051181,0.016432824860154013,0.9957888815861753,6,47,cofactor transport,BP
GO:0033120,0.016435023606994704,0.9964714094065984,5,34,positive regulation of RNA splicing,BP
GO:0031252,0.016445744907117706,0.9904655938764089,28,403,cell leading edge,CC
GO:0014004,0.016514822002136997,0.9992853580272995,2,5,microglia differentiation,BP
GO:0030224,0.01655500033731868,0.9964219293734227,5,36,monocyte differentiation,BP
GO:1903131,0.01655500033731868,0.9964219293734227,5,36,mononuclear cell differentiation,BP
GO:0031072,0.01660074985950564,0.9934501537405268,11,119,heat shock protein binding,MF
GO:0008622,0.016606006611965082,0.9992792972097916,2,5,epsilon DNA polymerase complex,CC
GO:0045931,0.0166069092572068,0.9928309380893673,13,160,positive regulation of mitotic cell cycle,BP
GO:0043618,0.016727188623613214,0.9933890053136678,11,121,regulation of transcription from RNA polymerase II promoter in response to stress,BP
GO:0032414,0.01679540673923563,0.9937218114102555,10,102,positive regulation of ion transmembrane transporter activity,BP
GO:0033028,0.016821000076721354,0.9963767827577774,5,33,myeloid cell apoptotic process,BP
GO:1905477,0.01682627060037859,0.9933421582240476,11,122,positive regulation of protein localization to membrane,BP
GO:0051291,0.01686788140399379,0.9933159315031612,11,126,protein heterooligomerization,BP
GO:0098660,0.016886722586683785,0.9886098559808345,51,820,inorganic ion transmembrane transport,BP
GO:0004536,0.016888202544229958,0.9950546088235701,7,59,deoxyribonuclease activity,MF
GO:0030175,0.016891155763723464,0.9936803930177114,10,102,filopodium,CC
GO:0001227,0.016939389623548032,0.9913731380594273,19,239,"DNA-binding transcription repressor activity, RNA polymerase II-specific",MF
GO:0034309,0.017007962222911118,0.9981599142588449,3,12,primary alcohol biosynthetic process,BP
GO:0045428,0.017036280154181852,0.9949758855583728,7,65,regulation of nitric oxide biosynthetic process,BP
GO:0002478,0.01707797337862322,0.9926100010437389,13,153,antigen processing and presentation of exogenous peptide antigen,BP
GO:0043087,0.01709800719225222,0.9896680441246248,32,477,regulation of GTPase activity,BP
GO:1904019,0.017115073621275605,0.9935692459588309,10,108,epithelial cell apoptotic process,BP
GO:0010573,0.017164839609472703,0.9962558948760695,5,36,vascular endothelial growth factor production,BP
GO:0010594,0.017165180841152098,0.992018592991322,15,219,regulation of endothelial cell migration,BP
GO:0010935,0.017165371260986686,0.998105874956124,3,13,regulation of macrophage cytokine production,BP
GO:0009164,0.017235741577339453,0.9962544855621445,5,34,nucleoside catabolic process,BP
GO:0005244,0.01725067000017909,0.9915886748326609,17,197,voltage-gated ion channel activity,MF
GO:0022832,0.01725067000017909,0.9915886748326609,17,197,voltage-gated channel activity,MF
GO:1902414,0.01725411280005108,0.9981230885829556,3,12,protein localization to cell junction,BP
GO:0000738,0.01725411765570282,0.9992356968516586,2,5,"DNA catabolic process, exonucleolytic",BP
GO:0045821,0.017254581847759014,0.9970906694588405,4,23,positive regulation of glycolytic process,BP
GO:0070412,0.017333612427357054,0.997073317367225,4,23,R-SMAD binding,MF
GO:0098993,0.017421860331585142,0.9980667474237647,3,13,anchored component of synaptic vesicle membrane,CC
GO:0006984,0.017454515503329115,0.9954732825153922,6,46,ER-nucleus signaling pathway,BP
GO:0006596,0.017510613996967534,0.9980531551289111,3,13,polyamine biosynthetic process,BP
GO:0070849,0.017513032249920187,0.9954480108449106,6,47,response to epidermal growth factor,BP
GO:1904031,0.017519513402896612,0.9961674958230641,5,35,positive regulation of cyclin-dependent protein kinase activity,BP
GO:1904376,0.01760969598747142,0.9969979412267966,4,24,negative regulation of protein localization to cell periphery,BP
GO:0061659,0.017655965670983813,0.9911497630968754,18,230,ubiquitin-like protein ligase activity,MF
GO:0000463,0.017683003013978855,0.9979998484520578,3,14,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)",BP
GO:0046660,0.017698655062372885,0.992959477540496,11,115,female sex differentiation,BP
GO:0044774,0.017763104246066218,0.9932914174847196,10,106,mitotic DNA integrity checkpoint,BP
GO:0071005,0.017825685682246573,0.9953296285501818,6,50,U2-type precatalytic spliceosome,CC
GO:0052150,0.01784848650373434,0.9991949157840198,2,5,modulation by symbiont of host apoptotic process,BP
GO:0000726,0.01788172655402009,0.9936596062633746,9,92,non-recombinational repair,BP
GO:0000377,0.017891102286412792,0.9900363691836619,24,345,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",BP
GO:0000398,0.017891102286412792,0.9900363691836619,24,345,"mRNA splicing, via spliceosome",BP
GO:0046822,0.017892230117188036,0.9932398828549236,10,104,regulation of nucleocytoplasmic transport,BP
GO:0032155,0.017924382818770294,0.9946688217209074,7,63,cell division site part,CC
GO:0051169,0.0180314831804482,0.9899510195882739,24,345,nuclear transport,BP
GO:0015631,0.018065336225604262,0.9899369625168644,24,333,tubulin binding,MF
GO:0042063,0.018098877787115226,0.9903606384208249,21,286,gliogenesis,BP
GO:0008296,0.018162018700824185,0.9979525713360478,3,13,3'-5'-exodeoxyribonuclease activity,MF
GO:0031589,0.018180950013526077,0.989731652369656,25,353,cell-substrate adhesion,BP
GO:0000212,0.01819651807424867,0.9979472041624267,3,13,meiotic spindle organization,BP
GO:0019054,0.01823769227597333,0.9968439332538992,4,25,modulation by virus of host process,BP
GO:0009791,0.018241645823745614,0.9935256578572845,9,87,post-embryonic development,BP
GO:0006164,0.018255062247195177,0.9902638091846798,21,294,purine nucleotide biosynthetic process,BP
GO:0006631,0.01826431940405077,0.9895476685908814,26,382,fatty acid metabolic process,BP
GO:0016895,0.01826656015784948,0.9968666114275853,4,23,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters",MF
GO:0003231,0.018271181025536088,0.9923560542945401,12,127,cardiac ventricle development,BP
GO:0090068,0.018288314118738026,0.9902430193530273,21,296,positive regulation of cell cycle process,BP
GO:0070527,0.018397323564196873,0.9945195424747881,7,59,platelet aggregation,BP
GO:0005740,0.018402559686574563,0.9879616356045474,43,717,mitochondrial envelope,CC
GO:0050657,0.01841355282244043,0.9913930805494728,15,191,nucleic acid transport,BP
GO:0050658,0.01841355282244043,0.9913930805494728,15,191,RNA transport,BP
GO:0046104,0.018414428958749743,0.999155386978038,2,5,thymidine metabolic process,BP
GO:0046125,0.018414428958749743,0.999155386978038,2,5,pyrimidine deoxyribonucleoside metabolic process,BP
GO:0098974,0.01843735779558319,0.9979432059618224,3,12,postsynaptic actin cytoskeleton organization,BP
GO:0051017,0.01851500305255934,0.9919049692746937,13,151,actin filament bundle assembly,BP
GO:0043534,0.018562693254911916,0.9921491316845814,12,170,blood vessel endothelial cell migration,BP
GO:0036091,0.018614641500602713,0.9991412414970794,2,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP
GO:0010831,0.018633074349765126,0.9958497190832697,5,36,positive regulation of myotube differentiation,BP
GO:0008235,0.01866958062449786,0.9944064565364426,7,62,metalloexopeptidase activity,MF
GO:0070671,0.018703810774201197,0.9950466097619126,6,50,response to interleukin-12,BP
GO:0031674,0.018709127458150135,0.9918225994781162,13,143,I band,CC
GO:0042278,0.018725373316205253,0.9938218257014546,8,74,purine nucleoside metabolic process,BP
GO:0050921,0.018730140537397928,0.9921205129311352,12,135,positive regulation of chemotaxis,BP
GO:1901068,0.01876503101893984,0.9950539411980849,6,46,guanosine-containing compound metabolic process,BP
GO:0005216,0.018773970622328415,0.988784655124378,30,416,ion channel activity,MF
GO:0005534,0.01882479288108798,0.9991263036927727,2,5,galactose binding,MF
GO:0045569,0.01884349376717464,0.9991249699533166,2,5,TRAIL binding,MF
GO:0070914,0.01885165139709574,0.9978445274545631,3,13,UV-damage excision repair,BP
GO:0032530,0.018869122299760042,0.99784176978421,3,13,regulation of microvillus organization,BP
GO:0051249,0.01888684916361782,0.9889206002045253,28,409,regulation of lymphocyte activation,BP
GO:0045722,0.018886990086860917,0.9977628411487928,3,16,positive regulation of gluconeogenesis,BP
GO:0098552,0.01889878106218992,0.9883973134449443,33,492,side of membrane,CC
GO:0033592,0.018946617852964993,0.9991176021283773,2,5,RNA strand annealing activity,MF
GO:0060711,0.01899339418691304,0.9949801412674288,6,46,labyrinthine layer development,BP
GO:0044450,0.01902045170238558,0.9910815936913326,15,185,microtubule organizing center part,CC
GO:0061014,0.019025462094988992,0.99495534002654,6,48,positive regulation of mRNA catabolic process,BP
GO:2000563,0.019081921512910632,0.9991079017248867,2,5,"positive regulation of CD4-positive, alpha-beta T cell proliferation",BP
GO:0005913,0.019107018583676867,0.9923075656018007,11,117,cell-cell adherens junction,CC
GO:0002200,0.019141004486648575,0.9936634149859683,8,73,somatic diversification of immune receptors,BP
GO:0001845,0.019154557801141506,0.9977965733176336,3,13,phagolysosome assembly,BP
GO:0001892,0.01921394235268759,0.9931202643512496,9,87,embryonic placenta development,BP
GO:1903426,0.019231831540398526,0.9930845770227832,9,96,regulation of reactive oxygen species biosynthetic process,BP
GO:0010922,0.01930510992159604,0.9956814744285404,5,34,positive regulation of phosphatase activity,BP
GO:0033273,0.019323020905545798,0.9930580826744227,9,92,response to vitamin,BP
GO:0007369,0.019339135874648607,0.9909163564433835,15,183,gastrulation,BP
GO:0001704,0.01935533755944463,0.9921878863752259,11,119,formation of primary germ layer,BP
GO:0001947,0.01936112801447759,0.9941672464983363,7,60,heart looping,BP
GO:0005732,0.01941798677667921,0.996537099607391,4,28,small nucleolar ribonucleoprotein complex,CC
GO:0098631,0.019495393626095044,0.9941242323041474,7,59,cell adhesion mediator activity,MF
GO:0045599,0.019500877806439346,0.9947806036359881,6,51,negative regulation of fat cell differentiation,BP
GO:2001137,0.019520690022274814,0.9990761847371746,2,5,positive regulation of endocytic recycling,BP
GO:0050680,0.019556381016682323,0.9916884870531639,12,155,negative regulation of epithelial cell proliferation,BP
GO:0006475,0.019571328793304567,0.9910751911409198,14,166,internal protein amino acid acetylation,BP
GO:0097368,0.01958969897539459,0.9990711603049223,2,5,establishment of Sertoli cell barrier,BP
GO:0086001,0.01963394057357084,0.9934742221777156,8,72,cardiac muscle cell action potential,BP
GO:0007498,0.019634780991976398,0.9916889921586056,12,133,mesoderm development,BP
GO:0010742,0.019669617320063164,0.9955576923359862,5,36,macrophage derived foam cell differentiation,BP
GO:0090077,0.019669617320063164,0.9955576923359862,5,36,foam cell differentiation,BP
GO:0032536,0.019706937624268478,0.9977083527185474,3,13,regulation of cell projection size,BP
GO:0006081,0.019718433072021403,0.9934320702783345,8,74,cellular aldehyde metabolic process,BP
GO:0099532,0.019765909131594067,0.9990582865066295,2,5,synaptic vesicle endosomal processing,BP
GO:0001652,0.019775367921559733,0.9990575936596033,2,5,granular component,CC
GO:0071011,0.01978587530561255,0.9946870398862364,6,51,precatalytic spliceosome,CC
GO:0001727,0.019877790761794908,0.9990500796041242,2,5,lipid kinase activity,MF
GO:0009308,0.01998698293117449,0.9915085804343415,12,138,amine metabolic process,BP
GO:0010718,0.020030429306876547,0.9946130620018003,6,50,positive regulation of epithelial to mesenchymal transition,BP
GO:0071634,0.02014881897091575,0.9954212597965688,5,36,regulation of transforming growth factor beta production,BP
GO:0050863,0.02016503446263352,0.9889670241343186,22,307,regulation of T cell activation,BP
GO:0048711,0.020166595578118916,0.9976341902122376,3,13,positive regulation of astrocyte differentiation,BP
GO:0004722,0.02020545677850852,0.9932308817109083,8,76,protein serine/threonine phosphatase activity,MF
GO:0022839,0.020278676056325974,0.9884457152936137,25,334,ion gated channel activity,MF
GO:0045619,0.020309728850735544,0.9906928572517649,14,167,regulation of lymphocyte differentiation,BP
GO:0046513,0.020326991403652822,0.9938100465398122,7,61,ceramide biosynthetic process,BP
GO:0048806,0.02034514090937158,0.9945310569247504,6,47,genitalia development,BP
GO:0048738,0.02035527614976167,0.9898551417167232,17,224,cardiac muscle tissue development,BP
GO:0002092,0.020355328571523945,0.9963743098886175,4,24,positive regulation of receptor internalization,BP
GO:0046209,0.020360675341532474,0.9931495030006152,8,81,nitric oxide metabolic process,BP
GO:0006705,0.020365198692527297,0.9976019383948657,3,13,mineralocorticoid biosynthetic process,BP
GO:0008212,0.020365198692527297,0.9976019383948657,3,13,mineralocorticoid metabolic process,BP
GO:0017144,0.02039266637726697,0.9861922278012291,49,830,drug metabolic process,BP
GO:0046824,0.02042015987782079,0.9937703902440528,7,62,positive regulation of nucleocytoplasmic transport,BP
GO:0034764,0.020425596981646595,0.9900698069067281,16,202,positive regulation of transmembrane transport,BP
GO:0002526,0.02044360319071477,0.9909303967052622,13,158,acute inflammatory response,BP
GO:0060601,0.02055093796330645,0.99757166249988,3,13,lateral sprouting from an epithelium,BP
GO:0045345,0.02058538837410474,0.9989975868188871,2,5,positive regulation of MHC class I biosynthetic process,BP
GO:0005201,0.020593754033271454,0.9905523827215055,14,163,extracellular matrix structural constituent,MF
GO:0071004,0.020595004273052425,0.9975033933640935,3,15,U2-type prespliceosome,CC
GO:0071010,0.020595004273052425,0.9975033933640935,3,15,prespliceosome,CC
GO:0033059,0.020626432813264074,0.9944160161244676,6,50,cellular pigmentation,BP
GO:0042274,0.02068000650744891,0.9936543181264348,7,66,ribosomal small subunit biogenesis,BP
GO:0006296,0.020704395461884982,0.9952517489612223,5,37,"nucleotide-excision repair, DNA incision, 5'-to lesion",BP
GO:0007052,0.020736616631092344,0.991974149031074,10,106,mitotic spindle organization,BP
GO:0045211,0.020746484465285226,0.9883019284642919,24,323,postsynaptic membrane,CC
GO:0051236,0.02074965557028003,0.9901545309858413,15,194,establishment of RNA localization,BP
GO:0097350,0.020875528942715632,0.9989757714093366,2,5,neutrophil clearance,BP
GO:1903902,0.020920068484729458,0.9935922181472128,7,61,positive regulation of viral life cycle,BP
GO:0007215,0.021068433923049835,0.9918434335996072,10,100,glutamate receptor signaling pathway,BP
GO:1902105,0.021075647508175907,0.9887958222225525,20,270,regulation of leukocyte differentiation,BP
GO:0097386,0.021080143245618896,0.9962050090135879,4,24,glial cell projection,CC
GO:0031103,0.021095103995052995,0.9942601061040353,6,50,axon regeneration,BP
GO:0007613,0.02111246645094019,0.9913724106785122,11,117,memory,BP
GO:0001919,0.021252323112689295,0.9961645151872502,4,24,regulation of receptor recycling,BP
GO:0098563,0.021288237707250853,0.9942186566739867,6,47,intrinsic component of synaptic vesicle membrane,CC
GO:0044390,0.02130569679221009,0.9950776909992078,5,37,ubiquitin-like protein conjugating enzyme binding,MF
GO:0098813,0.021396968448760163,0.9888089287666876,19,261,nuclear chromosome segregation,BP
GO:0031639,0.02145721741705061,0.9960991518754089,4,25,plasminogen activation,BP
GO:0070492,0.021485968489978812,0.9973529770928183,3,15,oligosaccharide binding,MF
GO:0030813,0.021490224394506777,0.9960913205934542,4,25,positive regulation of nucleotide catabolic process,BP
GO:0051197,0.021490224394506777,0.9960913205934542,4,25,positive regulation of coenzyme metabolic process,BP
GO:0048644,0.02151281528093924,0.9921470669005672,9,87,muscle organ morphogenesis,BP
GO:0051414,0.02154260037011331,0.9989249787377903,2,5,response to cortisol,BP
GO:0031497,0.021561598658105086,0.9907193936294257,12,149,chromatin assembly,BP
GO:2000482,0.021603755582724007,0.9960643546788582,4,25,regulation of interleukin-8 secretion,BP
GO:0042826,0.021673673023051128,0.9915462397025377,10,108,histone deacetylase binding,MF
GO:2001057,0.02175569302372712,0.9925859764033673,8,82,reactive nitrogen species metabolic process,BP
GO:0007009,0.02180893481430255,0.9915001140423312,10,103,plasma membrane organization,BP
GO:0045580,0.021899582396626007,0.9905768614314616,12,137,regulation of T cell differentiation,BP
GO:1903076,0.021903889488930815,0.9919503709877109,9,95,regulation of protein localization to plasma membrane,BP
GO:0043435,0.021904260887933225,0.998897073223982,2,5,response to corticotropin-releasing hormone,BP
GO:0071376,0.021904260887933225,0.998897073223982,2,5,cellular response to corticotropin-releasing hormone stimulus,BP
GO:0031570,0.021946256229258568,0.990171992260765,13,157,DNA integrity checkpoint,BP
GO:0002433,0.021960027730367305,0.9925198371984738,8,78,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP
GO:0038096,0.021960027730367305,0.9925198371984738,8,78,Fc-gamma receptor signaling pathway involved in phagocytosis,BP
GO:0000187,0.02197082232439303,0.9901687301525466,13,152,activation of MAPK activity,BP
GO:0099171,0.02200549061388915,0.9972948913257891,3,14,presynaptic modulation of chemical synaptic transmission,BP
GO:0032835,0.022048872081275674,0.9931679206866648,7,62,glomerulus development,BP
GO:0009648,0.02205825148380567,0.9959559500028041,4,25,photoperiodism,BP
GO:0055105,0.022201953296990883,0.9987784797434928,2,6,ubiquitin-protein transferase inhibitor activity,MF
GO:0001894,0.022216771078341805,0.9888173331013606,17,223,tissue homeostasis,BP
GO:0032959,0.02224109444745599,0.9959494460051931,4,23,inositol trisphosphate biosynthetic process,BP
GO:0044548,0.022307251428073806,0.9972121139737811,3,15,S100 protein binding,MF
GO:0035050,0.022317196434718793,0.9923891755751229,8,75,embryonic heart tube development,BP
GO:0001508,0.022358597875483714,0.9903647867668668,12,131,action potential,BP
GO:0008536,0.0223614762782677,0.9947482501470798,5,39,Ran GTPase binding,MF
GO:0046033,0.022380204443703904,0.9972309804515835,3,14,AMP metabolic process,BP
GO:0097433,0.02240095765383066,0.9987616007633368,2,6,dense body,CC
GO:0032204,0.022437306365336532,0.9923138390852229,8,81,regulation of telomere maintenance,BP
GO:0005814,0.022479270759965243,0.9902869580228503,12,139,centriole,CC
GO:0034616,0.02249271810042489,0.9971800144718898,3,15,response to laminar fluid shear stress,BP
GO:0046635,0.02251437283409611,0.9930000821420722,7,61,positive regulation of alpha-beta T cell activation,BP
GO:1903037,0.02255284886660806,0.9877112841039888,21,298,regulation of leukocyte cell-cell adhesion,BP
GO:0005092,0.022571366666521014,0.9971663705570168,3,15,GDP-dissociation inhibitor activity,MF
GO:1902043,0.02258354401994495,0.9971961197546366,3,14,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP
GO:0016445,0.02261048957357142,0.9929578883819649,7,62,somatic diversification of immunoglobulins,BP
GO:0010756,0.022841925099919846,0.9987239040017202,2,6,positive regulation of plasminogen activation,BP
GO:0033290,0.022863017268869322,0.9971156101519786,3,15,eukaryotic 48S preinitiation complex,CC
GO:0060411,0.02288562269072937,0.9921688303544284,8,73,cardiac septum morphogenesis,BP
GO:0006360,0.022887663250339245,0.9928418704036883,7,64,transcription by RNA polymerase I,BP
GO:0051205,0.022923282471900685,0.9936520854102965,6,49,protein insertion into membrane,BP
GO:0033646,0.022973919999939075,0.9971288425723481,3,14,host intracellular part,CC
GO:0043656,0.022973919999939075,0.9971288425723481,3,14,intracellular region of host,CC
GO:0072376,0.022983451866222315,0.9914835094090009,9,95,protein activation cascade,BP
GO:0016126,0.023007281287487316,0.9920817093242613,8,81,sterol biosynthetic process,BP
GO:1902930,0.02301806801852294,0.99207730512311,8,81,regulation of alcohol biosynthetic process,BP
GO:0051785,0.023052299830510433,0.9927685574656165,7,66,positive regulation of nuclear division,BP
GO:0061676,0.023181068997459385,0.9986946366235321,2,6,importin-alpha family protein binding,MF
GO:0006189,0.02319880348085913,0.9986930996240094,2,6,'de novo' IMP biosynthetic process,BP
GO:0014850,0.02323081017353819,0.9956917938814117,4,24,response to muscle activity,BP
GO:0086007,0.02330613778304522,0.9987864970120344,2,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF
GO:0046328,0.023360259418333876,0.9887655980728698,15,185,regulation of JNK cascade,BP
GO:0055010,0.023440215689773312,0.9934934389714407,6,47,ventricular cardiac muscle tissue morphogenesis,BP
GO:0030018,0.023491471656119575,0.9898021808702306,12,132,Z disc,CC
GO:2000516,0.023563672441247685,0.9944242117182616,5,36,"positive regulation of CD4-positive, alpha-beta T cell activation",BP
GO:0031492,0.02361967206623839,0.9943634543247172,5,40,nucleosomal DNA binding,MF
GO:0003170,0.023679663144972003,0.9925614324977485,7,61,heart valve development,BP
GO:0045109,0.02370193580380594,0.9955983642187823,4,23,intermediate filament organization,BP
GO:0051495,0.023718844685848794,0.987971053595117,17,223,positive regulation of cytoskeleton organization,BP
GO:1900101,0.023775365252268577,0.995539981228531,4,25,regulation of endoplasmic reticulum unfolded protein response,BP
GO:0006896,0.023915110628355416,0.9969647634841609,3,14,Golgi to vacuole transport,BP
GO:0043455,0.024013351493590487,0.9969474858907285,3,14,regulation of secondary metabolic process,BP
GO:0043029,0.02406261260568195,0.9942628087406818,5,37,T cell homeostasis,BP
GO:0004065,0.02410782286416022,0.9969308445183618,3,14,arylsulfatase activity,MF
GO:0032330,0.024218483900308826,0.993200354437659,6,50,regulation of chondrocyte differentiation,BP
GO:0006623,0.024224051810271725,0.9942142618050446,5,37,protein targeting to vacuole,BP
GO:0090407,0.0242293412222883,0.9839402205541956,42,693,organophosphate biosynthetic process,BP
GO:0030048,0.024233067015954603,0.9894230924712839,12,136,actin filament-based movement,BP
GO:0015935,0.024234421511400393,0.9922928855320158,7,71,small ribosomal subunit,CC
GO:0043558,0.02427460478768896,0.9969014016779011,3,14,regulation of translational initiation in response to stress,BP
GO:0044057,0.024292730858526894,0.9842562096762238,38,606,regulation of system process,BP
GO:0046826,0.024318333056186383,0.9985947657223703,2,6,negative regulation of protein export from nucleus,BP
GO:0045111,0.024409127755395603,0.9889222747116617,13,151,intermediate filament cytoskeleton,CC
GO:0045840,0.024415674790247394,0.9931085361190748,6,53,positive regulation of mitotic nuclear division,BP
GO:0033169,0.024459980840770192,0.9968685810733243,3,14,histone H3-K9 demethylation,BP
GO:1903428,0.02455510588174576,0.993067810033776,6,52,positive regulation of reactive oxygen species biosynthetic process,BP
GO:0019226,0.02456690640326487,0.9914869505397425,8,72,transmission of nerve impulse,BP
GO:0030178,0.02458348233816085,0.9877743441941,16,207,negative regulation of Wnt signaling pathway,BP
GO:1901861,0.02462854480091229,0.9891960652517515,12,149,regulation of muscle tissue development,BP
GO:0004529,0.024693557308380777,0.9953135003525291,4,25,exodeoxyribonuclease activity,MF
GO:0032040,0.024702398817534242,0.9940579791824578,5,38,small-subunit processome,CC
GO:0043462,0.024739082716443827,0.9913740581358617,8,80,regulation of ATPase activity,BP
GO:0048278,0.024745019413742783,0.9921363487731962,7,64,vesicle docking,BP
GO:0048207,0.02474536731812,0.9921300178508622,7,65,"vesicle targeting, rough ER to cis-Golgi",BP
GO:0048208,0.02474536731812,0.9921300178508622,7,65,COPII vesicle coating,BP
GO:0070679,0.024787988562445906,0.9968524328695805,3,13,"inositol 1,4,5 trisphosphate binding",MF
GO:0051145,0.02490645557707992,0.9920296283729307,7,72,smooth muscle cell differentiation,BP
GO:0098858,0.024948255870929435,0.987572354199456,16,206,actin-based cell projection,CC
GO:1902749,0.024949785117821303,0.9875618233721687,16,213,regulation of cell cycle G2/M phase transition,BP
GO:1905898,0.025058758772960148,0.9939618392175386,5,37,positive regulation of response to endoplasmic reticulum stress,BP
GO:0017160,0.025082615163814503,0.9967209485720115,3,15,Ral GTPase binding,MF
GO:0034656,0.02514999562469259,0.9928776202421089,6,50,nucleobase-containing small molecule catabolic process,BP
GO:0006270,0.02515838956992182,0.9939315530612133,5,37,DNA replication initiation,BP
GO:0034383,0.025190548649088276,0.9938575882069944,5,43,low-density lipoprotein particle clearance,BP
GO:0019432,0.02524216378370267,0.9938609524204483,5,41,triglyceride biosynthetic process,BP
GO:0072665,0.02532404759340396,0.9919076142708106,7,65,protein localization to vacuole,BP
GO:0006268,0.02533739452273478,0.9967118872907397,3,14,DNA unwinding involved in DNA replication,BP
GO:0045332,0.025401712832317343,0.9951369517802625,4,25,phospholipid translocation,BP
GO:0045621,0.025403212497867228,0.9904304228062605,9,93,positive regulation of lymphocyte differentiation,BP
GO:0051654,0.025417070359420597,0.9951331051739772,4,25,establishment of mitochondrion localization,BP
GO:0002694,0.02548476583271892,0.9841020551754462,32,493,regulation of leukocyte activation,BP
GO:1904646,0.025527958486353176,0.9937537160628468,5,43,cellular response to amyloid-beta,BP
GO:0035102,0.025558666097733995,0.9966344219460261,3,15,PRC1 complex,CC
GO:0001302,0.025618902304282425,0.9984773405020763,2,6,replicative cell aging,BP
GO:0045727,0.025657189101830416,0.9891768110599866,11,125,positive regulation of translation,BP
GO:0033522,0.02566729302762981,0.9950703257983202,4,25,histone H2A ubiquitination,BP
GO:0044773,0.025669899338735116,0.9902965949000023,9,97,mitotic DNA damage checkpoint,BP
GO:0021591,0.02569445853355506,0.9950439224874369,4,26,ventricular system development,BP
GO:0007569,0.025702573285365307,0.9896730508775358,10,115,cell aging,BP
GO:0048549,0.025750875894385527,0.9984652358804238,2,6,positive regulation of pinocytosis,BP
GO:0032688,0.025758233885827157,0.9966359491787251,3,14,negative regulation of interferon-beta production,BP
GO:0032153,0.025761157875549848,0.9917206327504119,7,68,cell division site,CC
GO:0007020,0.02577446260252035,0.9950237250452837,4,26,microtubule nucleation,BP
GO:0050704,0.025778978710152514,0.9926408442356925,6,52,regulation of interleukin-1 secretion,BP
GO:0070257,0.025813165007002013,0.9984595107127927,2,6,positive regulation of mucus secretion,BP
GO:0010216,0.02583355055537753,0.9984576353489174,2,6,maintenance of DNA methylation,BP
GO:0046834,0.025833784960340066,0.9917172810206691,7,64,lipid phosphorylation,BP
GO:0090090,0.025872786176545964,0.9877497681156214,14,175,negative regulation of canonical Wnt signaling pathway,BP
GO:0046634,0.025877889321196685,0.9902243640621521,9,92,regulation of alpha-beta T cell activation,BP
GO:0009743,0.02587908594880458,0.9867381903803544,17,226,response to carbohydrate,BP
GO:0032609,0.025909052974869014,0.9895991831514195,10,108,interferon-gamma production,BP
GO:1905031,0.02592060886886963,0.9983057171864831,2,8,regulation of membrane repolarization during cardiac muscle cell action potential,BP
GO:0070141,0.02596792649336541,0.9984452528714349,2,6,response to UV-A,BP
GO:1990226,0.025994847749572055,0.9984427678346391,2,6,histone methyltransferase binding,MF
GO:0009208,0.026047201623730087,0.9965449506818715,3,15,pyrimidine ribonucleoside triphosphate metabolic process,BP
GO:0005682,0.026074918934920102,0.996506425264561,3,16,U5 snRNP,CC
GO:0043601,0.026103660425823398,0.9949821246516751,4,24,nuclear replisome,CC
GO:0000788,0.026118159361147066,0.9948326209245401,4,33,nuclear nucleosome,CC
GO:0010494,0.02612652609760599,0.9915909697171894,7,66,cytoplasmic stress granule,CC
GO:0019208,0.026126657752308158,0.9901014463022972,9,95,phosphatase regulator activity,MF
GO:0035635,0.026128534136019097,0.9965299893354336,3,15,entry of bacterium into host cell,BP
GO:0033135,0.02615979932363937,0.98844763911923,12,139,regulation of peptidyl-serine phosphorylation,BP
GO:0032534,0.026181422794526357,0.9984255061960554,2,6,regulation of microvillus assembly,BP
GO:0033683,0.026226073853683016,0.9935800379283779,5,39,"nucleotide-excision repair, DNA incision",BP
GO:0009744,0.026402894850158863,0.9984049268716702,2,6,response to sucrose,BP
GO:0034285,0.026402894850158863,0.9984049268716702,2,6,response to disaccharide,BP
GO:0061134,0.02640797107755119,0.9867387683372674,16,217,peptidase regulator activity,MF
GO:0042824,0.026411569436999675,0.9984041188599031,2,6,MHC class I peptide loading complex,CC
GO:0022836,0.026500689001463545,0.98451794090007,25,343,gated channel activity,MF
GO:1902083,0.02651683146042935,0.9983082687663614,2,7,negative regulation of peptidyl-cysteine S-nitrosylation,BP
GO:0015030,0.02652076580047428,0.9913779959306142,7,77,Cajal body,CC
GO:0008310,0.026543115277763873,0.9983918476482327,2,6,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF
GO:1905323,0.02655453311891229,0.9983907809370267,2,6,telomerase holoenzyme complex assembly,BP
GO:1903935,0.02657312669733271,0.9983890432858755,2,6,response to sodium arsenite,BP
GO:0032352,0.026598106218478273,0.9964432445787738,3,15,positive regulation of hormone metabolic process,BP
GO:0005671,0.026625855221927924,0.9964380990322023,3,15,Ada2/Gcn5/Ada3 transcription activator complex,CC
GO:0098888,0.026629943620062737,0.9983837292974143,2,6,extrinsic component of presynaptic membrane,CC
GO:0051170,0.026633471296332097,0.987742980691686,13,162,import into nucleus,BP
GO:1902175,0.026642768145897194,0.9947843555519088,4,27,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP
GO:0000077,0.02671577641156393,0.9881512815101988,12,145,DNA damage checkpoint,BP
GO:0031056,0.026726885140326312,0.9881528912224437,12,142,regulation of histone modification,BP
GO:0044531,0.02673567720464421,0.9983738233900479,2,6,modulation of programmed cell death in other organism,BP
GO:0044532,0.02673567720464421,0.9983738233900479,2,6,modulation of apoptotic process in other organism,BP
GO:0052040,0.02673567720464421,0.9983738233900479,2,6,modulation by symbiont of host programmed cell death,BP
GO:0052248,0.02673567720464421,0.9983738233900479,2,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP
GO:0052433,0.02673567720464421,0.9983738233900479,2,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP
GO:0031432,0.026795306188330325,0.9964466849422051,3,14,titin binding,MF
GO:0032411,0.026847188473251342,0.9891529456411152,10,110,positive regulation of transporter activity,BP
GO:0010934,0.02690005790182151,0.9963871371499521,3,15,macrophage cytokine production,BP
GO:0016363,0.02690348577902175,0.9891299765191098,10,109,nuclear matrix,CC
GO:0016573,0.026945405576720913,0.9875923772771674,13,156,histone acetylation,BP
GO:0070206,0.026959188574591286,0.9922158796240814,6,53,protein trimerization,BP
GO:0048609,0.026972707082328587,0.9813454123199695,50,831,multicellular organismal reproductive process,BP
GO:1905314,0.027023986585331748,0.9933584011446193,5,37,semi-lunar valve development,BP
GO:0014823,0.02705910024198449,0.9912341236688109,7,65,response to activity,BP
GO:0060393,0.027081659479555806,0.9912465758113577,7,62,regulation of pathway-restricted SMAD protein phosphorylation,BP
GO:0021540,0.027088377631558008,0.998340621869326,2,6,corpus callosum morphogenesis,BP
GO:0010757,0.027124659259445377,0.9983371927393918,2,6,negative regulation of plasminogen activation,BP
GO:0008306,0.02721984673514091,0.9903474438963719,8,78,associative learning,BP
GO:0051438,0.02724141058676389,0.9921241300840162,6,52,regulation of ubiquitin-protein transferase activity,BP
GO:0051702,0.027248543650491588,0.9903144569097772,8,82,interaction with symbiont,BP
GO:0061734,0.027253658685388964,0.9983249797330894,2,6,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP
GO:1903541,0.027261439649177516,0.9962841743779873,3,16,regulation of exosomal secretion,BP
GO:0045627,0.02735102069773563,0.9983157405983304,2,6,positive regulation of T-helper 1 cell differentiation,BP
GO:0060740,0.027366409003998365,0.9946388219735228,4,25,prostate gland epithelium morphogenesis,BP
GO:0002521,0.027432119047961143,0.9826525328402,33,512,leukocyte differentiation,BP
GO:0001936,0.027459723201490108,0.9877283620238294,12,166,regulation of endothelial cell proliferation,BP
GO:1900452,0.027464385408139037,0.9963229927945597,3,14,regulation of long-term synaptic depression,BP
GO:0006287,0.027481604933315924,0.9983033200008087,2,6,"base-excision repair, gap-filling",BP
GO:2000095,0.02749234494607549,0.996276342876098,3,15,"regulation of Wnt signaling pathway, planar cell polarity pathway",BP
GO:0045073,0.027621771419293156,0.9962520028340578,3,15,regulation of chemokine biosynthetic process,BP
GO:0042762,0.027678575059028467,0.9962413057268712,3,15,regulation of sulfur metabolic process,BP
GO:0008081,0.027701418258939823,0.9894012917201038,9,94,phosphoric diester hydrolase activity,MF
GO:0050865,0.027745716855312706,0.9823074135536148,34,536,regulation of cell activation,BP
GO:0008064,0.027863124040958392,0.9866721940082259,14,178,regulation of actin polymerization or depolymerization,BP
GO:0050702,0.02798212927545476,0.9918509006293956,6,53,interleukin-1 beta secretion,BP
GO:0098839,0.02798807966840661,0.9900465161443609,8,74,postsynaptic density membrane,CC
GO:0007182,0.027998478428654473,0.9982538340124396,2,6,common-partner SMAD protein phosphorylation,BP
GO:0010639,0.028011630121309757,0.9835236136989094,25,378,negative regulation of organelle organization,BP
GO:0002931,0.028026179455332364,0.9918629328198011,6,50,response to ischemia,BP
GO:0016936,0.028060284297442582,0.9981541594603845,2,7,galactoside binding,MF
GO:0019372,0.028142890849678484,0.9961165155566705,3,16,lipoxygenase pathway,BP
GO:0060332,0.028239326205305216,0.9982305994353716,2,6,positive regulation of response to interferon-gamma,BP
GO:0060335,0.028239326205305216,0.9982305994353716,2,6,positive regulation of interferon-gamma-mediated signaling pathway,BP
GO:0060841,0.028251180677460463,0.9961759720602128,3,14,venous blood vessel development,BP
GO:0010970,0.028282407686727393,0.9868822666092045,13,159,transport along microtubule,BP
GO:0099111,0.028282407686727393,0.9868822666092045,13,159,microtubule-based transport,BP
GO:0140098,0.02831515550967366,0.98332760688548,25,379,"catalytic activity, acting on RNA",MF
GO:0010667,0.02833066645058502,0.9942286768853822,4,35,negative regulation of cardiac muscle cell apoptotic process,BP
GO:0009165,0.0283776689569539,0.9832866593715787,25,380,nucleotide biosynthetic process,BP
GO:0072126,0.028388788788319505,0.9982161248914801,2,6,positive regulation of glomerular mesangial cell proliferation,BP
GO:0051284,0.028435421542112434,0.9960275940573173,3,17,positive regulation of sequestering of calcium ion,BP
GO:0042985,0.0284429931279929,0.9981152010304293,2,7,negative regulation of amyloid precursor protein biosynthetic process,BP
GO:0097066,0.02847652951034793,0.9943298546101557,4,26,response to thyroid hormone,BP
GO:0019228,0.028499541293792674,0.9929448893194827,5,34,neuronal action potential,BP
GO:0055131,0.02851684082808414,0.9982036898593746,2,6,C3HC4-type RING finger domain binding,MF
GO:0003887,0.028545983655047995,0.9943117252916925,4,26,DNA-directed DNA polymerase activity,MF
GO:0006303,0.028572107820433807,0.9897421555992374,8,84,double-strand break repair via nonhomologous end joining,BP
GO:1902004,0.028577117871401624,0.9960331350413784,3,16,positive regulation of amyloid-beta formation,BP
GO:0007093,0.028579073357719337,0.9867123194372919,13,165,mitotic cell cycle checkpoint,BP
GO:1903409,0.028600383142791518,0.9883002344150132,10,117,reactive oxygen species biosynthetic process,BP
GO:0051496,0.028610092720674975,0.9916438041499076,6,51,positive regulation of stress fiber assembly,BP
GO:0005852,0.028653336139723377,0.9960184464152672,3,16,eukaryotic translation initiation factor 3 complex,CC
GO:0035612,0.028701572240315987,0.9980887124207266,2,7,AP-2 adaptor complex binding,MF
GO:0072523,0.02870277134238617,0.9916104596205267,6,51,purine-containing compound catabolic process,BP
GO:0032946,0.02870615214802688,0.9876738778279861,11,127,positive regulation of mononuclear cell proliferation,BP
GO:0033866,0.02873935665127831,0.9905520810784814,7,68,nucleoside bisphosphate biosynthetic process,BP
GO:0034030,0.02873935665127831,0.9905520810784814,7,68,ribonucleoside bisphosphate biosynthetic process,BP
GO:0034033,0.02873935665127831,0.9905520810784814,7,68,purine nucleoside bisphosphate biosynthetic process,BP
GO:0034204,0.028794539272645667,0.9942467276707684,4,26,lipid translocation,BP
GO:0045341,0.028809985089990664,0.9981751051228669,2,6,MHC class I biosynthetic process,BP
GO:0045343,0.028809985089990664,0.9981751051228669,2,6,regulation of MHC class I biosynthetic process,BP
GO:0007004,0.028867129930024278,0.9904885478916324,7,70,telomere maintenance via telomerase,BP
GO:0045124,0.02890145536036523,0.992729577555986,5,40,regulation of bone resorption,BP
GO:0072318,0.02891239178757165,0.9981650808273649,2,6,clathrin coat disassembly,BP
GO:0060029,0.02892828007007064,0.9981635237845584,2,6,convergent extension involved in organogenesis,BP
GO:0003726,0.028933338443815546,0.9981630279661987,2,6,double-stranded RNA adenosine deaminase activity,MF
GO:0016702,0.028958701467810703,0.9941827753806668,4,27,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen",MF
GO:0000776,0.02896274919717343,0.9875234737424899,11,135,kinetochore,CC
GO:0098586,0.02897927591474532,0.9914663028955231,6,56,cellular response to virus,BP
GO:0009008,0.028992448464735195,0.9981572304433906,2,6,DNA-methyltransferase activity,MF
GO:0017048,0.028994884799245432,0.9860595005415154,14,177,Rho GTPase binding,MF
GO:0032154,0.029014648623460162,0.9914617072116794,6,55,cleavage furrow,CC
GO:0072349,0.029141925131029832,0.9959626983785029,3,15,modified amino acid transmembrane transporter activity,MF
GO:0030832,0.029166528156305983,0.9859620126933846,14,179,regulation of actin filament length,BP
GO:0045913,0.02917172661442682,0.9894906230945547,8,83,positive regulation of carbohydrate metabolic process,BP
GO:1904375,0.02917622128843161,0.988032331269362,10,115,regulation of protein localization to cell periphery,BP
GO:0097427,0.02922394224730678,0.9981344617417546,2,6,microtubule bundle,CC
GO:0090342,0.029227418259566543,0.991353122055913,6,59,regulation of cell aging,BP
GO:1904415,0.0292432934824129,0.9981325538466795,2,6,regulation of xenophagy,BP
GO:1904417,0.0292432934824129,0.9981325538466795,2,6,positive regulation of xenophagy,BP
GO:0034393,0.02928434774762321,0.9958962336401005,3,16,positive regulation of smooth muscle cell apoptotic process,BP
GO:0060267,0.029315718321697284,0.9980252657908026,2,7,positive regulation of respiratory burst,BP
GO:0048569,0.029385444191555546,0.9959157739908036,3,15,post-embryonic animal organ development,BP
GO:0030073,0.02940837258746399,0.9850550055619067,16,206,insulin secretion,BP
GO:0098684,0.029429900839403344,0.998114119378665,2,6,photoreceptor ribbon synapse,CC
GO:0005681,0.029584706476678123,0.9857260022836015,14,183,spliceosomal complex,CC
GO:0021782,0.02962821426966892,0.9878197089890823,10,114,glial cell development,BP
GO:0019883,0.029682628826854903,0.995858294393102,3,15,antigen processing and presentation of endogenous antigen,BP
GO:0048639,0.02970810126710781,0.9856623952246834,14,181,positive regulation of developmental growth,BP
GO:0000075,0.02978951405818122,0.98482110886927,16,216,cell cycle checkpoint,BP
GO:0016447,0.029818452656695187,0.9911970280520139,6,52,somatic recombination of immunoglobulin gene segments,BP
GO:1904672,0.02982989134246488,0.9979715726582764,2,7,regulation of somatic stem cell population maintenance,BP
GO:0038031,0.029903684896593924,0.9980670207814853,2,6,non-canonical Wnt signaling pathway via JNK cascade,BP
GO:0046321,0.029924445684550837,0.9958113506986942,3,15,positive regulation of fatty acid oxidation,BP
GO:0006308,0.02998867204605193,0.9923822563591661,5,40,DNA catabolic process,BP
GO:0006687,0.029992724593844774,0.9900661955611304,7,66,glycosphingolipid metabolic process,BP
GO:0030318,0.030013606978570775,0.9939252914090279,4,26,melanocyte differentiation,BP
GO:0001764,0.030077306160329303,0.9859397290915588,13,155,neuron migration,BP
GO:0070198,0.030081153956649263,0.9938651497633235,4,28,"protein localization to chromosome, telomeric region",BP
GO:0000779,0.03011621021159093,0.9875718078394502,10,118,"condensed chromosome, centromeric region",CC
GO:0005587,0.03014522202189073,0.9980428476133397,2,6,collagen type IV trimer,CC
GO:0009166,0.030167419607455677,0.9854089856692279,14,182,nucleotide catabolic process,BP
GO:0051188,0.030227932771660658,0.982766801552432,22,323,cofactor biosynthetic process,BP
GO:0010771,0.03024966540420685,0.9882317557765412,9,97,negative regulation of cell morphogenesis involved in differentiation,BP
GO:0060136,0.030262582277139728,0.9980310627531271,2,6,embryonic process involved in female pregnancy,BP
GO:0060969,0.030352530213929994,0.9938129705267066,4,27,negative regulation of gene silencing,BP
GO:0046885,0.03036090979022301,0.9938107301177334,4,27,regulation of hormone biosynthetic process,BP
GO:1900449,0.030474977539967946,0.9898881759773402,7,64,regulation of glutamate receptor signaling pathway,BP
GO:0035249,0.03051566305389135,0.9881289132073972,9,93,"synaptic transmission, glutamatergic",BP
GO:0009649,0.03054370318895567,0.9937618069211437,4,27,entrainment of circadian clock,BP
GO:0035864,0.03057890926223141,0.9956835270133751,3,15,response to potassium ion,BP
GO:0020005,0.030594684886717644,0.9979975751360571,2,6,symbiont-containing vacuole membrane,CC
GO:0002285,0.030603039163888554,0.9851781235679591,14,178,lymphocyte activation involved in immune response,BP
GO:2001181,0.030606934668847743,0.9978894433147681,2,7,positive regulation of interleukin-10 secretion,BP
GO:0009814,0.03069132331810103,1,1,1,"defense response, incompatible interaction",BP
GO:0009817,0.03069132331810103,1,1,1,"defense response to fungus, incompatible interaction",BP
GO:0014006,0.03069132331810103,1,1,1,regulation of microglia differentiation,BP
GO:0014008,0.03069132331810103,1,1,1,positive regulation of microglia differentiation,BP
GO:1905313,0.03069132331810103,1,1,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP
GO:1990402,0.03069132331810103,1,1,1,embryonic liver development,BP
GO:0032687,0.03076913759125592,0.9979799019916459,2,6,negative regulation of interferon-alpha production,BP
GO:0001891,0.03081338081673093,0.9936894538119518,4,27,phagocytic cup,CC
GO:1903828,0.03087430707382636,0.9872285173358059,10,112,negative regulation of cellular protein localization,BP
GO:0071867,0.030909138296247942,0.9921140464194336,5,38,response to monoamine,BP
GO:0071869,0.030909138296247942,0.9921140464194336,5,38,response to catecholamine,BP
GO:0003785,0.030914074110038763,0.9936414170943711,4,28,actin monomer binding,MF
GO:0045687,0.030931784054057915,0.9920780887098858,5,40,positive regulation of glial cell differentiation,BP
GO:1902003,0.0309372512146548,0.993635162784356,4,28,regulation of amyloid-beta formation,BP
GO:0019915,0.031063974450016584,0.9896208651727488,7,68,lipid storage,BP
GO:0030952,0.031115804070193563,0.9955354918961127,3,16,establishment or maintenance of cytoskeleton polarity,BP
GO:0008207,0.031132787794434715,0.9920269618951725,5,39,C21-steroid hormone metabolic process,BP
GO:0010939,0.03113802542763014,0.9934815046181069,4,34,regulation of necrotic cell death,BP
GO:1904888,0.0311567755717283,0.9895981578787457,7,66,cranial skeletal system development,BP
GO:0043486,0.03120970051297265,0.9906251773046684,6,59,histone exchange,BP
GO:0061371,0.031214863202301255,0.989574697737435,7,66,determination of heart left/right asymmetry,BP
GO:0099170,0.031233255454888857,0.9955120559178271,3,16,postsynaptic modulation of chemical synaptic transmission,BP
GO:1901293,0.031256067053816006,0.9814204327754087,25,384,nucleoside phosphate biosynthetic process,BP
GO:1904062,0.031294295879178494,0.98185431703536,23,337,regulation of cation transmembrane transport,BP
GO:2000535,0.03136258015817605,0.9978084474675688,2,7,regulation of entry of bacterium into host cell,BP
GO:0034511,0.03143805311431783,0.997911614542901,2,6,U3 snoRNA binding,MF
GO:0051393,0.03146470873317733,0.9919501660409538,5,37,alpha-actinin binding,MF
GO:0097527,0.03148441071655452,0.9979068514620857,2,6,necroptotic signaling pathway,BP
GO:0032266,0.03151294276340523,0.9919035908644978,5,39,phosphatidylinositol-3-phosphate binding,MF
GO:0048070,0.03152842071006624,0.9954960902728965,3,15,regulation of developmental pigmentation,BP
GO:0060339,0.03158911004033996,0.9954840307333315,3,15,negative regulation of type I interferon-mediated signaling pathway,BP
GO:0046184,0.031593114193154234,0.9954832347375144,3,15,aldehyde biosynthetic process,BP
GO:0051591,0.031645508995929245,0.9875948313147604,9,96,response to cAMP,BP
GO:0051492,0.03165039778559992,0.9884245242827465,8,82,regulation of stress fiber assembly,BP
GO:0010496,0.03167114691189946,0.9978876249721895,2,6,intercellular transport,BP
GO:0045349,0.031725363090258515,0.9978820308443707,2,6,interferon-alpha biosynthetic process,BP
GO:0045354,0.031725363090258515,0.9978820308443707,2,6,regulation of interferon-alpha biosynthetic process,BP
GO:0010810,0.03176082530441918,0.9836902703992545,16,215,regulation of cell-substrate adhesion,BP
GO:0045429,0.03188619982007951,0.9917408998392578,5,42,positive regulation of nitric oxide biosynthetic process,BP
GO:0072006,0.03194420074756106,0.985465936782646,12,142,nephron development,BP
GO:0044068,0.03198493516439571,0.9933305749092186,4,29,modulation by symbiont of host cellular process,BP
GO:0042393,0.03204285170956884,0.9839386449873908,15,196,histone binding,MF
GO:0071466,0.03204719951536526,0.9843826285240684,14,178,cellular response to xenobiotic stimulus,BP
GO:0086045,0.03208880408219855,0.9978443912986905,2,6,membrane depolarization during AV node cell action potential,BP
GO:0000028,0.03216312547426385,0.9952524862352986,3,18,ribosomal small subunit assembly,BP
GO:0048365,0.032264814598379786,0.9891262317064933,7,69,Rac GTPase binding,MF
GO:0051770,0.03237800007699086,0.9953264127000234,3,15,positive regulation of nitric-oxide synthase biosynthetic process,BP
GO:0030307,0.03238811732906181,0.9846760029843389,13,165,positive regulation of cell growth,BP
GO:0097028,0.03239628201554426,0.9915866248989098,5,41,dendritic cell differentiation,BP
GO:0006206,0.03239826176195688,0.9952776580504455,3,16,pyrimidine nucleobase metabolic process,BP
GO:0004420,0.03244720058089527,1,1,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF
GO:0042282,0.03244720058089527,1,1,1,hydroxymethylglutaryl-CoA reductase activity,MF
GO:0051152,0.03245915318360447,0.9951089637572256,3,21,positive regulation of smooth muscle cell differentiation,BP
GO:0040029,0.032491199956673066,0.9792172731811587,32,821,"regulation of gene expression, epigenetic",BP
GO:0006901,0.03249272869749789,0.9890332201099199,7,69,vesicle coating,BP
GO:0043473,0.03261197370424045,0.9871377015260004,9,98,pigmentation,BP
GO:0009746,0.032661868359763216,0.9835841444469027,15,198,response to hexose,BP
GO:2001023,0.03275356023817502,0.9870625002693599,9,100,regulation of response to drug,BP
GO:0030046,0.032802662441214145,0.997651044964589,2,7,parallel actin filament bundle assembly,BP
GO:0050920,0.03281518257548783,0.9830823855529668,16,214,regulation of chemotaxis,BP
GO:2001025,0.03284376813782885,0.9931154684235666,4,28,positive regulation of response to drug,BP
GO:0001042,0.03286460097484435,0.9977632406297126,2,6,RNA polymerase I core binding,MF
GO:0042033,0.03287568039268805,0.9951805957853849,3,16,chemokine biosynthetic process,BP
GO:0050755,0.03287568039268805,0.9951805957853849,3,16,chemokine metabolic process,BP
GO:0030670,0.03288327019256572,0.988873497441659,7,69,phagocytic vesicle membrane,CC
GO:0071141,0.032994963041639964,0.9976297269671116,2,7,SMAD protein complex,CC
GO:0031968,0.03301929100186882,0.983379291449222,15,199,organelle outer membrane,CC
GO:0016701,0.0330323754199819,0.9930635023000585,4,28,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen",MF
GO:0045582,0.03304146348804777,0.9878155226648411,8,82,positive regulation of T cell differentiation,BP
GO:0000027,0.03313511367580698,0.9930139732503239,4,29,ribosomal large subunit assembly,BP
GO:0018393,0.033139657190698696,0.984279807386805,13,161,internal peptidyl-lysine acetylation,BP
GO:0045981,0.0331838567227291,0.9899250318538083,6,55,positive regulation of nucleotide metabolic process,BP
GO:1900544,0.0331838567227291,0.9899250318538083,6,55,positive regulation of purine nucleotide metabolic process,BP
GO:0036290,0.033194206089840764,1,1,1,protein trans-autophosphorylation,BP
GO:0070054,0.033194206089840764,1,1,1,"mRNA splicing, via endonucleolytic cleavage and ligation",BP
GO:1990332,0.033194206089840764,1,1,1,Ire1 complex,CC
GO:1990579,0.033194206089840764,1,1,1,peptidyl-serine trans-autophosphorylation,BP
GO:0010001,0.033201590772290464,0.9828583166918465,16,214,glial cell differentiation,BP
GO:0002174,0.03326464917996929,1,1,1,mammary stem cell proliferation,BP
GO:0002581,0.03326464917996929,1,1,1,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP
GO:1904677,0.03326464917996929,1,1,1,positive regulation of somatic stem cell division,BP
GO:2000101,0.03326464917996929,1,1,1,regulation of mammary stem cell proliferation,BP
GO:2000103,0.03326464917996929,1,1,1,positive regulation of mammary stem cell proliferation,BP
GO:0060512,0.033316470485182104,0.9930080537595611,4,27,prostate gland morphogenesis,BP
GO:1902474,0.033321571527917926,0.997593359494654,2,7,positive regulation of protein localization to synapse,BP
GO:0050777,0.03332158043126436,0.9847292733559831,12,147,negative regulation of immune response,BP
GO:0006278,0.03333695656600953,0.988665902232914,7,72,RNA-dependent DNA biosynthetic process,BP
GO:0060537,0.03334216541068868,0.9798418015318281,26,399,muscle tissue development,BP
GO:0034067,0.033355714050736764,0.9929972317212115,4,27,protein localization to Golgi apparatus,BP
GO:0051444,0.03337953936874453,0.995077530608249,3,16,negative regulation of ubiquitin-protein transferase activity,BP
GO:1900363,0.033412368458429674,0.9950301002131103,3,17,regulation of mRNA polyadenylation,BP
GO:0048535,0.03342438452519539,0.9950683263954273,3,16,lymph node development,BP
GO:1901568,0.0334261738563518,0.9841095888413995,13,167,fatty acid derivative metabolic process,BP
GO:0046394,0.03343593006837058,0.979179789198262,29,460,carboxylic acid biosynthetic process,BP
GO:0043392,0.03348469229187954,0.9898222758846318,6,54,negative regulation of DNA binding,BP
GO:0030282,0.03358397286741402,0.9859081917724045,10,113,bone mineralization,BP
GO:0050855,0.03359231822236271,0.992887100807135,4,29,regulation of B cell receptor signaling pathway,BP
GO:0060669,0.033598572096401005,0.9929553375856616,4,26,embryonic placenta morphogenesis,BP
GO:0007018,0.03361084842891693,0.9812109249677259,20,281,microtubule-based movement,BP
GO:0008278,0.03364087091513901,0.9950238226543276,3,16,cohesin complex,CC
GO:0014015,0.033665598461629545,0.9885375408272762,7,71,positive regulation of gliogenesis,BP
GO:0006701,0.03378132922401298,0.9975418250553693,2,7,progesterone biosynthetic process,BP
GO:0010885,0.033811057610861055,0.9949887543028318,3,16,regulation of cholesterol storage,BP
GO:0005024,0.03381188268788397,0.9950358941137414,3,15,transforming growth factor beta-activated receptor activity,MF
GO:0090494,0.033833499597680596,0.9950314749596261,3,15,dopamine uptake,BP
GO:0030870,0.03389258949136075,0.9975292941261577,2,7,Mre11 complex,CC
GO:1900087,0.033897215202138314,0.9910050606343073,5,48,positive regulation of G1/S transition of mitotic cell cycle,BP
GO:0004411,0.03391034161358384,1,1,1,"homogentisate 1,2-dioxygenase activity",MF
GO:0033268,0.033912494137698854,0.9950153162062954,3,15,node of Ranvier,CC
GO:1900221,0.03391783956445307,0.9948886035177266,3,18,regulation of amyloid-beta clearance,BP
GO:0010046,0.033925423861589615,0.9975255916464775,2,7,response to mycotoxin,BP
GO:0004642,0.03396222230436535,1,1,1,phosphoribosylformylglycinamidine synthase activity,MF
GO:0005996,0.03400050552919689,0.9809570731603565,20,291,monosaccharide metabolic process,BP
GO:0043981,0.034022690346807355,0.9949450445644344,3,16,histone H4-K5 acetylation,BP
GO:0043982,0.034022690346807355,0.9949450445644344,3,16,histone H4-K8 acetylation,BP
GO:1903918,0.03403128495554974,1,1,1,regulation of actin filament severing,BP
GO:1903919,0.03403128495554974,1,1,1,negative regulation of actin filament severing,BP
GO:0034718,0.034065768337751254,1,1,1,SMN-Gemin2 complex,CC
GO:0043914,0.034065768337751254,1,1,1,NADPH:sulfur oxidoreductase activity,MF
GO:0016053,0.0340814753787998,0.9787416136145272,29,461,organic acid biosynthetic process,BP
GO:0051413,0.03408299802094693,1,1,1,response to cortisone,BP
GO:0034235,0.03409511401508308,0.9975064247958926,2,7,GPI anchor binding,MF
GO:0022038,0.03411225674155813,0.9949265122245466,3,16,corpus callosum development,BP
GO:0045208,0.03415183655398118,1,1,1,MAPK phosphatase export from nucleus,BP
GO:0045209,0.03415183655398118,1,1,1,"MAPK phosphatase export from nucleus, leptomycin B sensitive",BP
GO:0030894,0.03416783665918921,0.992798034283915,4,26,replisome,CC
GO:0048668,0.03418494241969823,0.992767574757464,4,27,collateral sprouting,BP
GO:0004766,0.034237703798289554,1,1,1,spermidine synthase activity,MF
GO:0070820,0.03429718336202237,0.9836437870764986,13,164,tertiary granule,CC
GO:0031714,0.03432336928321231,1,1,1,C5a anaphylatoxin chemotactic receptor binding,MF
GO:0031715,0.03432336928321231,1,1,1,C5L2 anaphylatoxin chemotactic receptor binding,MF
GO:0032787,0.03435784689554314,0.977016594168807,39,650,monocarboxylic acid metabolic process,BP
GO:0090677,0.034364829973063574,0.9972105901475068,2,11,reversible differentiation,BP
GO:0034754,0.034374700912494865,0.9848125055429315,11,129,cellular hormone metabolic process,BP
GO:0010823,0.034376092149384266,0.9894763671509628,6,55,negative regulation of mitochondrion organization,BP
GO:1903674,0.03444296050734533,1,1,1,regulation of cap-dependent translational initiation,BP
GO:1903676,0.03444296050734533,1,1,1,positive regulation of cap-dependent translational initiation,BP
GO:0071548,0.03450262357764568,0.9909030559658497,5,40,response to dexamethasone,BP
GO:0070491,0.034518229774171454,0.9881850761921573,7,71,repressing transcription factor binding,MF
GO:0032781,0.03456479204910659,0.9894049921430695,6,55,positive regulation of ATPase activity,BP
GO:0015318,0.0345711451318934,0.9757993948702225,49,807,inorganic molecular entity transmembrane transporter activity,MF
GO:0018149,0.03460653311157229,0.989351061525163,6,59,peptide cross-linking,BP
GO:0010822,0.034608783340746505,0.9853887141074397,10,117,positive regulation of mitochondrion organization,BP
GO:0005975,0.034649916795115046,0.9769388427123135,38,623,carbohydrate metabolic process,BP
GO:0007159,0.034653302156989495,0.9799576661736493,22,331,leukocyte cell-cell adhesion,BP
GO:0052739,0.034682315745297,0.9974396839628704,2,7,phosphatidylserine 1-acylhydrolase activity,MF
GO:0000453,0.034714809548346104,1,1,1,enzyme-directed rRNA 2'-O-methylation,BP
GO:0032957,0.03472535834191583,0.9926431273019952,4,26,inositol trisphosphate metabolic process,BP
GO:0032943,0.03472598294090243,0.9808369069165618,19,269,mononuclear cell proliferation,BP
GO:0006273,0.03473811950559258,0.997433307933176,2,7,lagging strand elongation,BP
GO:0050771,0.03474827554276276,0.9881048764066752,7,69,negative regulation of axonogenesis,BP
GO:0009211,0.03479836018544604,0.997426418454278,2,7,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP
GO:0102339,0.034883644771564914,1,1,1,3-oxo-arachidoyl-CoA reductase activity,MF
GO:0102340,0.034883644771564914,1,1,1,3-oxo-behenoyl-CoA reductase activity,MF
GO:0102341,0.034883644771564914,1,1,1,3-oxo-lignoceroyl-CoA reductase activity,MF
GO:0102342,0.034883644771564914,1,1,1,3-oxo-cerotoyl-CoA reductase activity,MF
GO:0004435,0.034884955398412354,0.9925986298745304,4,26,phosphatidylinositol phospholipase C activity,MF
GO:0097345,0.03497972832794032,0.9892582945957878,6,54,mitochondrial outer membrane permeabilization,BP
GO:0009646,0.03498454744979033,1,1,1,response to absence of light,BP
GO:0071485,0.03498454744979033,1,1,1,cellular response to absence of light,BP
GO:1990603,0.03498454744979033,1,1,1,dark adaptation,BP
GO:2000626,0.03498454744979033,1,1,1,negative regulation of miRNA catabolic process,BP
GO:2000629,0.03498454744979033,1,1,1,negative regulation of miRNA metabolic process,BP
GO:0050700,0.03499979926738608,0.9947417930680613,3,16,CARD domain binding,MF
GO:0072588,0.03501387111411014,0.997175391447631,2,10,box H/ACA RNP complex,CC
GO:0006749,0.035055318341946404,0.9892087725032748,6,56,glutathione metabolic process,BP
GO:1904407,0.03510299421226152,0.9906581934701288,5,43,positive regulation of nitric oxide metabolic process,BP
GO:0032504,0.03512068819607953,0.9752916492467547,50,846,multicellular organism reproduction,BP
GO:0099604,0.03513904382323255,0.9925010324106802,4,27,ligand-gated calcium channel activity,MF
GO:2000483,0.03517309614836554,0.997287012977128,2,8,negative regulation of interleukin-8 secretion,BP
GO:1902373,0.035214821699090446,0.9891917091647545,6,52,negative regulation of mRNA catabolic process,BP
GO:0048286,0.035277423432909655,0.9906433714777447,5,40,lung alveolus development,BP
GO:0015931,0.03534708364451422,0.981183142080747,17,239,nucleobase-containing compound transport,BP
GO:0021891,0.0353523018166256,0.9973627510480824,2,7,olfactory bulb interneuron development,BP
GO:1903952,0.03538513956540829,1,1,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP
GO:1903954,0.03538513956540829,1,1,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP
GO:0006109,0.03541491277956562,0.981999160027454,15,205,regulation of carbohydrate metabolic process,BP
GO:0070224,0.035418302488923976,1,1,1,sulfide:quinone oxidoreductase activity,MF
GO:0042590,0.03542506949816442,0.9878005786311429,7,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP
GO:0046875,0.03545565284817526,0.9924120450231398,4,27,ephrin receptor binding,MF
GO:0045104,0.035493031574964,0.9891109167385677,6,50,intermediate filament cytoskeleton organization,BP
GO:0040016,0.03549659061623805,0.9973460740376752,2,7,embryonic cleavage,BP
GO:0002440,0.03551512455977231,0.9819556381628551,15,198,production of molecular mediator of immune response,BP
GO:0019867,0.03551903603093319,0.9819472496176967,15,201,outer membrane,CC
GO:0043024,0.03556733087081122,0.9945784238633162,3,17,ribosomal small subunit binding,MF
GO:0010424,0.035633029456260505,1,1,1,DNA methylation on cytosine within a CG sequence,BP
GO:0006267,0.035646462659537664,0.9973287110708865,2,7,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP
GO:0036388,0.035646462659537664,0.9973287110708865,2,7,pre-replicative complex assembly,BP
GO:1902299,0.035646462659537664,0.9973287110708865,2,7,pre-replicative complex assembly involved in cell cycle DNA replication,BP
GO:0015139,0.0356494869449623,1,1,1,alpha-ketoglutarate transmembrane transporter activity,MF
GO:1903461,0.0356494869449623,1,1,1,Okazaki fragment processing involved in mitotic DNA replication,BP
GO:0004113,0.03571523085116003,1,1,1,"2',3'-cyclic-nucleotide 3'-phosphodiesterase activity",MF
GO:0031489,0.0358737082170409,0.9945132736232722,3,17,myosin V binding,MF
GO:0030578,0.035901887156614284,0.9972990243951404,2,7,PML body organization,BP
GO:0008016,0.035917413257435075,0.9804691558825834,18,248,regulation of heart contraction,BP
GO:0008361,0.0359262484222863,0.9822202029690041,14,178,regulation of cell size,BP
GO:0090389,0.03594424530154518,1,1,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP
GO:0004711,0.035970346223523554,0.9972910473812153,2,7,ribosomal protein S6 kinase activity,MF
GO:0045685,0.035980047498479086,0.9875839774142996,7,70,regulation of glial cell differentiation,BP
GO:1904354,0.03601880272497388,0.9971854726477206,2,8,negative regulation of telomere capping,BP
GO:0032868,0.036046421517002825,0.9800202728026077,19,272,response to insulin,BP
GO:0004493,0.036074345189849734,1,1,1,methylmalonyl-CoA epimerase activity,MF
GO:0046491,0.036074345189849734,1,1,1,L-methylmalonyl-CoA metabolic process,BP
GO:1903322,0.03610451816064159,0.9839063265441105,11,134,positive regulation of protein modification by small protein conjugation or removal,BP
GO:0097726,0.03633285950276821,1,1,1,LEM domain binding,MF
GO:0030893,0.036361194101599284,0.9972453403379071,2,7,meiotic cohesin complex,CC
GO:0032914,0.03638979103803269,0.9972419851432246,2,7,positive regulation of transforming growth factor beta1 production,BP
GO:0032364,0.03639936468155868,0.9972408615618418,2,7,oxygen homeostasis,BP
GO:0043401,0.0364179005836561,0.981931477093322,14,183,steroid hormone mediated signaling pathway,BP
GO:0006595,0.03646162182926001,0.994387613600287,3,17,polyamine metabolic process,BP
GO:0061158,0.03650808931983266,0.9944234498320377,3,16,3'-UTR-mediated mRNA destabilization,BP
GO:0019897,0.036567503722474914,0.982399006778037,13,165,extrinsic component of plasma membrane,CC
GO:0015872,0.036588749072648016,0.98866815680535,6,52,dopamine transport,BP
GO:0061518,0.03662771326861118,0.9972140125363652,2,7,microglial cell proliferation,BP
GO:0009922,0.03664904456558107,0.9972114995638415,2,7,fatty acid elongase activity,MF
GO:0019367,0.03664904456558107,0.9972114995638415,2,7,"fatty acid elongation, saturated fatty acid",BP
GO:0019368,0.03664904456558107,0.9972114995638415,2,7,"fatty acid elongation, unsaturated fatty acid",BP
GO:0034625,0.03664904456558107,0.9972114995638415,2,7,"fatty acid elongation, monounsaturated fatty acid",BP
GO:0034626,0.03664904456558107,0.9972114995638415,2,7,"fatty acid elongation, polyunsaturated fatty acid",BP
GO:0102336,0.03664904456558107,0.9972114995638415,2,7,3-oxo-arachidoyl-CoA synthase activity,MF
GO:0102337,0.03664904456558107,0.9972114995638415,2,7,3-oxo-cerotoyl-CoA synthase activity,MF
GO:0102338,0.03664904456558107,0.9972114995638415,2,7,3-oxo-lignoceronyl-CoA synthase activity,MF
GO:0102756,0.03664904456558107,0.9972114995638415,2,7,very-long-chain 3-ketoacyl-CoA synthase activity,MF
GO:0097194,0.0366974171940849,0.986176413961546,8,84,execution phase of apoptosis,BP
GO:0016607,0.036730974562857864,0.9775932253075561,26,396,nuclear speck,CC
GO:0007254,0.036774502800174955,0.9807699845758688,16,214,JNK cascade,BP
GO:0003983,0.03682725214562516,1,1,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF
GO:0016590,0.03682725214562516,1,1,1,ACF complex,CC
GO:0051748,0.03682725214562516,1,1,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF
GO:0051592,0.03682742326845052,0.9828691450584285,12,147,response to calcium ion,BP
GO:0070238,0.036858851585466,1,1,1,activated T cell autonomous cell death,BP
GO:0070239,0.036858851585466,1,1,1,regulation of activated T cell autonomous cell death,BP
GO:0070241,0.036858851585466,1,1,1,positive regulation of activated T cell autonomous cell death,BP
GO:0043236,0.03686252550738984,0.9919631529064714,4,29,laminin binding,MF
GO:0090224,0.036884523818885406,0.9900832661239239,5,41,regulation of spindle organization,BP
GO:2001229,0.03690618271335645,1,1,1,negative regulation of response to gamma radiation,BP
GO:0033116,0.0369215876986478,0.9871809691247498,7,71,endoplasmic reticulum-Golgi intermediate compartment membrane,CC
GO:0000118,0.0369268804229039,0.9884820421793868,6,57,histone deacetylase complex,CC
GO:0008088,0.03699639346717372,0.9871658108164965,7,69,axo-dendritic transport,BP
GO:0001780,0.037030668505650795,0.9943118691488237,3,16,neutrophil homeostasis,BP
GO:0071813,0.037102307526300574,0.9918716422465415,4,30,lipoprotein particle binding,MF
GO:0071814,0.037102307526300574,0.9918716422465415,4,30,protein-lipid complex binding,MF
GO:0035280,0.03713052303614857,0.9971545578464414,2,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP
GO:0032740,0.03715012622422921,0.9942393881776396,3,17,positive regulation of interleukin-17 production,BP
GO:0055024,0.03715864743194698,0.9859099304952391,8,94,regulation of cardiac muscle tissue development,BP
GO:0000481,0.037235201062743854,1,1,1,maturation of 5S rRNA,BP
GO:0006266,0.03724323355703357,0.9942192557975355,3,17,DNA ligation,BP
GO:1905476,0.03736965531724033,0.9917944866253761,4,30,negative regulation of protein localization to membrane,BP
GO:0005160,0.03751017997891269,0.9883271553274459,6,51,transforming growth factor beta receptor binding,MF
GO:0072606,0.0375253777073037,0.9917724314411711,4,29,interleukin-8 secretion,BP
GO:0003206,0.03754512847084111,0.983191107972576,11,126,cardiac chamber morphogenesis,BP
GO:1905794,0.037560153801418666,1,1,1,response to puromycin,BP
GO:1905795,0.037560153801418666,1,1,1,cellular response to puromycin,BP
GO:0031962,0.037575525344981237,1,1,1,mineralocorticoid receptor binding,MF
GO:0061767,0.037575525344981237,1,1,1,negative regulation of lung blood pressure,BP
GO:0030072,0.03758835827433055,0.979449955979777,18,249,peptide hormone secretion,BP
GO:0086003,0.03765772692742622,0.9869047453622153,7,67,cardiac muscle cell contraction,BP
GO:0042470,0.03767068769566461,0.9847126449971064,9,106,melanosome,CC
GO:0048770,0.03767068769566461,0.9847126449971064,9,106,pigment granule,CC
GO:0005819,0.0376889505691711,0.9777242283712232,23,347,spindle,CC
GO:0045362,0.037924865667964464,0.9970596972775612,2,7,positive regulation of interleukin-1 biosynthetic process,BP
GO:0050725,0.037924865667964464,0.9970596972775612,2,7,positive regulation of interleukin-1 beta biosynthetic process,BP
GO:0014020,0.03795817756784947,0.9846219657945902,9,97,primary neural tube formation,BP
GO:0055094,0.038004912500245056,0.9915683679222432,4,32,response to lipoprotein particle,BP
GO:0030014,0.038032506491600636,0.9940477600401514,3,17,CCR4-NOT complex,CC
GO:0002690,0.03807584108519578,0.9855342008859116,8,87,positive regulation of leukocyte chemotaxis,BP
GO:0043525,0.0381011361461059,0.9880274953498154,6,57,positive regulation of neuron apoptotic process,BP
GO:0021870,0.03813764192876728,1,1,1,Cajal-Retzius cell differentiation,BP
GO:1904797,0.03813764192876728,1,1,1,negative regulation of core promoter binding,BP
GO:0016333,0.03819763070758101,1,1,1,morphogenesis of follicular epithelium,BP
GO:0016334,0.03819763070758101,1,1,1,establishment or maintenance of polarity of follicular epithelium,BP
GO:0042247,0.03819763070758101,1,1,1,establishment of planar polarity of follicular epithelium,BP
GO:0060572,0.03819899523032501,0.9940600533138285,3,16,morphogenesis of an epithelial bud,BP
GO:1903435,0.038227567443732534,1,1,1,positive regulation of constitutive secretory pathway,BP
GO:0002413,0.038287325359561336,1,1,1,tolerance induction to tumor cell,BP
GO:0002843,0.038287325359561336,1,1,1,regulation of tolerance induction to tumor cell,BP
GO:0002845,0.038287325359561336,1,1,1,positive regulation of tolerance induction to tumor cell,BP
GO:0008446,0.038287325359561336,1,1,1,"GDP-mannose 4,6-dehydratase activity",MF
GO:1905404,0.038287325359561336,1,1,1,"positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process",BP
GO:0055037,0.038330757158677814,0.9814202222900663,13,167,recycling endosome,CC
GO:0038030,0.03834422127261286,0.9970091591027234,2,7,non-canonical Wnt signaling pathway via MAPK cascade,BP
GO:0010807,0.038359446224574864,0.9970073183454828,2,7,regulation of synaptic vesicle priming,BP
GO:0009645,0.038406377565745296,1,1,1,response to low light intensity stimulus,BP
GO:0046690,0.038406377565745296,1,1,1,response to tellurium ion,BP
GO:0031702,0.03841347447456642,0.9970007827618479,2,7,type 1 angiotensin receptor binding,MF
GO:0033157,0.03846481191473782,0.9797544484518559,16,223,regulation of intracellular protein transport,BP
GO:0045103,0.038503398691866544,0.9879435428558194,6,51,intermediate filament-based process,BP
GO:0040037,0.03851924913509476,0.9938978968231929,3,18,negative regulation of fibroblast growth factor receptor signaling pathway,BP
GO:0061351,0.038569764697375546,0.9819336664605496,12,147,neural precursor cell proliferation,BP
GO:0060710,0.0385951913451067,0.9969787628267052,2,7,chorio-allantoic fusion,BP
GO:0001897,0.03861322312331796,1,1,1,cytolysis by symbiont of host cells,BP
GO:0001898,0.03861322312331796,1,1,1,regulation of cytolysis by symbiont of host cells,BP
GO:0001899,0.03861322312331796,1,1,1,negative regulation of cytolysis by symbiont of host cells,BP
GO:0051623,0.03861322312331796,1,1,1,positive regulation of norepinephrine uptake,BP
GO:0051711,0.03861322312331796,1,1,1,negative regulation of killing of cells of other organism,BP
GO:0051713,0.03861322312331796,1,1,1,negative regulation of cytolysis in other organism,BP
GO:0051802,0.03861322312331796,1,1,1,regulation of cytolysis in other organism involved in symbiotic interaction,BP
GO:0051803,0.03861322312331796,1,1,1,negative regulation of cytolysis in other organism involved in symbiotic interaction,BP
GO:0072749,0.03861322312331796,1,1,1,cellular response to cytochalasin B,BP
GO:1901328,0.03861322312331796,1,1,1,response to cytochalasin B,BP
GO:0002578,0.038615570579989336,0.9969762896433437,2,7,negative regulation of antigen processing and presentation,BP
GO:0002151,0.03865454054657915,0.996971558257765,2,7,G-quadruplex RNA binding,MF
GO:0030507,0.03866617968829548,0.9914672002781961,4,28,spectrin binding,MF
GO:0002477,0.03867197023685593,1,1,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP
GO:0002481,0.03867197023685593,1,1,1,"antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent",BP
GO:0048565,0.0386753888576806,0.9825868516023448,11,130,digestive tract development,BP
GO:0006863,0.03869751694618629,0.9969663372987931,2,7,purine nucleobase transport,BP
GO:0005590,0.03871592755793568,1,1,1,collagen type VII trimer,CC
GO:0098648,0.03871592755793568,1,1,1,collagen anchoring fibril,CC
GO:0098652,0.03871592755793568,1,1,1,collagen type VII anchoring fibril,CC
GO:0042568,0.03873056034325948,1,1,1,insulin-like growth factor binary complex,CC
GO:1901292,0.03893485706290059,0.9804935302821084,14,188,nucleoside phosphate catabolic process,BP
GO:0022890,0.03901226483645083,0.9739583894777314,37,585,inorganic cation transmembrane transporter activity,MF
GO:0061770,0.039035566658198004,1,1,1,translation elongation factor binding,MF
GO:1904843,0.039035566658198004,1,1,1,cellular response to nitroglycerin,BP
GO:0008859,0.03904998156679259,1,1,1,exoribonuclease II activity,MF
GO:0060038,0.039075727119507006,0.9876067854460382,6,61,cardiac muscle cell proliferation,BP
GO:0072658,0.03907878145188717,1,1,1,maintenance of protein location in membrane,BP
GO:0072660,0.03907878145188717,1,1,1,maintenance of protein location in plasma membrane,BP
GO:1900827,0.03907878145188717,1,1,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP
GO:0034284,0.03908680329938158,0.979879522956709,15,203,response to monosaccharide,BP
GO:0007626,0.039087520289586813,0.9798925625791984,15,197,locomotory behavior,BP
GO:0060430,0.039106479642863304,0.9969164897758842,2,7,lung saccule development,BP
GO:0071674,0.03913769906320752,0.9850319229722395,8,90,mononuclear cell migration,BP
GO:0099020,0.0392507400419442,1,1,1,perinuclear endoplasmic reticulum lumen,CC
GO:1902847,0.0392507400419442,1,1,1,regulation of neuronal signal transduction,BP
GO:1902998,0.0392507400419442,1,1,1,positive regulation of neurofibrillary tangle assembly,BP
GO:1905891,0.0392507400419442,1,1,1,regulation of cellular response to thapsigargin,BP
GO:1905892,0.0392507400419442,1,1,1,negative regulation of cellular response to thapsigargin,BP
GO:1905894,0.0392507400419442,1,1,1,regulation of cellular response to tunicamycin,BP
GO:1905895,0.0392507400419442,1,1,1,negative regulation of cellular response to tunicamycin,BP
GO:0042987,0.03930708710343689,0.9892017456199267,5,44,amyloid precursor protein catabolic process,BP
GO:0001906,0.03930790718479492,0.9814945011572791,12,160,cell killing,BP
GO:1905331,0.03942708767082968,0.9937411334602779,3,17,negative regulation of morphogenesis of an epithelium,BP
GO:0044304,0.03945499013215278,0.9861423853054329,7,67,main axon,CC
GO:0072319,0.03954909269471737,0.9968622051897772,2,7,vesicle uncoating,BP
GO:0060149,0.0395562737822552,0.9936675703957426,3,18,negative regulation of posttranscriptional gene silencing,BP
GO:0060967,0.0395562737822552,0.9936675703957426,3,18,negative regulation of gene silencing by RNA,BP
GO:0004070,0.03956222623735465,1,1,1,aspartate carbamoyltransferase activity,MF
GO:0004151,0.03956222623735465,1,1,1,dihydroorotase activity,MF
GO:0070335,0.03956222623735465,1,1,1,aspartate binding,MF
GO:0090247,0.03956222623735465,1,1,1,cell motility involved in somitogenic axis elongation,BP
GO:0090249,0.03956222623735465,1,1,1,regulation of cell motility involved in somitogenic axis elongation,BP
GO:1901229,0.03956222623735465,1,1,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP
GO:1901231,0.03956222623735465,1,1,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP
GO:1901232,0.03956222623735465,1,1,1,regulation of convergent extension involved in axis elongation,BP
GO:1901233,0.03956222623735465,1,1,1,negative regulation of convergent extension involved in axis elongation,BP
GO:0016616,0.03956294298695609,0.9829081108865446,10,119,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",MF
GO:0044550,0.03975686486784579,0.9911221036326391,4,29,secondary metabolite biosynthetic process,BP
GO:0070665,0.03975783405903677,0.9820009466705304,11,135,positive regulation of leukocyte proliferation,BP
GO:2001029,0.03975787852785304,1,1,1,regulation of cellular glucuronidation,BP
GO:2001031,0.03975787852785304,1,1,1,positive regulation of cellular glucuronidation,BP
GO:0008484,0.03979090082206275,0.9936603922664524,3,17,sulfuric ester hydrolase activity,MF
GO:0004721,0.03985081045467531,0.9799859743100446,14,182,phosphoprotein phosphatase activity,MF
GO:0017151,0.039942747300894095,0.9966967954256478,2,8,DEAD/H-box RNA helicase binding,MF
GO:1903747,0.03995266537537237,0.9858846101289152,7,72,regulation of establishment of protein localization to mitochondrion,BP
GO:0032344,0.039959817185130024,0.9968115208135878,2,7,regulation of aldosterone metabolic process,BP
GO:0032347,0.039959817185130024,0.9968115208135878,2,7,regulation of aldosterone biosynthetic process,BP
GO:0060644,0.03997614112772145,0.9936191636022458,3,17,mammary gland epithelial cell differentiation,BP
GO:0006750,0.04002813687308716,0.9936075766835323,3,17,glutathione biosynthetic process,BP
GO:0070252,0.04003761142715789,0.9826913963087462,10,114,actin-mediated cell contraction,BP
GO:0035518,0.040045208532261796,0.9936037710080364,3,17,histone H2A monoubiquitination,BP
GO:0017020,0.04010223140077531,1,1,1,myosin phosphatase regulator activity,MF
GO:0018210,0.0401192600786075,0.9818149186004385,11,134,peptidyl-threonine modification,BP
GO:0070242,0.04020092469563213,0.9935690270683131,3,17,thymocyte apoptotic process,BP
GO:0023035,0.04021294658828394,0.9966621001411178,2,8,CD40 signaling pathway,BP
GO:0046965,0.04025343703225774,0.9935572976892159,3,17,retinoid X receptor binding,MF
GO:0043022,0.040324692062466465,0.9871570120144524,6,57,ribosome binding,MF
GO:0006334,0.040325360193844646,0.982477203501903,10,130,nucleosome assembly,BP
GO:0030429,0.04033266904507572,1,1,1,kynureninase activity,MF
GO:0034516,0.04033266904507572,1,1,1,response to vitamin B6,BP
GO:0061981,0.04033266904507572,1,1,1,3-hydroxykynureninase activity,MF
GO:0009108,0.040421739729522635,0.9776926584092794,18,260,coenzyme biosynthetic process,BP
GO:0046316,0.04050683057382326,1,1,1,gluconokinase activity,MF
GO:0043627,0.04059179147860336,0.9856015391916597,7,73,response to estrogen,BP
GO:1905269,0.04065456538704203,0.9832940456821851,9,102,positive regulation of chromatin organization,BP
GO:0071622,0.04068073428493622,0.9887202184311363,5,44,regulation of granulocyte chemotaxis,BP
GO:0017059,0.040685533741766304,0.9966010977703843,2,8,serine C-palmitoyltransferase complex,CC
GO:0031211,0.040685533741766304,0.9966010977703843,2,8,endoplasmic reticulum palmitoyltransferase complex,CC
GO:1905961,0.040685533741766304,0.9966010977703843,2,8,protein-cysteine S-palmitoyltransferase complex,CC
GO:0031102,0.040692150207091424,0.987000707322668,6,58,neuron projection regeneration,BP
GO:0030258,0.04075662774079638,0.9779270035497789,17,238,lipid modification,BP
GO:0098911,0.040764438400853795,0.9934428263116272,3,17,regulation of ventricular cardiac muscle cell action potential,BP
GO:0042277,0.04081401627625353,0.9770573702349409,19,271,peptide binding,MF
GO:0060073,0.04081509662234748,0.9967050220255074,2,7,micturition,BP
GO:0014732,0.04090027947307135,0.9966943447192195,2,7,skeletal muscle atrophy,BP
GO:0070661,0.04090504743382199,0.9766166748864792,20,293,leukocyte proliferation,BP
GO:0033858,0.040992641816685216,1,1,1,N-acetylgalactosamine kinase activity,MF
GO:0005657,0.04101661171166489,0.9854446147008673,7,70,replication fork,CC
GO:0086010,0.041042230216649066,0.9887230630162416,5,37,membrane depolarization during action potential,BP
GO:0047066,0.04104427696242385,1,1,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF
GO:0097707,0.04104427696242385,1,1,1,ferroptosis,BP
GO:0110075,0.04104427696242385,1,1,1,regulation of ferroptosis,BP
GO:0110076,0.04104427696242385,1,1,1,negative regulation of ferroptosis,BP
GO:1990048,0.04114845965790269,0.9966631639400946,2,7,anterograde neuronal dense core vesicle transport,BP
GO:0042609,0.04122243353878275,0.9965313027946153,2,8,CD4 receptor binding,MF
GO:2001237,0.041245546266076356,0.9830010524701843,9,103,negative regulation of extrinsic apoptotic signaling pathway,BP
GO:0031490,0.04133029665372612,0.9829542669781018,9,104,chromatin DNA binding,MF
GO:0001315,0.04135041613855411,1,1,1,age-dependent response to reactive oxygen species,BP
GO:0003068,0.04135041613855411,1,1,1,regulation of systemic arterial blood pressure by acetylcholine,BP
GO:0003069,0.04135041613855411,1,1,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP
GO:0003070,0.04135041613855411,1,1,1,regulation of systemic arterial blood pressure by neurotransmitter,BP
GO:0017085,0.0413601788676702,0.9933086156907347,3,17,response to insecticide,BP
GO:0002566,0.0414035567285897,0.9932988117004932,3,17,somatic diversification of immune receptors via somatic mutation,BP
GO:0006929,0.041439431345930144,0.9906235035111606,4,29,substrate-dependent cell migration,BP
GO:0020003,0.04150079484777688,0.996618712440393,2,7,symbiont-containing vacuole,CC
GO:0072348,0.04152400833004844,0.9884383524325375,5,43,sulfur compound transport,BP
GO:0048673,0.041600680033333816,1,1,1,collateral sprouting of intact axon in response to injury,BP
GO:0048683,0.041600680033333816,1,1,1,regulation of collateral sprouting of intact axon in response to injury,BP
GO:0048685,0.041600680033333816,1,1,1,negative regulation of collateral sprouting of intact axon in response to injury,BP
GO:0004018,0.041625461714452576,1,1,1,"N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity",MF
GO:0070626,0.041625461714452576,1,1,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF
GO:0009148,0.04164057642620043,0.9931970531924789,3,18,pyrimidine nucleoside triphosphate biosynthetic process,BP
GO:0042698,0.04172551806777074,0.9851478767101834,7,69,ovulation cycle,BP
GO:0047280,0.04179767931044037,1,1,1,nicotinamide phosphoribosyltransferase activity,MF
GO:1905377,0.04179767931044037,1,1,1,response to D-galactose,BP
GO:0045737,0.04192963775507869,0.9904260117704704,4,31,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP
GO:0009295,0.0419314303534157,0.9882939500150505,5,43,nucleoid,CC
GO:0042645,0.0419314303534157,0.9882939500150505,5,43,mitochondrial nucleoid,CC
GO:0032225,0.04193149078017304,0.9932342540571019,3,16,"regulation of synaptic transmission, dopaminergic",BP
GO:0048199,0.041936600654884526,0.9850200325579257,7,73,"vesicle targeting, to, from or within Golgi",BP
GO:0032602,0.04193934495225414,0.9837481300552131,8,89,chemokine production,BP
GO:0072684,0.04218300436013649,1,1,1,"mitochondrial tRNA 3'-trailer cleavage, endonucleolytic",BP
GO:0007143,0.042199374864664546,0.9903447055135637,4,31,female meiotic nuclear division,BP
GO:0007172,0.04222301913667921,0.9963998447580271,2,8,signal complex assembly,BP
GO:0043045,0.042241871279903725,0.996397350708904,2,8,DNA methylation involved in embryo development,BP
GO:1901538,0.042241871279903725,0.996397350708904,2,8,changes to DNA methylation involved in embryo development,BP
GO:1990814,0.042265737019993276,1,1,1,DNA/DNA annealing activity,MF
GO:0071960,0.04232448679048426,1,1,1,"maintenance of mitotic sister chromatid cohesion, centromeric",BP
GO:2000718,0.04232448679048426,1,1,1,"regulation of maintenance of mitotic sister chromatid cohesion, centromeric",BP
GO:2000719,0.04232448679048426,1,1,1,"negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric",BP
GO:0036317,0.04237127901573653,1,1,1,tyrosyl-RNA phosphodiesterase activity,MF
GO:0070260,0.04237127901573653,1,1,1,5'-tyrosyl-DNA phosphodiesterase activity,MF
GO:0001938,0.04237874211768208,0.9824102954214424,9,110,positive regulation of endothelial cell proliferation,BP
GO:0031859,0.04238294818792772,1,1,1,platelet activating factor receptor binding,MF
GO:0005637,0.0424067048486054,0.9863189022455432,6,58,nuclear inner membrane,CC
GO:0090091,0.04251918370535033,0.9963605902097192,2,8,positive regulation of extracellular matrix disassembly,BP
GO:0006253,0.04256807770373525,1,1,1,dCTP catabolic process,BP
GO:0032556,0.04256807770373525,1,1,1,pyrimidine deoxyribonucleotide binding,MF
GO:0046065,0.04256807770373525,1,1,1,dCTP metabolic process,BP
GO:0047840,0.04256807770373525,1,1,1,dCTP diphosphatase activity,MF
GO:0050849,0.042570936544496514,0.9902324177812211,4,31,negative regulation of calcium-mediated signaling,BP
GO:0071578,0.04257502565283331,0.99635317120256,2,8,zinc ion import across plasma membrane,BP
GO:0034381,0.04257768918814676,0.9861605929128232,6,67,plasma lipoprotein particle clearance,BP
GO:0033029,0.04261577977573409,0.9964766200678199,2,7,regulation of neutrophil apoptotic process,BP
GO:0090398,0.04265379668213387,0.9846750007951759,7,77,cellular senescence,BP
GO:2000562,0.0427625253081632,0.9963282198479078,2,8,"negative regulation of CD4-positive, alpha-beta T cell proliferation",BP
GO:0001844,0.042832241832225164,0.9901784662798855,4,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP
GO:0031800,0.04289599521019311,1,1,1,type 3 metabotropic glutamate receptor binding,MF
GO:1901658,0.04292210485817549,0.9879411250943395,5,43,glycosyl compound catabolic process,BP
GO:0070878,0.042947809577013774,0.9963035018126578,2,8,primary miRNA binding,MF
GO:0034263,0.04296260128891012,1,1,1,positive regulation of autophagy in response to ER overload,BP
GO:0033129,0.042972114704153776,0.9963002548324538,2,8,positive regulation of histone phosphorylation,BP
GO:0004629,0.043038781019487576,0.9901724597798679,4,28,phospholipase C activity,MF
GO:0036138,0.043072659982236534,1,1,1,peptidyl-histidine hydroxylation,BP
GO:0036139,0.043072659982236534,1,1,1,peptidyl-histidine dioxygenase activity,MF
GO:0036140,0.043072659982236534,1,1,1,peptidyl-asparagine 3-dioxygenase activity,MF
GO:0042265,0.043072659982236534,1,1,1,peptidyl-asparagine hydroxylation,BP
GO:0102113,0.043072659982236534,1,1,1,hypoxia-inducible factor-asparagine oxygenase activity,MF
GO:0046719,0.0430813701551304,0.9964166490984911,2,7,regulation by virus of viral protein levels in host cell,BP
GO:0097371,0.0430923075462663,0.9962841825514974,2,8,MDM2/MDM4 family protein binding,MF
GO:0150002,0.043127241702034656,1,1,1,distal dendrite,CC
GO:0150014,0.043127241702034656,1,1,1,apical distal dendrite,CC
GO:2000575,0.043127241702034656,1,1,1,negative regulation of microtubule motor activity,BP
GO:0043270,0.04313494742717604,0.9755963784317636,19,272,positive regulation of ion transport,BP
GO:0061082,0.04314682141997378,0.9901104843222518,4,29,myeloid leukocyte cytokine production,BP
GO:1903564,0.043217516183025315,0.996267412274452,2,8,regulation of protein localization to cilium,BP
GO:0016887,0.04337414378238813,0.9733959062290596,25,378,ATPase activity,MF
GO:0019150,0.0434378856781184,1,1,1,D-ribulokinase activity,MF
GO:0045358,0.0434378856781184,1,1,1,negative regulation of interferon-beta biosynthetic process,BP
GO:0033676,0.043448416019242285,1,1,1,double-stranded DNA-dependent ATPase activity,MF
GO:0036121,0.043448416019242285,1,1,1,double-stranded DNA-dependent ATP-dependent DNA helicase activity,MF
GO:0003323,0.04346338648465922,0.9927774230701407,3,18,type B pancreatic cell development,BP
GO:0047820,0.04352178740976177,1,1,1,D-glutamate cyclase activity,MF
GO:0010879,0.04353222024799943,1,1,1,cholesterol transport involved in cholesterol storage,BP
GO:0050693,0.04356855885663168,0.9963534967882656,2,7,LBD domain binding,MF
GO:0031995,0.043605596848855635,0.9962152567175443,2,8,insulin-like growth factor II binding,MF
GO:0002118,0.04361240096662046,0.9962143399096121,2,8,aggressive behavior,BP
GO:0006904,0.04368040956138481,0.9876694455508848,5,43,vesicle docking involved in exocytosis,BP
GO:0036474,0.04376686916854382,0.9898006890074375,4,34,cell death in response to hydrogen peroxide,BP
GO:0043203,0.04380994398312619,0.9961876866795999,2,8,axon hillock,CC
GO:0007096,0.04389373782304574,0.9926314313630759,3,19,regulation of exit from mitosis,BP
GO:0006473,0.04395635353562397,0.9770163037776755,15,204,protein acetylation,BP
GO:1904948,0.04398703436425086,0.9927072549607946,3,17,midbrain dopaminergic neuron differentiation,BP
GO:0080058,0.04398895938786448,1,1,1,protein deglutathionylation,BP
GO:0097573,0.04398895938786448,1,1,1,glutathione oxidoreductase activity,MF
GO:0009200,0.04402611461035235,0.9926463684098963,3,18,deoxyribonucleoside triphosphate metabolic process,BP
GO:0071250,0.04406752430908886,1,1,1,cellular response to nitrite,BP
GO:0080033,0.04406752430908886,1,1,1,response to nitrite,BP
GO:1903210,0.04406752430908886,1,1,1,glomerular visceral epithelial cell apoptotic process,BP
GO:1904633,0.04406752430908886,1,1,1,regulation of glomerular visceral epithelial cell apoptotic process,BP
GO:1904635,0.04406752430908886,1,1,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP
GO:1990843,0.04406752430908886,1,1,1,subsarcolemmal mitochondrion,CC
GO:1990844,0.04406752430908886,1,1,1,interfibrillar mitochondrion,CC
GO:0005591,0.0442983878465298,1,1,1,collagen type VIII trimer,CC
GO:0005598,0.0442983878465298,1,1,1,short-chain collagen trimer,CC
GO:0030935,0.0442983878465298,1,1,1,sheet-forming collagen trimer,CC
GO:0098646,0.0442983878465298,1,1,1,collagen sheet,CC
GO:0030217,0.04434505133361892,0.9757349648544751,17,237,T cell differentiation,BP
GO:0070988,0.044355941181251635,0.9839916409063952,7,70,demethylation,BP
GO:0000281,0.04437333693965384,0.983955310795284,7,73,mitotic cytokinesis,BP
GO:0043197,0.04439708722243235,0.9780121914519934,13,169,dendritic spine,CC
GO:0035066,0.04442302569877897,0.9896941516843047,4,30,positive regulation of histone acetylation,BP
GO:0060598,0.04444823874498283,1,1,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP
GO:0061517,0.0444789462664497,0.995992090450649,2,9,macrophage proliferation,BP
GO:1903788,0.04449439642389878,1,1,1,positive regulation of glutathione biosynthetic process,BP
GO:1903943,0.04457667246630005,1,1,1,regulation of hepatocyte apoptotic process,BP
GO:1903944,0.04457667246630005,1,1,1,negative regulation of hepatocyte apoptotic process,BP
GO:0098918,0.04461293803794318,0.992561699029969,3,17,structural constituent of synapse,MF
GO:0050684,0.04465073620831353,0.97939734153078,11,137,regulation of mRNA processing,BP
GO:0032462,0.04465350547143373,0.9924106210036769,3,20,regulation of protein homooligomerization,BP
GO:0006055,0.04472926561949071,1,1,1,CMP-N-acetylneuraminate biosynthetic process,BP
GO:0046381,0.04472926561949071,1,1,1,CMP-N-acetylneuraminate metabolic process,BP
GO:0047444,0.04472926561949071,1,1,1,N-acylneuraminate-9-phosphate synthase activity,MF
GO:0050462,0.04472926561949071,1,1,1,N-acetylneuraminate synthase activity,MF
GO:0001726,0.04474833147257852,0.9778034624042695,13,172,ruffle,CC
GO:0072341,0.04475496284331938,0.9824477202085425,8,87,modified amino acid binding,MF
GO:0046086,0.04477345008957852,1,1,1,adenosine biosynthetic process,BP
GO:0043484,0.04481616682985559,0.9793213717055086,11,134,regulation of RNA splicing,BP
GO:0030118,0.04489677676699373,0.9871963102431867,5,45,clathrin coat,CC
GO:0097655,0.04490412270236522,1,1,1,serpin family protein binding,MF
GO:0042564,0.04491273441566826,1,1,1,NLS-dependent protein nuclear import complex,CC
GO:0106137,0.04491273441566826,1,1,1,IkappaB kinase complex binding,MF
GO:1905492,0.04491273441566826,1,1,1,positive regulation of branching morphogenesis of a nerve,BP
GO:1902110,0.04497327093114824,0.9852611008282648,6,60,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP
GO:0034101,0.045033416763536546,0.9800955419591016,10,122,erythrocyte homeostasis,BP
GO:0001221,0.04503763591380408,0.9871797472001169,5,43,transcription cofactor binding,MF
GO:0004747,0.04506562996067663,1,1,1,ribokinase activity,MF
GO:0019003,0.0451205343735825,0.9836260342968686,7,73,GDP binding,MF
GO:0010675,0.04517140560514319,0.9791017875410065,11,141,regulation of cellular carbohydrate metabolic process,BP
GO:0033925,0.04523085858228705,1,1,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF
GO:0009120,0.045251410321702074,0.9959911200569017,2,8,deoxyribonucleoside metabolic process,BP
GO:0043547,0.04528170519183618,0.9718115092412523,26,404,positive regulation of GTPase activity,BP
GO:1904764,0.045303631472424985,1,1,1,chaperone-mediated autophagy translocation complex disassembly,BP
GO:1990832,0.045303631472424985,1,1,1,slow axonal transport,BP
GO:1990833,0.045303631472424985,1,1,1,clathrin-uncoating ATPase activity,MF
GO:0031572,0.04533447205135038,0.9893869169255077,4,31,G2 DNA damage checkpoint,BP
GO:0046486,0.04535759829033534,0.971751962540119,26,412,glycerolipid metabolic process,BP
GO:0060611,0.04535956076007167,1,1,1,mammary gland fat development,BP
GO:1902228,0.04535956076007167,1,1,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP
GO:0010972,0.045451646435353626,0.9820770445101294,8,93,negative regulation of G2/M transition of mitotic cell cycle,BP
GO:0035148,0.04552650234939954,0.9781267421736481,12,148,tube formation,BP
GO:0046902,0.045538231589286216,0.9834143233806247,7,76,regulation of mitochondrial membrane permeability,BP
GO:1904714,0.04557552561802264,0.9959464209150288,2,8,regulation of chaperone-mediated autophagy,BP
GO:0006666,0.04559267703067933,1,1,1,3-keto-sphinganine metabolic process,BP
GO:0047560,0.04559267703067933,1,1,1,3-dehydrosphinganine reductase activity,MF
GO:0043372,0.045609099253130905,0.9893291692708769,4,30,"positive regulation of CD4-positive, alpha-beta T cell differentiation",BP
GO:0014012,0.04570536425358513,0.9958192452647106,2,9,peripheral nervous system axon regeneration,BP
GO:0010586,0.045727449285554264,0.9892925703914062,4,30,miRNA metabolic process,BP
GO:0061418,0.04573407232487195,0.9833189157900573,7,77,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP
GO:0044320,0.04573610618368071,0.9922438233322461,3,18,cellular response to leptin stimulus,BP
GO:0070459,0.045778141294359864,0.9959183849865997,2,8,prolactin secretion,BP
GO:0036289,0.045799312847528244,0.9959154513583564,2,8,peptidyl-serine autophosphorylation,BP
GO:0003746,0.04581449678208176,0.9921766940859044,3,19,translation elongation factor activity,MF
GO:0045655,0.045848577986280975,0.99212513806491,3,20,regulation of monocyte differentiation,BP
GO:0016202,0.045856330417594765,0.9787139379914537,11,146,regulation of striated muscle tissue development,BP
GO:0009394,0.045876516327185195,0.9892189715889491,4,31,2'-deoxyribonucleotide metabolic process,BP
GO:0008297,0.0460909327563851,0.9958749639257831,2,8,single-stranded DNA exodeoxyribonuclease activity,MF
GO:0036314,0.04610346319537003,0.9890985132298878,4,33,response to sterol,BP
GO:0048873,0.0462167931393073,0.98914090048094,4,30,homeostasis of number of cells within a tissue,BP
GO:0017022,0.04624517101885957,0.983147733355996,7,71,myosin binding,MF
GO:0044387,0.046293231681340606,0.9958467908109824,2,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP
GO:0015292,0.046295367268493946,1,1,1,uniporter activity,MF
GO:0003707,0.04631699015637112,0.9847780825355885,6,55,steroid hormone receptor activity,MF
GO:0010989,0.04632466071072247,0.9954226957889982,2,14,negative regulation of low-density lipoprotein particle clearance,BP
GO:0035886,0.04634594464059663,0.988939298791466,4,37,vascular smooth muscle cell differentiation,BP
GO:0008061,0.046353577906437675,0.9958383729770603,2,8,chitin binding,MF
GO:0018394,0.04638116300018385,0.9768825770554224,13,169,peptidyl-lysine acetylation,BP
GO:0008140,0.04639575375665454,0.9958324860276487,2,8,cAMP response element binding protein binding,MF
GO:0038128,0.04640203070808474,0.9890294955174571,4,32,ERBB2 signaling pathway,BP
GO:0005882,0.046425351357682304,0.9794151053961917,10,114,intermediate filament,CC
GO:0004540,0.04643618883070487,0.9804061482973297,9,109,ribonuclease activity,MF
GO:1903573,0.046483750119822705,0.9866348090848938,5,44,negative regulation of response to endoplasmic reticulum stress,BP
GO:0022894,0.046575982634195656,1,1,1,Intermediate conductance calcium-activated potassium channel activity,MF
GO:0048710,0.04663876818588873,0.9889816475077572,4,31,regulation of astrocyte differentiation,BP
GO:0009750,0.04679615602229277,0.9957764442522201,2,8,response to fructose,BP
GO:0036353,0.046806307549315015,0.9957750198078884,2,8,histone H2A-K119 monoubiquitination,BP
GO:0043902,0.04682260134562212,0.9759351447809044,14,188,positive regulation of multi-organism process,BP
GO:0060907,0.04682851264992419,0.9957719034075978,2,8,positive regulation of macrophage cytokine production,BP
GO:0001707,0.04690519235670101,0.982834388305131,7,73,mesoderm formation,BP
GO:0043555,0.04695514290551115,0.9919529486282509,3,18,regulation of translation in response to stress,BP
GO:0002831,0.0470028555956558,0.9781223195207377,11,139,regulation of response to biotic stimulus,BP
GO:0004675,0.047048994259284875,0.9919870424470019,3,17,transmembrane receptor protein serine/threonine kinase activity,MF
GO:0008442,0.0470955882642426,1,1,1,3-hydroxyisobutyrate dehydrogenase activity,MF
GO:0048678,0.04717358982213466,0.9826865512942268,7,76,response to axon injury,BP
GO:0009032,0.047219356980395914,1,1,1,thymidine phosphorylase activity,MF
GO:0016154,0.047219356980395914,1,1,1,pyrimidine-nucleoside phosphorylase activity,MF
GO:0099571,0.047233429587769445,0.995714925836135,2,8,postsynaptic cytoskeleton,CC
GO:0031701,0.047276356283654904,0.9957088688917181,2,8,angiotensin receptor binding,MF
GO:0001013,0.04728493790917272,0.9957076576467783,2,8,RNA polymerase I regulatory region DNA binding,MF
GO:0001163,0.04728493790917272,0.9957076576467783,2,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF
GO:0001164,0.04728493790917272,0.9957076576467783,2,8,RNA polymerase I CORE element sequence-specific DNA binding,MF
GO:0102773,0.04729082956371879,1,1,1,dihydroceramide kinase activity,MF
GO:0019217,0.047316691023802704,0.981171735947711,8,96,regulation of fatty acid metabolic process,BP
GO:0039513,0.047328106297031713,1,1,1,suppression by virus of host catalytic activity,BP
GO:0039516,0.047328106297031713,1,1,1,modulation by virus of host catalytic activity,BP
GO:0039650,0.047328106297031713,1,1,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP
GO:0052053,0.047328106297031713,1,1,1,negative regulation by symbiont of host catalytic activity,BP
GO:0052148,0.047328106297031713,1,1,1,modulation by symbiont of host catalytic activity,BP
GO:1904675,0.04733524096675345,0.9994266635476609,1,2,regulation of somatic stem cell division,BP
GO:0071156,0.047365805773505035,0.9799464657821639,9,108,regulation of cell cycle arrest,BP
GO:0032635,0.04738208646544348,0.9770462455521312,12,161,interleukin-6 production,BP
GO:0032627,0.04740239572781684,0.9956910664565924,2,8,interleukin-23 production,BP
GO:0032667,0.04740239572781684,0.9956910664565924,2,8,regulation of interleukin-23 production,BP
GO:0015914,0.0474200460227662,0.9825855247235307,7,75,phospholipid transport,BP
GO:0010389,0.047465682099467596,0.9755357905151605,14,196,regulation of G2/M transition of mitotic cell cycle,BP
GO:1990738,0.04750161238862376,1,1,1,pseudouridine 5'-phosphatase activity,MF
GO:2000169,0.04750609645800964,0.9955606140136815,2,9,regulation of peptidyl-cysteine S-nitrosylation,BP
GO:0004757,0.04752288749748577,1,1,1,sepiapterin reductase activity,MF
GO:0004123,0.04757719173210454,1,1,1,cystathionine gamma-lyase activity,MF
GO:0018272,0.04757719173210454,1,1,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP
GO:0044524,0.04757719173210454,1,1,1,protein sulfhydration,BP
GO:0044540,0.04757719173210454,1,1,1,L-cystine L-cysteine-lyase (deaminating),MF
GO:0080146,0.04757719173210454,1,1,1,L-cysteine desulfhydrase activity,MF
GO:0051491,0.04760201346852347,0.9887085778794237,4,30,positive regulation of filopodium assembly,BP
GO:0034767,0.04761363165860437,0.9769420121159083,12,154,positive regulation of ion transmembrane transport,BP
GO:0006913,0.047623916745118455,0.9715058199214007,22,342,nucleocytoplasmic transport,BP
GO:0060401,0.04765093415948167,0.9761555152611481,13,169,cytosolic calcium ion transport,BP
GO:0071453,0.04772154057761184,0.9741610543101701,16,232,cellular response to oxygen levels,BP
GO:0050701,0.047752499396204906,0.9841224118247305,6,60,interleukin-1 secretion,BP
GO:0036316,0.047791187642054575,1,1,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP
GO:1901303,0.047791187642054575,1,1,1,negative regulation of cargo loading into COPII-coated vesicle,BP
GO:0005381,0.04788559534292097,0.9955053790749753,2,9,iron ion transmembrane transporter activity,MF
GO:0008398,0.04789411312151208,1,1,1,sterol 14-demethylase activity,MF
GO:0033488,0.04789411312151208,1,1,1,"cholesterol biosynthetic process via 24,25-dihydrolanosterol",BP
GO:0075713,0.04792370477944568,0.9956171445859832,2,8,establishment of integrated proviral latency,BP
GO:0030690,0.04793810993828159,1,1,1,Noc1p-Noc2p complex,CC
GO:0030691,0.04793810993828159,1,1,1,Noc2p-Noc3p complex,CC
GO:0043548,0.04796095911893439,0.988595839860641,4,30,phosphatidylinositol 3-kinase binding,MF
GO:0044309,0.04805420478491592,0.9759172141330865,13,171,neuron spine,CC
GO:0002377,0.048096387263815696,0.9795854376511273,9,107,immunoglobulin production,BP
GO:0016579,0.04809747677302703,0.9724266650694138,19,281,protein deubiquitination,BP
GO:1901533,0.048105915283104504,0.9955911972627436,2,8,negative regulation of hematopoietic progenitor cell differentiation,BP
GO:0019843,0.04810747252287313,0.983951668670854,6,62,rRNA binding,MF
GO:0071402,0.04812168064132244,0.9884396003306279,4,34,cellular response to lipoprotein particle stimulus,BP
GO:0004654,0.04816160930997473,1,1,1,polyribonucleotide nucleotidyltransferase activity,MF
GO:0044795,0.04816160930997473,1,1,1,trans-Golgi network to recycling endosome transport,BP
GO:0090616,0.04816160930997473,1,1,1,mitochondrial mRNA 3'-end processing,BP
GO:0097222,0.04816160930997473,1,1,1,mitochondrial mRNA polyadenylation,BP
GO:0005090,0.04817274111152662,1,1,1,Sar guanyl-nucleotide exchange factor activity,MF
GO:0048160,0.04821082433352074,1,1,1,primary follicle stage,BP
GO:0046434,0.048231564816741054,0.9733082983487752,17,248,organophosphate catabolic process,BP
GO:0006888,0.04823757662397159,0.9744438856414704,15,211,ER to Golgi vesicle-mediated transport,BP
GO:1902115,0.048249175368185224,0.9750886991351149,14,191,regulation of organelle assembly,BP
GO:0005115,0.04825781212605192,1,1,1,receptor tyrosine kinase-like orphan receptor binding,MF
GO:0036517,0.04825781212605192,1,1,1,chemoattraction of serotonergic neuron axon,BP
GO:0061347,0.04825781212605192,1,1,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP
GO:0061348,0.04825781212605192,1,1,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP
GO:0061349,0.04825781212605192,1,1,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP
GO:0061350,0.04825781212605192,1,1,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP
GO:0061354,0.04825781212605192,1,1,1,planar cell polarity pathway involved in pericardium morphogenesis,BP
GO:1904934,0.04825781212605192,1,1,1,negative regulation of cell proliferation in midbrain,BP
GO:1904955,0.04825781212605192,1,1,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP
GO:0034640,0.04830747158364099,1,1,1,establishment of mitochondrion localization by microtubule attachment,BP
GO:0099098,0.04830747158364099,1,1,1,microtubule polymerization based movement,BP
GO:0050807,0.04831357164128981,0.9738334908699054,16,217,regulation of synapse organization,BP
GO:0034127,0.04832680753552902,0.9955596654488539,2,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP
GO:0016938,0.048336007641806226,1,1,1,kinesin I complex,CC
GO:0003947,0.04834992747228196,1,1,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF
GO:0052894,0.048383726835037666,1,1,1,norspermine:oxygen oxidoreductase activity,MF
GO:0052895,0.048383726835037666,1,1,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF
GO:0034312,0.048426851702822904,0.9915975188733464,3,18,diol biosynthetic process,BP
GO:0004454,0.04848259103560735,1,1,1,ketohexokinase activity,MF
GO:0042628,0.04849210157002406,1,1,1,mating plug formation,BP
GO:0045297,0.04849210157002406,1,1,1,post-mating behavior,BP
GO:0061108,0.04849210157002406,1,1,1,seminal vesicle epithelium development,BP
GO:2000772,0.0485535503773815,0.985758609667215,5,51,regulation of cellular senescence,BP
GO:0046459,0.04855914889098481,0.9915653416178828,3,18,short-chain fatty acid metabolic process,BP
GO:0006214,0.04866807221799741,1,1,1,thymidine catabolic process,BP
GO:0017113,0.04866807221799741,1,1,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF
GO:0046127,0.04866807221799741,1,1,1,pyrimidine deoxyribonucleoside catabolic process,BP
GO:0002041,0.04868582304672945,1,1,1,intussusceptive angiogenesis,BP
GO:0090649,0.048719121374148015,0.9955034584337958,2,8,response to oxygen-glucose deprivation,BP
GO:0090650,0.048719121374148015,0.9955034584337958,2,8,cellular response to oxygen-glucose deprivation,BP
GO:0071575,0.048721906877018155,1,1,1,integral component of external side of plasma membrane,CC
GO:0006903,0.04872767506036568,0.9805243384448784,8,92,vesicle targeting,BP
GO:0070813,0.04875591951593609,0.995498172895662,2,8,hydrogen sulfide metabolic process,BP
GO:0099050,0.048761335755000204,1,1,1,vesicle scission,BP
GO:0098830,0.04880146155508912,1,1,1,presynaptic endosome,CC
GO:0036294,0.048823285939389956,0.9740816711869864,15,215,cellular response to decreased oxygen levels,BP
GO:0072591,0.04885539643588919,1,1,1,citrate-L-glutamate ligase activity,MF
GO:0060674,0.04885797612506977,0.9883128347630813,4,30,placenta blood vessel development,BP
GO:0015431,0.04887400390821452,1,1,1,glutathione S-conjugate-exporting ATPase activity,MF
GO:0034634,0.04887400390821452,1,1,1,glutathione transmembrane transporter activity,MF
GO:0042937,0.04887400390821452,1,1,1,tripeptide transmembrane transporter activity,MF
GO:0071716,0.04887400390821452,1,1,1,leukotriene transport,BP
GO:0071997,0.04887400390821452,1,1,1,glutathione S-conjugate-transporting ATPase activity,MF
GO:0000183,0.04889233165907139,0.9881294339910588,4,37,chromatin silencing at rDNA,BP
GO:1904906,0.04889304488629252,1,1,1,positive regulation of endothelial cell-matrix adhesion via fibronectin,BP
GO:1901254,0.048903288943342935,1,1,1,positive regulation of intracellular transport of viral material,BP
GO:0048792,0.048903642565652106,1,1,1,spontaneous exocytosis of neurotransmitter,BP
GO:0110077,0.048903642578759086,1,1,1,vesicle-mediated intercellular transport,BP
GO:0031959,0.04890364457821636,1,1,1,mineralocorticoid receptor signaling pathway,BP
GO:0035400,0.04890364457821636,1,1,1,histone tyrosine kinase activity,MF
GO:0035401,0.04890364457821636,1,1,1,histone kinase activity (H3-Y41 specific),MF
GO:0035406,0.04890364457821636,1,1,1,histone-tyrosine phosphorylation,BP
GO:0035409,0.04890364457821636,1,1,1,histone H3-Y41 phosphorylation,BP
GO:2000230,0.04890365306948787,1,1,1,negative regulation of pancreatic stellate cell proliferation,BP
GO:0046725,0.04890371986584757,1,1,1,negative regulation by virus of viral protein levels in host cell,BP
GO:0072308,0.04890371986584757,1,1,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP
GO:0008832,0.04890374802884681,1,1,1,dGTPase activity,MF
GO:0016793,0.04890374802884681,1,1,1,triphosphoric monoester hydrolase activity,MF
GO:0032560,0.04890374802884681,1,1,1,guanyl deoxyribonucleotide binding,MF
GO:0032567,0.04890374802884681,1,1,1,dGTP binding,MF
GO:0061580,0.04890376281870327,1,1,1,colon epithelial cell migration,BP
GO:0007499,0.048903866963130885,1,1,1,ectoderm and mesoderm interaction,BP
GO:0032625,0.048904209014899794,1,1,1,interleukin-21 production,BP
GO:0072619,0.048904209014899794,1,1,1,interleukin-21 secretion,BP
GO:0046521,0.04890470937321957,1,1,1,sphingoid catabolic process,BP
GO:1905364,0.04890470937321957,1,1,1,regulation of endosomal vesicle fusion,BP
GO:1900022,0.04890476319635145,1,1,1,regulation of D-erythro-sphingosine kinase activity,BP
GO:0002264,0.04890567590017171,1,1,1,endothelial cell activation involved in immune response,BP
GO:0035238,0.0489070414009827,1,1,1,vitamin A biosynthetic process,BP
GO:1901810,0.0489070414009827,1,1,1,beta-carotene metabolic process,BP
GO:0030527,0.04890767943332298,1,1,1,structural constituent of chromatin,MF
GO:0008518,0.04890883567006063,1,1,1,folate:anion antiporter activity,MF
GO:0061395,0.04891107399020204,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP
GO:1901384,0.04891591157271287,1,1,1,positive regulation of chorionic trophoblast cell proliferation,BP
GO:0098891,0.04891745577432765,1,1,1,extrinsic component of presynaptic active zone membrane,CC
GO:0003026,0.04891767587967554,1,1,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP
GO:0048562,0.04893446664435585,0.9714690584606479,20,286,embryonic organ morphogenesis,BP
GO:0051913,0.0489390122220578,1,1,1,regulation of synaptic plasticity by chemical substance,BP
GO:0051914,0.0489390122220578,1,1,1,positive regulation of synaptic plasticity by chemical substance,BP
GO:0051915,0.0489390122220578,1,1,1,induction of synaptic plasticity by chemical substance,BP
GO:0097510,0.048939977028356785,1,1,1,"base-excision repair, AP site formation via deaminated base removal",BP
GO:1905535,0.0489467568995014,1,1,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP
GO:1905537,0.0489467568995014,1,1,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP
GO:1905610,0.0489467568995014,1,1,1,regulation of mRNA cap binding,BP
GO:1905612,0.0489467568995014,1,1,1,positive regulation of mRNA cap binding,BP
GO:0070869,0.0489672805344597,1,1,1,heterochromatin assembly involved in chromatin silencing,BP
GO:0016332,0.04898994784617563,1,1,1,establishment or maintenance of polarity of embryonic epithelium,BP
GO:0072060,0.04898994784617563,1,1,1,outer medullary collecting duct development,BP
GO:0008269,0.049004018449124505,1,1,1,JAK pathway signal transduction adaptor activity,MF
GO:1902748,0.04900790046907429,1,1,1,positive regulation of lens fiber cell differentiation,BP
GO:0061143,0.0490087451437567,1,1,1,alveolar primary septum development,BP
GO:0071938,0.0490087451437567,1,1,1,vitamin A transport,BP
GO:0071939,0.0490087451437567,1,1,1,vitamin A import,BP
GO:0097489,0.049009594367906834,1,1,1,"multivesicular body, internal vesicle lumen",CC
GO:0034346,0.04905522472797675,1,1,1,positive regulation of type III interferon production,BP
GO:1904235,0.049118676476662224,1,1,1,"regulation of substrate-dependent cell migration, cell attachment to substrate",BP
GO:1904237,0.049118676476662224,1,1,1,"positive regulation of substrate-dependent cell migration, cell attachment to substrate",BP
GO:0030519,0.04917059512725629,1,1,1,snoRNP binding,MF
GO:0062064,0.04917059512725629,1,1,1,box C/D snoRNP complex binding,MF
GO:0062065,0.04917059512725629,1,1,1,box H/ACA snoRNP complex binding,MF
GO:0015854,0.0491855808200927,1,1,1,guanine transport,BP
GO:0035344,0.0491855808200927,1,1,1,hypoxanthine transport,BP
GO:0035364,0.0491855808200927,1,1,1,thymine transport,BP
GO:1900170,0.04919774093131533,1,1,1,negative regulation of glucocorticoid mediated signaling pathway,BP
GO:1902211,0.04919774093131533,1,1,1,regulation of prolactin signaling pathway,BP
GO:1902213,0.04919774093131533,1,1,1,positive regulation of prolactin signaling pathway,BP
GO:0002476,0.049233880037192826,1,1,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP
GO:0002488,0.049233880037192826,1,1,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP
GO:0002489,0.049233880037192826,1,1,1,"antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent",BP
GO:0046980,0.049233880037192826,1,1,1,tapasin binding,MF
GO:0001165,0.04925553035491386,1,1,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF
GO:0031058,0.04928118617949889,0.9802815790574014,8,89,positive regulation of histone modification,BP
GO:0006195,0.04930846750603686,0.9855910542981274,5,44,purine nucleotide catabolic process,BP
GO:0044228,0.04931193732494652,1,1,1,host cell surface,CC
GO:0035602,0.04936386985773531,1,1,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP
GO:0035603,0.04936386985773531,1,1,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP
GO:0035604,0.04936386985773531,1,1,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP
GO:0060999,0.04937480122904644,0.9855860651473453,5,43,positive regulation of dendritic spine development,BP
GO:0002135,0.04939432195011028,1,1,1,CTP binding,MF
GO:0017098,0.04939432195011028,1,1,1,sulfonylurea receptor binding,MF
GO:1901389,0.04939432195011028,1,1,1,negative regulation of transforming growth factor beta activation,BP
GO:1990917,0.04939432195011028,1,1,1,ooplasm,CC
GO:2001242,0.04940542830813788,0.9759075791862247,12,162,regulation of intrinsic apoptotic signaling pathway,BP
GO:0098695,0.0494299165580971,1,1,1,"inositol 1,4,5-trisphosphate receptor activity involved in regulation of postsynaptic cytosolic calcium levels",MF
GO:0000388,0.049432339181726064,1,1,1,spliceosome conformational change to release U4 (or U4atac) and U1 (or U11),BP
GO:0010766,0.04944896859581691,0.9913479576486574,3,18,negative regulation of sodium ion transport,BP
GO:0070976,0.04947109247833721,1,1,1,TIR domain binding,MF
GO:0038191,0.049550305622846055,0.991323094989189,3,18,neuropilin binding,MF
GO:2001182,0.04956950702280455,0.9953807248790626,2,8,regulation of interleukin-12 secretion,BP
GO:0035307,0.04963199113430389,0.9854703567759967,5,44,positive regulation of protein dephosphorylation,BP
GO:0023029,0.04967298051217638,0.99536570722461,2,8,MHC class Ib protein binding,MF
GO:0030279,0.04978340334538482,0.9815127607493077,7,76,negative regulation of ossification,BP
GO:0055076,0.04981699861902257,0.9775541549069608,10,130,transition metal ion homeostasis,BP
GO:0048857,0.049853659996093785,0.9832371681232238,6,61,neural nucleus development,BP
GO:1902895,0.0498583102136514,0.9879646788920321,4,31,positive regulation of pri-miRNA transcription by RNA polymerase II,BP
GO:0010887,0.04987342183641919,0.9953365646270148,2,8,negative regulation of cholesterol storage,BP
GO:0006521,0.049908616709301606,0.9832018864216375,6,62,regulation of cellular amino acid metabolic process,BP
GO:0048536,0.049929137633562826,0.9879725332778126,4,30,spleen development,BP
GO:0046085,0.04994727609187463,0.9953258096891988,2,8,adenosine metabolic process,BP
GO:1902600,0.9897913999077309,0.04026987772274157,2,152,proton transmembrane transport,BP
GO:0007186,0.9916839284435705,0.012294500515865567,45,1341,G protein-coupled receptor signaling pathway,BP
GO:0060089,0.9978712213094214,0.0032801231529149912,49,1500,molecular transducer activity,MF
GO:0016442,0.9983507061192856,0.008147399364807031,2,484,RISC complex,CC
GO:0031332,0.9983507061192856,0.008147399364807031,2,484,RNAi effector complex,CC
GO:0038023,0.9995016496642659,8.276231170745404e-4,44,1446,signaling receptor activity,MF
GO:0007600,0.9997513713945022,4.946065887128109e-4,24,952,sensory perception,BP
GO:0004888,0.9998700103473929,2.4079391108468076e-4,34,1240,transmembrane signaling receptor activity,MF
GO:0051606,0.999970868711152,8.119888284830132e-5,12,667,detection of stimulus,BP
GO:0007606,0.9999820200390528,6.549309666927579e-5,7,503,sensory perception of chemical stimulus,BP
GO:0007608,0.999985841150669,6.222525901840295e-5,5,431,sensory perception of smell,BP
GO:0050906,0.9999967233971487,1.410876274339108e-5,6,508,detection of stimulus involved in sensory perception,BP
GO:0009593,0.9999997474286604,1.5625113769528117e-6,4,488,detection of chemical stimulus,BP
GO:0004930,0.999999885744892,3.821523558211755e-7,13,840,G protein-coupled receptor activity,MF
GO:0050907,0.9999999885761166,1.3206153858502639e-7,2,454,detection of chemical stimulus involved in sensory perception,BP
GO:0004984,0.9999999947666867,1.0823934609376717e-7,1,404,olfactory receptor activity,MF
GO:0050911,0.9999999947666867,1.0823934609376717e-7,1,404,detection of chemical stimulus involved in sensory perception of smell,BP
GO:0005549,1,0.012411626643357572,0,94,odorant binding,MF
GO:0005801,1,0.043219780639034124,0,67,cis-Golgi network,CC
GO:0055013,1,0.025016727241831106,0,85,cardiac muscle cell development,BP
GO:0098982,1,0.030820736460161643,0,71,GABA-ergic synapse,CC
GO:1903231,1,0.029591484282285245,0,222,mRNA binding involved in posttranscriptional gene silencing,MF
